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Abstract
Maternal infection during the first or second trimester of pregnancy poses a risk factor for
the child to have neurodevelopmental disorders like autism spectrum disorder (ASD) and
schizophrenia. Various clinical and preclinical studies have shown that the maternal
immune response to infection, also known as maternal immune activation (MIA), can
disrupt fetal brain development.
Over the past two decades, MIA has been studied in rodents using the Polyinosinic
Polycytidylic acid (Poly I:C) rodent model. Poly I:C has a molecular pattern resembling
viruses that can induce a robust immune response. Following exposure to Poly I:C MIA,
rodent offspring exhibit many brain and behavioural symptoms related to ASD and
schizophrenia.
Despite the well-established validity of the Poly I:C model, there are knowledge gaps that
require further investigation to obtain a comprehensive understanding of the effects of MIA
on brain development. Firstly, few studies have directly compared the effects of
administering Poly I:C MIA at different times during gestation. Secondly, the role of many
molecular and cellular components of the maternal immune response to Poly I:C remain
unknown. Thirdly, few studies have attempted to study how Poly I:C MIA interacts with
other neurodevelopmental risk factors such as genetic mutations.
In this thesis, my work shows that Poly I:C MIA is more detrimental in early gestation
compared to late gestation with regards to altering offspring sensory processing phenotypes
measured through the acoustic startle response. Using a genetic knockout model, my
experiments also showed that Interleukin (IL)-15, a cytokine that is involved in the antiviral
immune response, modulates the effects of early gestation Poly I:C MIA. Lastly, I found
that Poly I:C MIA interacts with a genetic deficiency in the ASD risk gene CNTNAP2 to
exacerbate sensory processing disruptions in the offspring.
Together, the findings from this thesis provide a detailed assessment of sensory processing
in the Poly I:C MIA model and offer insight into its potential underlying mechanisms.
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Summary for Lay Audience
The human brain is a complex organ that develops over decades, from its time in the womb
until early adulthood. During pregnancy, many highly specific foundational processes must
take place to transform the fetal brain from a tiny ball of cells to a complex organ with a
variety of structures and functions.
Throughout its elaborate journey, the fetal brain is susceptible to bumps in the road, often
related to the maternal environment. Some of these bumps are widely known and include
smoking and alcohol consumption during pregnancy. Others like maternal infection during
pregnancy are known but not well understood.
Human studies have shown that maternal infection during pregnancy increases a child’s
risk to later develop autism spectrum disorder or schizophrenia. This risk is highest if the
infection is severe and occurs in the first half of pregnancy. Moreover, the risk exists
regardless of infection type. Be it a bacterial infection like salmonella or a viral infection
like COVID-19, all infections activate the maternal immune response, which is thought to
be the culprit.
Research in animal models has supported the maternal immune activation (MIA)
hypothesis. We know that MIA during pregnancy in rodents can alter the structure of the
offspring’s brain as well as their behaviour. However, there are still many unknowns, some
of which were the focus of my thesis. First, it is still unclear how MIA at different times
during pregnancy impacts the brain differently. In addition, the maternal immune response
has many molecular components, but the role of many of them remains unknown. Finally,
it is unclear if other risk factors like genetic mutations can increase the susceptibility to
MIA and worsen symptoms related to autism or schizophrenia.
My thesis investigates these 3 questions in greater detail in a rat model. My findings
support the conclusion that earlier MIA leads to worse outcomes. Additionally, the results
identify Interleukin-15 as a molecule that could mediate some of MIA’s effects and suggest
that those with a genetic mutation related to autism may be more susceptible to the effects
of MIA during pregnancy.
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1

General Introduction

Versions of sections 1.1 and 1.2 of Chapter 1 and Appendices A & B are published in
Haddad, F.L., Patel, S.V., Schmid, S., 2020b. Maternal Immune Activation by Poly I:C as
a preclinical Model for Neurodevelopmental Disorders: A focus on Autism and
Schizophrenia.

Neuroscience

&

Biobehavioral

Reviews

113,

546–567.

https://doi.org/10.1016/j.neubiorev.2020.04.012

1.1
Maternal
disorders

infection

and

neurodevelopmental

Prenatal brain development is an elaborate process during which any external
environmental influence can be severely detrimental to the individual. This is exemplified
in the severe effects caused by fetal exposure to alcohol, nicotine and psychoactive drugs
(Ross et al., 2015). The human brain is particularly susceptible during this pregnancy as it
undergoes an enormous degree of prenatal development, with vital processes such as
neurogenesis, neural migration, and basic connections being, in large part, complete by
birth (translatingtime. org; Workman et al., 2013). It is therefore unsurprising that even
slight environmental insults during these extensive developmental processes can lead to
long-lasting structural and functional alterations in the offspring.
Over the last two decades, numerous studies have shown that maternal infection is an
environmental insult that can disrupt prenatal brain development. The harmful effects of
maternal infection during pregnancy are exemplified by the recent Zika outbreak and its
association with microcephaly in offspring born to infected mothers (de Oliveira and da
Costa Vasconcelos, 2016; Klase et al., 2016).
Interest in maternal infection was ignited by epidemiological studies linking seasonal births
or influenza epidemics with an increased incidence of psychiatric disorders (reviewed by
Brown and Derkits, 2010). Follow-up studies unraveled the relationship between a wide
variety of different infections occurring during early pregnancy and the risk of psychiatric
disorders in the offspring - particularly those with a neurodevelopmental component. Some
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of these studies went as far as to correlate specific maternal serological immune markers
with the risk increase (Abdallah et al., 2013; Brown et al., 2004b; Goines et al., 2011).
Disorders most commonly associated with maternal infection are autism spectrum disorder
(ASD) and schizophrenia (SCZ), although direct and indirect associations with other
disorders do exist (Knuesel et al., 2014). Given that the majority of ASD and SCZ cases
are idiopathic and that only a small subset of known cases can be attributed to monogenic
causes (Geschwind, 2008; Henriksen et al., 2017), the association of a common
environmental factor like maternal infection has implications for understanding the
etiology of these complex disorders. In addition, environmental factors are particularly
important to consider in disorders such as ASD and SCZ, which cannot be solely attributed
to severe genetic mutations. Alternatively, it is thought that most cases arise from slightly
variation in risk genes that is compounded by environmental risk factors to lead to the
disorder. (Insel, 2010; Varghese et al., 2017).
The neurodevelopmental impact of maternal infection during pregnancy poses questions
on the long-term consequences of the COVID-19 pandemic as many mothers around the
world experience COVID-19 infection during pregnancy, potentially making their children
susceptible to neurodevelopmental disorders. So far, limited evidence suggests that
COVID-19 may be linked to preterm birth, a nonspecific negative outcome linked to a
large number of developmental disorders (Ryan et al., 2020). It may take several years or
even decades before associations between maternal COVID-19 infections and disorders
like ASD or SCZ can be fully investigated.
Broadly, effects of maternal infection on the fetal brain can be attributed to two main
culprits: The infectious agent or the maternal immune response that develops against it.
While pathogen-specific effects exist such as in the case of the Zika virus, evidence from
epidemiological studies seems to implicate the maternal immune response in the increased
offspring risk of developing ASD and SCZ (Brown and Derkits, 2010).
Different infections in pregnant mothers whether they were viral or bacterial, have been
associated with increased offspring risk of both ASD and SCZ. This indicates a common
underlying mechanism that is independent of infection type, and the maternal immune
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response rose to prominence as common factor across different infections. This hypothesis
was supported by associations of specific immune markers related to both viral and
bacterial infections with the degree of risk(Abdallah et al., 2013; Brown et al., 2004b;
Goines et al., 2011). Therefore, the maternal immune response emerged as a likely culprit
through which different types of infection can increase the risk of ASD and SCZ.
This evidence served as the basis for maternal immune activation (MIA) preclinical
models, which set out to decipher the effects of the maternal immune response on brain
development and the resulting functional and behavioural changes in the offspring. MIA
models utilize pathogen-associated molecular markers to elicit an acute pathogen-free
immune response during gestation. Commonly, the bacterial cell-wall component
lipopolysaccharide (LPS) or the synthetic double stranded RNA (dsRNA) analogue
polyinosinic polycytidylic acid (Poly I:C) are used to elicit bacterial-like or viral-like innate
immune responses, respectively (Solek et al., 2018).
Over the past 15 years, Poly I:C models have been frequently used as a preclinical model
to study ASD and SCZ-related changes in neuronal circuits and behavioural outcomes in
rodents (Boksa, 2010; Knuesel et al., 2014; Meyer et al., 2011; Reisinger et al., 2015; Scola
and Duong, 2017; Solek et al., 2018) and to a lesser extent in nonhuman primates (Bauman
et al., 2014; Machado et al., 2015; Rose et al., 2017; Weir et al., 2015). The Poly I:C MIA
model has shown substantial face, construct, and predictive validity, as demonstrated in a
large body of literature.
In Sections 1.1 and 1.2, I first revisit some epidemiological evidence that provides the basis
for the Poly I:C model, focusing on viral infections and their associations with psychiatric
disorders in the offspring. Next, I introduce Poly I:C and some methodological
considerations that are pertinent to the field. I then group and summarize results from Poly
I:C MIA studies as they relate to brain and behavioural changes in ASD and SCZ. The
latter portion of section 1.2 focuses on the relationship between Poly I:C MIA and
important aspects of ASD and SCZ such as age and sex-specific findings. Finally, Section
1.3 outlines the aims of the thesis and introduces the goals of each experimental chapter.
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1.1.1

Epidemiological evidence overview

Initial epidemiological studies that investigated the effects of infection exposure during
pregnancy were published with a focus on the 1957 Influenza pandemic (Barr et al., 1990;
Mednick et al., 1988; see Appendix A for a chronological summary of the epidemiological
studies discussed in this section). In the period between 2000 and 2010, studies began to
focus on other exposures such as general occurrence of infection (Sørensen et al., 2009),
infections affecting different organ systems (Babulas et al., 2006; Byrne et al., 2007) or
specific exposures to Toxoplasma gondii (Brown et al., 2005), Cytomegalovirus (CMV;
commonly reported as neonatal rather than prenatal exposure; Blomström et al., 2012),
Herpes Simplex Viruses (HSV) 1 & 2 (Buka et al., 2001) and Rubella (Brown et al., 2001).
Additionally, these new studies took a new approach by measuring exposure through the
presence of pathogen-specific antibodies, instead of simply inspecting hospital records or
maternally reported data.
Typically, these were case-control studies that identify patients based on the International
Classification of Diseases (ICD) or Diagnostic and Statistical Manual of Mental Disorders
(DSM) and retrospectively examine exposure data. With the rise of the MIA hypothesis,
exposure measures became more specific to maternal inflammatory markers with the most
common ones measured being Interleukin (IL)-6 (Abdallah et al., 2013; Allswede et al.,
2016; Brown et al., 2004b; Goines et al., 2011; Goldstein et al., 2014; Jones et al., 2017;
Mac Giollabhui et al., 2019), C Reactive Protein (Brown et al., 2014; Canetta et al., 2014;
Koks et al., 2016; Zerbo et al., 2016) and Tumor Necrosis Factor (Abdallah et al., 2013;
Allswede et al., 2016; Brown et al., 2004b; Goldstein et al., 2014; Jones et al., 2017; Mac
Giollabhui et al., 2019).
In general, many different pathogen exposures were associated with SCZ/ASD, as can be
seen in supplementary Appendix A., supporting the MIA hypothesis that immune
activation rather than specific pathogens are involved in disrupting neurodevelopment. The
association of maternal infection and MIA with SCZ was established by the early waves
of epidemiological studies, while evidence for the associations with ASD only recently
began to accumulate. In addition, some studies have associated maternal exposures with
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specific SCZ or ASD-related behavioural outcomes, rather than simply a diagnosis of the
disorders (Brown et al., 2009; Koks et al., 2016; Mazina et al., 2015; Slawinski et al., 2018).

1.1.1.1

Timing, Type and extent of infection, interaction with other
risk factors

Numerous SCZ studies and a few ASD studies have shown that the risk due to maternal
infection is higher if infection occurs in the first or second trimester. (Appendix A.;
Atladóttir et al., 2010; Barr et al., 1990; Brown et al., 2004; Hornig et al., 2018; Izumoto
et al., 1999; Limosin et al., 2003; Mednick et al., 1988; Sham et al., 1992; Suvisaari et al.,
1999; Takei et al., 1996, 1994). In addition, more severe infection is associated with
increased risk, and this is typically measured as the number of hospital visits, the number
of infections or number and extent of febrile episodes (Atladóttir et al., 2012; Fang et al.,
2015; Hornig et al., 2018; Zerbo et al., 2015; Appendix A.).
On a similar note, the extent of molecular changes associated with infection also seems to
play a role in determining the risk for development of SCZ or ASD in the offspring, and
this has typically been measured as the level of pathogen-specific antibodies (Brown et al.,
2005; Mortensen et al., 2007; Spann et al., 2017), cytokines (Allswede et al., 2016) or CReactive Protein (CRP; (Brown et al., 2014; Koks et al., 2016). In the study by Brown et
al. (2014), there was a 43% increase in SCZ risk when comparing the group with upper
quartile CRP levels against the group with the lower quartile CRP levels.
Beyond the infection itself, interaction with other risk factors, genetic or environmental,
can have a synergistic effect with maternal infection (Appendix A.). In context of gene
mutations or single nucleotide polymorphisms (SNPs), it seems that this effect is unique to
certain genes and certain SNPs within those genes, with examples given in the study by
Demontis et al. (2011) who focused on genes associated with NMDA receptors.
Alternatively, exposure to maternal infection has been reported to increase the risk of SCZ
only in cases with family history of psychiatric disorders (Børglum et al., 2014; Clarke et
al., 2009) or experiences of peripubertal trauma (Debost et al., 2017).
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1.1.1.2

Limitations of epidemiological study samples

Despite their strengths, the epidemiological studies linking maternal infection with
neurodevelopmental disorders like ASD and SCZ have some limitations that can influence
the interpretation of their results.
For starters, certain populations have been overrepresented in the epidemiological literature
that were summarized in Appendix A., as can be seen in column 1. Notably, most of these
studies have been performed in select European countries (Denmark, Finland and Sweden)
or in the United States. For studies performed in the United States, the Child Health and
Development Study (CHDS) and the closely related Prenatal Determinants of
Schizophrenia Study (PDS) have been utilized several times. While databases such as
CHDS, PDS and the Danish National Birth Cohort are excellent sources of information,
they represent geographically distinct populations that may be associated with specific
genetic or environmental factors that can modulate susceptibility to the effects of maternal
infection. For example, maternal diet is one factor that can modulate resilience or
susceptibility to MIA (Meyer, 2019) and can vary greatly by region. Appendix A. also
shows that most samples are temporally restricted to the mid to late 20th century, although
more recent studies have included subjects born from 2000 onwards. On one hand, this
restriction is necessary for exposures such as the 1957 Influenza pandemic and given the
time it takes for patients to be diagnosed with ASD or SCZ. However, commonly used
databases such as CHDS and PDS only followed births occurring between 1959 and 1966.
Since 1966, environmental risk factors such as diet or healthcare, even within the same
population where these studies were originally conducted, could have changed
substantially.
Another feature of epidemiological studies that needs to be highlighted is diagnosis.
Although I did not include this information in the table (see Khandaker et al., 2013 for
example), the referenced studies have either used the International Classification of
Diseases (ICD) or the Diagnostic and Statistical Manual for Mental Disorders (DSM) for
classifying the subjects’ diagnosis of ASD or SCZ, with exact versions of ICD or DSM
depending on when the study was conducted. The ICD and DSM share many similarities
in the diagnosis of ASD and SCZ, but differences in diagnostic criteria exist across the two
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manuals and between different versions of the same manual, which may be of importance
when considering older epidemiological literature (Biedermann and Fleischhacker, 2016;
Doernberg and Hollander, 2016). Studies where associations with maternal infection were
dependent on the precise diagnosis were marked by “X” in Appendix A..
Future epidemiological studies can be designed with some of these considerations in mind.
More prospective studies that follow the most recent diagnostic criteria and that are
conducted at multiple sites, states, or countries are needed to better understand the
association between maternal infection and offspring risk for neurodevelopmental
disorders.

1.1.1.3

Lack of evidence for pathogen-specificity

The MIA hypothesis is supported by associations of ASD and SCZ diagnosis with
multiple types of prenatal infections, as well as with immune markers common to a
variety of infections. However, there is still evidence for pathogen and cytokine
specificity (Appendix A.). For example, although Buka et al. (2001) and Mahic et al.
(2017) investigated a variety of prenatal infections for association with SCZ and ASD
risk, respectively, both studies only found a significant association for HSV-2, but there
was no association for HSV-1, CMV or rubella.
Similarly, but in context of cytokines, Brown et al. (2004a, 2004b) found an association
between second trimester IL-8, but not IL-6 or TNFα, with offspring SCZ. These data
highlight the importance of considering different kinds of immune reactions, which may
produce cytokine profiles that favor some cytokines over others (Takeda and Akira,
2005). Most MIA animal models have used either Poly I:C or LPS as immune stimulants,
and very few have investigated the effects of other immune stimulants (Solek et al.,
2018).

1.1.1.4
From

a

Translation of brain development across species.
translational

perspective,

it

is

essential

to

compare

and

contrast

neurodevelopmental timelines between humans and rodents (mice and rats), the species
most commonly used as preclinical models in Poly I:C MIA. Furthermore, developmental
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timeline variations between rats and mice must be considered when analyzing and
comparing results from MIA literature. MIA models administer a controlled level of
immune challenge at a specific time point during gestation. Precise control of the level of
immune challenge is one of the main reasons why MIA models were preferred as a model
system instead of infection models (Cunningham et al., 2007; Meyer et al., 2009). The time
point of MIA during gestation is critical since developmental processes occurring at or
shortly after the time of MIA administration will be most impacted.

1.1.1.4.1

Human-rodent neurodevelopmental comparison

Epidemiological studies show the strongest offspring risk for neurodevelopmental
disorders with first and second trimester maternal infections. Therefore, in most Poly I:C
MIA studies the immune challenge is administered at the rough developmental equivalent
in rodents, a period from gestation day (GD) 9.5 to GD18.5, out of a total gestation length
of 20-22 days. Developmental differences, however, cannot be easily generalized across
all organ systems or even within one organ such as the brain.
Based on the multi-species translational model developed by Workman et al (2013), I have
classified brain developmental events and constructed a figure that roughly summarizes
these processes in rats, mice and humans (Figure 1-1). As shown by the figure, prenatal
and postnatal development differ widely between rodents and humans. For example, while
cerebral neurogenesis and cortical layering are almost complete before birth in humans, it
continues postnatally in both rats and mice. Additionally, the onset of rapid synaptogenesis
occurs prenatally in humans but postnatally in both rats and mice, which means MIA
experiments are inherently unable to model developmental disruptions in this type of
process. Postnatal immune activation has been attempted in rodents for these later
developmental events (Baghel et al., 2018; Custódio et al., 2018; Majidi et al., 2016), but
this lacks the maternal-fetal interface which plays a large role in modulating the extent of
immune signaling that reaches the fetal brain (Hsiao and Patterson, 2012).
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Figure 1-1 Developmental timeline comparison between humans, rats and mice
adapted from the multi-species model by Workman et al., 2013
(translatingtime.org). Time of birth is marked by the end of the shaded gestation
period.
Linking MIA’s effects to distinct developmental processes in rodents is difficult, especially
given the large number of simultaneously developing structures during early gestation
(Figure 1-1). Historically, studies have tended to base their Poly I:C MIA timing on
epidemiological associations and translation of those timings into rodents, rather than
targeting specific prenatal developmental processes. In other words Poly I:C studies
typically induce MIA at the rodent equivalent of the human first trimester, as opposed to
inducing MIA at the time when specific brain regions or neurotransmitter systems are
developing.

1.1.2

Poly I:C: A viral immune stimulant

Poly I:C is a synthetic analog of double-stranded RNA (dsRNA) composed of homopolymers of inosine and cytidine nucleotides. The dsRNA molecular pattern is commonly
found in viral replication cycles, particularly of dsRNA viruses, single stranded RNA
viruses and double stranded DNA viruses (Lester and Li, 2014; Weber et al., 2006).
Mammalian immune systems have evolved to detect dsRNA through the innate immune
receptor Toll-like-Receptor 3 (TLR3). Binding of Poly I:C to TLR3 elicits proinflammatory downstream signaling with ensuing activation of the nuclear factor kappalight-chain-enhancer of activated B cells (NF-κB) and Interferon (IFN) Regulatory Factor
(IRF3) pathways (Takeda and Akira, 2005).
Ultimately, these signaling cascades result in the expression of pro-inflammatory cytokines
that travel within the tissue or through the bloodstream and trigger cellular and molecular
changes in a variety of different cell types including neurons and glia (Deverman and
Patterson, 2009). As the dsRNA molecular pattern is produced in the replication of
different viruses, TLR3 can be involved in immune responsivity to viruses most commonly
implicating maternal infection with offspring ASD or SCZ, which include influenza
(ssRNA), HSV (dsDNA), CMV (dsDNA) and Rubella (ssRNA; Table S1).
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Different TLRs employ different downstream signaling to exert their effects. For example,
type-I interferons are induced by TLR3 and TLR4 activation, but not by TLR2 and TLR5
activation (Takeda and Akira, 2005). Therefore, TLR3 activation is not reflective of the
same innate immune response elicited by all infectious agents that have shown
epidemiological associations. In the context of viral infections, TLR3 binds dsRNA and
activates both NF-κB and IRF3 pathways, whereas TLR7 and TLR8 bind ssRNA and only
activate the NF-κB pathway(Kawai and Akira, 2011; Lester and Li, 2014).
Beyond the mere activation of TLRs and associated downstream signaling, the expression
pattern of these TLRs in different tissues may also play a role in their impact on fetal
neurodevelopment. For example, placental expression of TLR3 is one of the highest
amongst all human tissue types, unlike TLR4 and TLR7 which are highly expressed in the
spleen (Nishimura and Naito, 2005; Zarember and Godowski, 2002). This places TLR3 in
closer proximity to the maternal-fetal interface and suggests that the effects of activating
different TLRs may produce phenotypes driven by different underlying mechanisms.
Indeed, a recent study by Missig et al. (2019) has shed light on differential TLR activation
in the context of MIA, showing that MIA using the TLR7 agonist imiquimod may produce
profoundly different effects on the offspring compared to Poly I:C MIA.
In rodents, the immune response elicited by Poly I:C is acute, with elevated individual
cytokine levels following a specific time course for up to 48 hours after injection
(Cunningham et al., 2007; Fortier et al., 2004; Meyer et al., 2009). Specific cytokines
within this response such as IL-6, IL-1β, and TNFα are considered crucial for the effects
of Poly I:C MIA. Studies have shown that administering these cytokines alone may be
sufficient in reproducing some of Poly I:C MIA’s effects in the offspring (Garbett et al.,
2012; Smith et al., 2007), and that Poly I:C MIA effects can be blocked by antagonizing
these cytokines during, or prior to, Poly I:C administration (Lammert et al., 2018; Lipina
et al., 2013; Pineda et al., 2013; Smith et al., 2007).
Despite the large number of preclinical studies that have utilized the Poly I:C MIA model
to investigate neurodevelopmental disorders, interpretation is not straightforward due to
the variability in MIA parameters and experimental conditions between studies, which has
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been previously brought to light (Meyer et al., 2009) and has received recent attention
(Careaga et al., 2018; Mueller et al., 2018).

1.1.2.1

Injection timing and frequency in Poly I:C literature

As mentioned above, Poly I:C is usually administered as early as GD9.5 and as late as
GD18.5. In most studies, a single Poly I:C or vehicle injection was performed at a single
time-point in all dams. In a few studies, a single Poly I:C injection was administered, but
at different days in separate cohorts, which allows for within-study comparison of the
effects of Poly I:C timing. This is a more reliable way of uncovering the effects of Poly I:C
MIA timing in contrast to between-study comparisons, as more variables such as housing,
animal care and Poly I:C batch are accounted for.
Additionally, in some studies, Poly I:C MIA injections were performed at multiple days
throughout gestation in the same cohort. Using multiple injections makes it difficult to
associate offspring effects to any one specific developmental event and do not necessarily
recapitulate the time course of the majority of human infections which usually last for a
short time period relative to the length of the pregnancy. However, they may still provide
insight into underlying MIA mechanisms or the extreme effects of chronic inflammatory
conditions on fetal brain development.

1.1.2.2

Poly I:C experimental variables

Results from Poly I:C MIA experiments have, at times, proven difficult to replicate when
MIA is performed at the same gestational timing. An example of this variability can be
seen in later sections of this Chapter but is more specifically highlighted elsewhere in
relation to microglia phenotypes (Smolders et al., 2018). Experimental variables that
influence the outcome of Poly I:C MIA experiments, such as route of administration, dose
and length of the Poly I:C nucleotide chain are crucial in determining the extent of the
immune response elicited by the animals. Offspring variables such as age, sex also play a
role in determining the phenotype elicited by Poly I:C MIA. These variables have been
discussed in detail elsewhere (Careaga et al., 2018; Kentner et al., 2019; Meyer et al., 2009;
Mueller et al., 2019).
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1.1.2.3

Poly I:C exposure categories:

In an attempt to group and summarize the results of Poly I:C literature, Poly I:C studies
were divided based on Poly I:C exposure timing categories. Each category contains studies
with similar Poly I:C injection timing, dose, routes of administration and model species
used. Injection timing and the extent of the maternal immune response are critical, as each
exposure category essentially represents a different model targeting distinct developmental
processes to different extents. Much of the Poly I:C literature has tended to follow initial
findings by Meyer et al. (2006) and Zuckerman et al. (2003) who used mouse MIA at
GD9.5 and 17.5, and rat Poly I:C models at GD14.5. Both of these initial findings were
discovered following Poly I:C MIA injected intravenously at a dose of 4-5mg/kg. Based
on the promise and high face validity shown by those early studies, the rest of the field
followed suit, with about two thirds of the studies in the literature sharing highly similar
Poly I:C dose, route of administration, and model species. Later on, a new mouse model
with intraperitoneal 20mg/kg Poly I:C injections at GD12.5 was introduced with new
insights into MIA phenotypes and mechanisms (Smith et al., 2007).

1.1.2.4

Offspring variables: Age, sex and strain

Besides maternal environment and immune responsiveness, offspring variables such as age
of testing, sex of the offspring, and animal strain used can also influence results and have
implications for the model’s validity, particularly in modeling ASD and SCZ. These two
disorders manifest differently throughout age, and they both seem to preferentially affect
males (Mendrek and Mancini-Marïe, 2016; Werling and Geschwind, 2013). Additionally,
different rat and mouse strains exhibit varying degrees of specific postnatal behaviours
such as exploration or sociability (Moy et al., 2007). Recently, a study conducted by Kim
et al. (2017) showed that mice obtained from different suppliers can respond extremely
differently to Poly I:C MIA, and this was attributed to differences in their gut microbiome.
These differences may mask or exacerbate the effects of prenatal Poly I:C. Later sections
will also discuss age and sex-specific effects more closely.
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1.2
Relevance of Poly I:C MIA findings to
neurodevelopmental disorders: A Focus on ASD and
SCZ:
No single preclinical model is expected to replicate the entire spectrum of ASD and SCZrelated dysfunction, but certain animal models (in this case, offspring exposed to different
MIA timings) may be more suitable than others for studying specific changes in neural
circuitry that reflects aspects of these complex disorders. In this section, I highlight a few
phenotypes which are relevant to ASD and SCZ and identify Poly I:C exposure categories
which show relevant deficits.

1.2.1

Relevance to Schizophrenia

Schizophrenia as described by the DSM V is characterized by recurrent presentation of
behavioural symptoms categorized as positive, negative, or cognitive. Positive symptoms
include hallucinations, delusions, disorganized speech, and disorganized behaviour.
Negative symptoms include diminished emotional expression, avolition, and blunted
affect. Cognitive symptoms include deficits in executive function and working memory
and may be present in the prodromal phase prior to the onset of positive symptoms. It is
thought that disruptions in both dopaminergic and glutamatergic circuitry in the brain
underlies the behavioural symptoms seen in schizophrenia (Howes et al., 2015).
Glutamatergic and dopaminergic functions both influence the dorsolateral prefrontal
cortex, which is often linked with the behavioural symptoms of Schizophrenia.

1.2.1.1

Dopaminergic hyperactivity

SCZ is often characterized by dopaminergic hyperactivity, which is seen through increased
dopamine production (Howes et al., 2013) and increased expression of dopamine receptors
in SCZ patients (Kaalund et al., 2014; Seeman et al., 1993). This is also supported by the
efficacy of typical antipsychotics. These antispsychotics antagonize dopaminergic activity
and ameliorate positive symptoms of SCZ which include hallucinations, delusions and
disorganized thought (Kahn et al., 2015). Dopaminergic hyperactivity is commonly tested
in Poly I:C offspring by measuring the response to amphetamine, a dopaminergic agonist.
Poly I:C offspring of GD9.5 and GD17.5 mouse MIA, as well as GD14.5 rat MIA, have
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shown an increased locomotor response to amphetamine, indicative of dopaminergic
hyperactivity. This is supported by molecular changes in offspring of GD9.5 MIA and to a
lesser extent in GD14.5 and GD17.5 MIA, with region-specific alterations in dopaminergic
molecular markers such as dopamine metabolite levels, tyrosine hydroxylase and
dopamine 1 receptor (Bitanihirwe et al., 2010a, Bitanihirwe et al., 2010b; Luchicchi et al.,
2016; Meyer et al., 2008b; Vuillermot et al., 2012, 2010; Winter et al., 2009).

1.2.1.2

Ventricular enlargement, cortical thinning

Brains of individuals with SCZ tend to show ventricular enlargement and gray matter loss
(Haijma et al., 2013), measures which have received attention mostly in GD9.5 and
GD14.5 MIA offspring (Abazyan et al., 2010; Crum et al., 2017; da Silveira et al., 2017;
Piontkewitz et al., 2011a, Piontkewitz et al., 2011b; Richetto et al., 2017a). Overall, these
MIA studies show that total brain volume are not altered (Crum et al., 2017; Richetto et
al., 2017a). However, Poly I:C offspring exhibit region-specific decreases in gray matter,
as well as increases in lateral ventricular volume (Abazyan et al., 2010; Piontkewitz et al.,
2011a, Piontkewitz et al., 2011b). In support of this notion and more directly implicating
maternal inflammation, a study by Ellman et al. (2010) found that maternal IL-8 during
pregnancy was correlated with increased ventricular volume and decreased entorhinal
cortex volume in adults with Schizophrenia Spectrum Disorder.

1.2.2

Relevance to Autism Spectrum Disorder

ASD as described by the DSM 5 is characterized by changes in social communication and
repetitive and restricted patterns of behaviour (American Psychiatric Association and
American Psychiatric Association, 2013). Social communication deficits include lack of
social-emotional reciprocity, impaired nonverbal communication and difficulty
maintaining relationships. The restricted patterns of behaviour include stereotyped
movements, insistence on sameness, as well as hyper/hyporeactivity to sensory input. The
precise brain mechanisms associated with ASD are still not well understood, although the
prefrontal cortex is often cited as an important brain region where a variety of structural
and functional changes may be linked to ASD phenotypes (Varghese et al., 2017).
Furthermore, disruption in sensory processing is emerging as an important factor that may
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influence higher order cognitive and social function, and this disruption can occur across
multiple modalities including sound and touch.

1.2.2.1

Social and repetitive behaviours

In Poly I:C rodent offspring, preference for social contact is consistently impaired across
all exposure categories (da Silveira et al., 2017; Hsiao et al., 2013, 2012; Hui et al., 2018;
Kim et al., 2018, 2017; Konefal and Stellwagen, 2017; Labouesse et al., 2015a, Labouesse
et al., 2015b; Lipina et al., 2013; Mattei et al., 2017; Mueller et al., 2018; Naviaux et al.,
2013; O’Leary et al., 2014; Osborne et al., 2017; Pendyala et al., 2017; Richetto et al.,
2017a, Richetto et al., 2017b; Schwartzer et al., 2013; Shi et al., 2003; Vuillermot et al.,
2017; Weiser et al., 2016). However, the strongest and most consistent evidence exists for
GD9.5 and GD12.5 MIA offspring. Offspring ultrasonic vocalizations in the first two
weeks of life, which communicate emotional state and promote maternal care (Simola,
2015),are impaired following GD12.5 mouse and to a lesser extent GD14.5 rat Poly I:C
MIA (Chou et al., 2015; Hsiao et al., 2013; Kim et al., 2017; Morais et al., 2018; Pendyala
et al., 2017; Schwartzer et al., 2013; Weiser et al., 2016; Yee et al., 2012). Marble burying
is a staple behavioural paradigm used to measure repetitive behaviour in mice and results
follow a very similar trend to the previous two phenotypes, that is, there are many reports
of increased marble burying in GD12.5 mouse offspring and very few studies investigating
this phenotype in other Poly I:C exposure time points (Hsiao et al., 2013, 2012; Hui et al.,
2018; Kim et al., 2017; Morais et al., 2018; Pendyala et al., 2017; Schwartzer et al., 2013;
Vuillermot et al., 2017; Wu et al., 2015; Xuan and Hampson, 2014). Therefore, it is
important to not entirely rule out the existence of changes in repetitive behaviour and
ultrasonic vocalization in later Poly I:C exposures until further investigation.

1.2.3
1.2.3.1

Relevance to both Schizophrenia and Autism Spectrum
Disorder
Sensorimotor gating

Prepulse inhibition (PPI) of the acoustic startle response is a staple operational measure of
sensorimotor gating, the ability of an organism to pre-attentively filter out redundant
sensory information. Decreased PPI is a hallmark of SCZ but has also been reported in
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ASD (Sinclair et al., 2017; Swerdlow et al., 2008). Poly I:C offspring from all the different
exposure categories exhibit reductions in PPI, but the evidence is least consistent for
GD17.5 mouse offspring (De Miranda et al., 2010; Giovanoli et al., 2016a; GonzalezLiencres et al., 2016; Hadar et al., 2017; Hsiao et al., 2013; Hui et al., 2018; Klein et al.,
2013; Li et al., 2009; Mattei et al., 2014; Meyer et al., 2010b; Richetto et al., 2017b; Song
et al., 2011; Vuillermot et al., 2012; Weber-Stadlbauer et al., 2017; Wu et al., 2015). A
broad PPI impairment across all exposure categories is perplexing but can be explained by
the variety of structures that can have top-down modulatory effects on the PPI pathway
(Bosch and Schmid, 2008, 2006; Fendt et al., 2001; Swerdlow et al., 2008). Therefore,
while PPI is a valuable measure, conclusions about underlying mechanisms are limited
without further investigation of PPI circuitry within Poly I:C models.

1.2.3.2

Changes in cognitive function and excitation-inhibition
imbalance

Changes in cognitive function are common to both ASD and SCZ, and it is thought that
excitation-inhibition imbalance may underlie cognitive changes in both disorders (Gao and
Penzes, 2015). Evidence from Poly I:C studies suggests that later MIA (GD14.5 and
GD17.5) has a bigger impact on cognitive function compared to earlier Poly I:C exposures
and this phenotype is seen across a variety of behavioural tests including novel object
recognition, Y-maze alternation and reversal learning (Connor et al., 2012, 2012; Gray et
al., 2019; Krstic et al., 2012; Lins et al., 2018; Mattei et al., 2017; Meehan et al., 2017;
Meyer, 2006; Meyer et al., 2008b, Meyer et al., 2010a, Meyer et al., 2010b; Mueller et al.,
2018; Murray et al., 2017; Osborne et al., 2017; Piontkewitz et al., 2011b; Richetto et al.,
2017a, Richetto et al., 2017b, 2014, 2013; Vernon et al., 2015; Vuillermot et al., 2012;
Wallace et al., 2014; Wolff et al., 2011; Zhang and van Praag, 2015). Moreover, numerous
Poly I:C studies have found molecular excitation-inhibition changes, particularly in
GABAergic and glutamatergic neurotransmission. Findings include increased NMDAR
binding following GD9.5 rat MIA (Rahman et al., 2017), and decreased GABA
neurotransmitter levels as well as various GABAergic markers (GAD65, 67, PV and
vGAT) following late MIA (Bitanihirwe et al., 2010a, Bitanihirwe et al., 2010b; Cassella
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et al., 2016; Dickerson et al., 2014; Luoni et al., 2017; Meyer et al., 2008b; Piontkewitz et
al., 2011a; Richetto et al., 2014, 2013; Zhang and van Praag, 2015).

1.2.3.3

Immune dysregulation

Immune dysregulation, most commonly a shift towards an inflammatory state, is associated
with ASD and SCZ and also consistently reported in Poly I:C offspring across different
Poly I:C exposures, with measures including microglia, brain cytokines and TLR signaling
(Duchatel et al., 2018a, Duchatel et al., 2018b; Garay et al., 2013; Giovanoli et al., 2016b;
Hadar et al., 2017; Hui et al., 2018; Juckel et al., 2011; Krstic et al., 2012; MacDowell et
al., 2017; Mattei et al., 2014, Mattei et al., 2017; Meyer et al., 2008a; Murray et al., 2019;
Paylor et al., 2016; Pratt et al., 2013; ; Van den Eynde et al., 2014; Willi et al., 2013).
Overall, Poly I:C MIA shows very strong relevance to both ASD and SCZ, although the
cumulative evidence shows that different aspects of these disorders are best translated by
different gestational exposures. For example, ASD-related communication and stereotypic
behaviours may be best studied with earlier immune activation, whereas cognitive
impairments and inflammatory dysregulation are best investigated by later gestational
exposures (see Section 1.1.2.1).

1.2.4

Correlation with the extent of maternal immune Response

One of the most important variables to control in MIA studies is the extent of the maternal
immune response and how much of it is transmitted to the fetus. The immune response can
vary across time and depends on housing conditions (Mueller et al., 2018) and Poly I:C
source, lot number and molecular weight (Careaga et al., 2018; Harvey and Boksa, 2012).
Some studies also have even shown differential effects of Poly I:C between different mouse
strains (Morais et al., 2018; Schwartzer et al., 2013). Therefore, quantification of the extent
of the immune response should be a top priority to allow accurate comparison of offspring
results across different studies.
Common immune response quantifications include: maternal temperature, maternal body
weight gain, and the maternal serum cytokine profile (Cunningham et al., 2007; Mueller et
al., 2019). Out of these three variables, the maternal serum cytokine profile is the most
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precise representation of Poly I:C’s potential effect on the fetus, given the mechanistic
implications of cytokines such as IL-6 in MIA. While being currently the best measure for
the extent of the maternal immune response, maternal cytokines are still only a surrogate
measure of what the fetus is exposed to, and there is still potential for inter-fetal variability
in the extent of exposure.
Changes in maternal temperature and body weight gain following Poly I:C MIA have been
inconsistent across studies, with some reporting an increase in temperature and others
reporting no change (Ballendine et al., 2015; Howland et al., 2012; Murray et al., 2017;
Sangha et al., 2014; Washington et al., 2015; Zhang et al., 2012). One study even reported
hypothermia as opposed an increase in body temperature and argued this effect may be
dose and species-specific (Cunningham et al., 2007).
Recent literature has begun to more regularly quantify the immune response in the dams
whose offspring undergo testing, and some have attempted correlation with offspring
phenotypes. For example, Lins et al. (2018) found no correlation between offspring
behavioural phenotypes and the level of maternal cytokines following Poly I:C. However,
they did find cytokine levels to be associated with neonatal pup mass. Overall,
quantification of the immune response in experimental or non-experimental animals is
missing from a significant portion of the studies reviewed here, leaving some doubt in the
ability to directly compare results across studies.
Numerous studies have detected an elevated immune response in fetal tissue after maternal
exposure to Poly I:C (Abazyan et al., 2010; Arrode-Brusés and Brusés, 2012; Arsenault et
al., 2014; Connor et al., 2012; Corradini et al., 2018; Ehninger, 2014; Meyer, 2006; Wu et
al., 2015). These results come from separate dams whose offspring were not used for
phenotyping and hence cannot be correlated to postnatal behavioural and molecular
findings. However, these results are still useful to compare across studies and help
understand the variability or similarity in offspring findings.
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1.2.5

An eye towards mechanisms: Cytokines and the developing
brain

The various behavioural and molecular changes discussed in Sections 1.2.1-1.2.3 suggest
that treating pregnant dames with Poly I:C can influence several developmental processes,
brain regions, and neurotransmitter systems in the offspring. . This is further emphasized
by the variety of treatments and preventions that have proven successful in ameliorating
some or all the observed deficits (Appendix B summarizes the effects of various
interventions following MIA induced by Poly I:C). However, a special mention must be
made to pro-/anti-inflammatory cytokine balance around the time of MIA. In particular,
the pro-inflammatory cytokine IL-6 is often cited as essential to poly I:C’s
neurodevelopmental effects, which is unsurprising given the importance of IL-6 family
cytokines and receptors in normal brain development (Deverman and Patterson, 2009). But
how exactly does a change in IL-6 signaling alter brain development?
IL-6 can either act directly on neurons and their precursors or it can activate glia which
have their own developmental roles and may respond by producing more cytokines,
providing another level of signal amplification (Macht, 2016). Serum IL-6 is elevated only
for about 6-8 hours following Poly I:C, even at high doses (McGarry et al., 2021). This
suggests that the role of glia depends on the timing of Poly I:C injection, since microglia
only migrate to the brain around GD8-9 (Ginhoux et al., 2010) and astrocyte differentiation
only begins around GD18.5 (Macht, 2016). Further support for the role of IL-6 in Poly I:C
MIA comes from a study by Garbett et al. (2012). Their results showed that the fetal
transcriptome is similarly altered following 3 different kinds of MIA: Influenza, poly I:C,
or IL-6.
IL-6 and other cytokines such as leukemia inhibitory factor (LIF), ciliary neurotrophic
factor (CNTF) and cardiotrophin-1 (CT-1) all signal via receptors that contain
Glycoprotein 130 Transmembrane Protein (gp130; Deverman and Patterson, 2009). This
activates downstream Janus Kinase (JAK) and Signal Transducer and Activator of
Transcription 3 (STAT3), with the latter being a transcription factor that drives the effects
of gp130 activation (Deverman and Patterson, 2009). Much like MIA’s timing-specific
effects, activation of gp130 signaling at different embryonic stages leads to diverse effects.
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Around GD12-15, gp130 signaling drives radial glial cell self-renewal (Gregg and Weiss,
2005; Hatta et al., 2002). Later in fetal development, gp130 signaling affects neural
precursor cell fate and drives astrogliogenesis over neurogenesis (Koblar et al., 1998;
Nakashima et al., 1999). In fact, neurons themselves produce CT-1 and as the number of
neurons increases, the levels of CT-1 and thereby the push for astrogliogenesis also
increases (Barnabé-Heider et al., 2005).
Elevated IL-6 levels driven by Poly I:C may therefore directly affect proliferation and
differentiation of neural precursors. Despite compelling evidence for the importance of IL6, the role of other cytokines and chemokines that are part of the immune response against
Poly I:C is still far from clear. Other cytokines like IL-1β and TNF also have roles in
nervous system physiology (Schafer et al., 2013; Schäfers and Sorkin, 2008) and future
research should attempt to elucidate the role of non-IL-6 cytokines and chemokines in the
mechanisms of Poly I:C MIA.
Poly I:C MIA can also indirectly affect neuronal development and function by activating
microglia, the brain’s resident immune cells. Poly I:C studies have found changes in
microglia both prenatally and postnatally (reviewed by Smolders et al., 2018), indicating
that microglial function may be permanently altered by a single prenatal MIA insult. One
explanation for this observation could be increased migration of macrophages destined to
become microglia into the brain which is known to occur around GD8-10. This can be
driven by changes in cytokines and chemokines such as macrophage-colony-stimulating
factor (M-CSF) which has previously shown alterations following Poly I:C injections
(Arrode-Brusés and Brusés, 2012; Ehninger, 2014). M-CSF is required for the
establishment of microglia in zebrafish (Herbomel et al., 2001) and also affects postnatal
microglial number in mouse brains (Kondo et al., 2007; Sasaki et al., 2000). Additionally,
microglia have other roles in the developing brain which include secreting neurotrophic
factors (Garden and Möller, 2006) and synaptic pruning (Schafer et al., 2013). As a result,
an increase in microglial number can have great implications for neurodevelopment, not
just at the time of MIA but much later on during postnatal development.
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1.2.6

Maternal versus fetal effects and the placenta

As Poly I:C spreads throughout the maternal circulation, it can bind to TLR3 receptors
expressed in a variety of tissues. Interestingly, human work shows that TLR3 expression
reaches some of its highest levels in the placenta (Kawai and Akira, 2011; Nishimura and
Naito, 2005). With the placenta being in close proximity to the fetus, these high levels of
TLR3 expression and their detection of Poly I:C may be largely responsible for amplifying
the MIA signal that reaches the fetal circulation and alters fetal brain development.
In support of this hypothesis, Poly I:C has been shown to increase placental immune
activation via IL-6 and that blocking IL-6 signaling in placental trophoblasts can prevent
the emergence of phenotypes in Poly I:C offspring (Hsiao and Patterson, 2011). Recently,
Tsukada et al. (2019) reviewed some mechanisms whereby MIA’s effects can be mediated
by the placenta, highlighting IL-6 and TNFα as modifiers of placental function, which in
turn can alter fetal brain development. For example, Poly I:C MIA has been linked with
reduced expression of Prolactin Family 2 Subfamily b Member 1 hormone (Prl2b1), which
has been linked to the regulation of placental angiogenesis and uterine growth. In addition,
Poly I:C MIA also increased levels of IL-6 production in the decidua and induced the
JAK/STAT pathway in placental spongiotrophoblast cells (Hsiao and Patterson, 2011; Wu
et al., 2017).
Another potential layer of immune signal amplification is the fetal response to MIA, not
just in the fetal brain but peripherally, although this is largely dependent on the extent of
fetal immune development during the time of MIA. This is where MIA may be limited in
replicating the human condition, as fetal immune development is quite delayed in rodents
compared to humans (Holsapple et al., 2003). On the other hand, this simplifies the
interpretation of rodent MIA results as they could be mostly attributed to the maternal
immune response with little contribution of the fetal immune system.

1.2.7

Sex-specific effects in Poly I:C literature

SCZ differentially affects males and females, with males showing earlier age of onset, more
cognitive deficits, weaker response to antipsychotics, and greater changes in brain and
ventricular volume (Mendrek and Mancini-Marïe, 2016). In some cases, SCZ patients
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show reversal of normal sexual dimorphisms in structural and functional phenotypes
(Mendrek and Mancini-Marïe, 2016). ASD also preferentially affects males, but unlike in
SCZ, it is not clear whether male and female phenotypes differ substantially (Werling and
Geschwind, 2013). Nevertheless, the prevalence of ASD is much higher in males, with a
ratio of almost 4:1.
The extent to which sex differences were studied and the degree to which offspring sex
impacted the effect of Poly I:C vary across studies. In general, relatively few sex-specific
effects are reported for all Poly I:C exposure time points, with GD14.5 being the exposure
category with relatively fewer studies that test both males and females.
In early GD9.5 MIA, a study by Hui et al. (2018) found male-specific changes in microglial
activation, PPI and elevated plus maze, but not in social behaviour or marble burying.
Meehan et al. (2017) also found decreased PPI specifically in males following early MIA
in rats, whereas Rahman et al. (2017) reported increased cortical and striatal NR2A subunit
binding in males but not females. There are few reports of sex-specific changes after
GD12.5 Poly I:C exposure despite most studies investigating both sexes and these include
reduced latency to fall in the rotarod and increased marble burying (Pendyala et al., 2017;
Schwartzer et al., 2013). At later MIA time points (GD14.5), decreased PPI, increased
lateral ventricular volume, and increased set shifting errors are found in males only, in
addition to differentially affecting male and female hippocampal cell firing and response
to amphetamine and MK801 across age (Howland et al., 2012; Patrich et al., 2016a;
Piontkewitz et al., 2011a). Late Poly I:C MIA was found to cause sex-specific effects on
neurotransmitter levels in various brain regions (Bitanihirwe et al., 2010a) while another
study by Duchatel et al. (2018a) reported increased complement 4 expression in the
cingulate cortex of male GD9.5 Poly I:C rat offspring.
Taken together, while some have shown sex-specific effects, and particularly male
vulnerability, following Poly I:C MIA, the disparity between male and female phenotypes
is not consistent across studies and Poly I:C exposure categories.
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1.2.8

Age-specific effects in Poly I:C literature

Since Poly I:C models have typically been used to investigate ASD and SCZ, some focus
must be directed to the age of onset of brain and behavioural symptoms, which in humans
greatly differ between these two disorders. Whereas ASD symptoms appear very early on
in the first few years of life, onset of SCZ symptoms is much later, with first episode
psychosis occurring commonly in late teens or early adulthood, despite more subtle
cognitive symptoms being present in the prodromal phase (Kahn et al., 2015).
Most Poly I:C studies examined changes in adult offspring, particularly in the GD14.5 MIA
studies, which is perhaps driven by early studies showing SCZ-like adult-onset behavioural
changes in latent inhibition (LI; Zuckerman et al., 2003; Zuckerman and Weiner, 2003).
Interestingly, adult-onset decreases in PPI and LI are also reported multiple times in GD9.5
MIA offspring, which indicates that structures involved in modulating these two
behavioural outcomes might be vulnerable at multiple stages of development (Giovanoli
et al., 2016a, Giovanoli et al., 2016b; Lipina et al., 2013; Pacheco-López et al., 2013;
Vuillermot et al., 2010).
One early-onset behavioural phenotype that is more in line with MIA's relevance to ASD
is altered pup-induced ultrasonic vocalization seen in both GD12.5 MIA mouse and
GD14.5 MIA rat offspring (Chou et al., 2015; Hsiao et al., 2013; Kim et al., 2017; Pendyala
et al., 2017; Schwartzer et al., 2013; Weiser et al., 2016; Yee et al., 2012).
In contrast, non-behavioural outcomes seem to have earlier onset across different Poly I:C
exposure time points. For example, GD9.5 MIA offspring exhibit a decrease in cortical
histone acetylation that is seen as early as postnatal day (PND) 24 (Tang et al., 2013) and
a decrease in cerebellar Purkinje cell density as early as six weeks of age (Shi et al., 2009).
Similarly, GD12.5 MIA reduced cortical dendritic spines and increased surface MHCI
proteins at PND17 (Coiro et al., 2015) and juvenile GD14.5 MIA offspring showed altered
hippocampal excitability and increased glutamate/GABA ratio (Patrich et al., 2016a;
Zhang et al., 2018b).
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In many cases, molecular phenotypes such as brain and peripheral cytokine levels are
dynamic throughout postnatal development and do not necessarily persist until adulthood.
A prominent example is the proinflammatory cytokine IL-6 being downregulated at
PND30 but upregulated at PND60 in the frontal cortex in GD12.5 MIA offspring (Garay
et al., 2013). In contrast, later Poly I:C exposures show adult changes such as increased
lateral ventricular volume and decreased PFC expression of GABAergic markers GAD65,
GAD67 and vGAT (Luoni et al., 2017; Meyer et al., 2008a; Piontkewitz et al., 2011a;
Richetto et al., 2014, 2013).
Taken together, these data show that Poly I:C MIA affects rodent offspring brains as early
as 2 weeks of life, but behavioural changes may present until much later in adolescence or
adulthood.

1.2.9

Double-hit Models:

Double-hit models are based on the hypothesis that multiple risk factors, genetic and/or
environmental, can synergize and lead to psychiatric disorders. Evidence of interaction
between multiple genetic and environmental risk factors in SCZ includes changes in
genetic liability under different contexts of urban environment and cannabis use, both of
which are known environmental risk factors for the disorder (van Os et al., 2010). Others
have similarly argued that early life or adolescent stress may act as a second hit leading to
the full adult phenotype Picci and Scherf (2014).
Double or multiple-hit models represent a more holistic approach to understanding
disorders with multiple risk factors and provide a fertile ground for linking these risk
factors with common underlying molecular pathways/mechanisms. The mammalian target
of rapamycin (mTOR) signaling pathway in mammals exemplifies one such target, where
numerous ASD risk genes converge, while external signals such as cytokines can also
modulate this signaling pathway (Estes and McAllister, 2016). A comprehensive
understanding of the interaction between different risk factors is key to designing more
effective treatment and prevention plans for such complex disorders.
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Given Poly I:C MIA does not impair fetal viability in most cases, it has potential for
studying how prenatal inflammation can either act as an environmental first-hit, priming
individuals for a later environmental insult, or as a second-hit in genetically predisposed
individuals. Genetic factors used in combination with Poly I:C include SCZ risk genes
coding for Disrupted In Schizophrenia 1 (DISC1), Nuclear Receptor Related 1 (NURR1),
Neuregulin (NRG)-1 and alpha 7 nicotinic acetylcholine receptor (Abazyan et al., 2010;
Lipina et al., 2013; O’Leary et al., 2014; Vuillermot et al., 2012; Wu et al., 2015).
DISC1 is closely linked with SCZ in humans and codes for the DISC1 protein which
regulates neural progenitor cell proliferation as well as neuronal migration (Brandon and
Sawa, 2011). Rodent studies have shown that Poly I:C MIA synergizes with Disc1 point
mutations and mutated human DISC1 expression (Abazyan et al., 2010; Lipina et al., 2013)
to exacerbate behavioural phenotypes such as PPI disruptions and changes in and anxietyrelated behaviours in the elevated plus maze. However, this double-hit effect was
dependent on the type of point mutation (Lipina et al., 2013) as well as the timing of
expression of mutant human DISC1 (Abazyan et al., 2010), with the latter only occurring
when mutant DISC1 was expressed post-weaning and not pre-weaning. Interestingly, one
of the DISC1 point mutations which exhibited more behavioural double-hit effects with
Poly I:C also increased the fetal cytokine response after Poly I:C.
Poly I:C MIA also resulted in double-hit effects in Nurr1 heterozygous animals. Nurr1
codes for a transcription factor that regulates key enzymes involved in dopamine synthesis,
linking it to dopamine-related disorders like Parkinson’s Disease and SCZ (Bissonette and
Roesch, 2016; Buervenich et al., 2000; Jankovic et al., 2005; Xing et al., 2006). Poly I:C
MIA and Nurr1 heterozygous genotype showed synergistic reductions in the expression of
Nurr1 and downstream dopaminergic markers, however, these double-hit effects were only
present if Poly I:C injections occurred during early (GD9.5) but not late (GD17.5) gestation
(Vuillermot et al., 2012, 2011). The Nurr+/- genotype also markedly influenced the immune
response to Poly I:C, with Nurr1+/- dams showing reductions in IL-6 and no change in TNF
or IL-10 following Poly I:C.
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Beyond genetics, some studies combined Poly I:C MIA with environmental second-hit
models including juvenile/peripubertal stress, adolescent cannabinoid exposure and
experimental autoimmune encephalitis (as a model for Multiple Sclerosis). Adolescent
stress double-hit effects were shown with GD9.5 mouse Poly I:C MIA (Giovanoli et al.,
2013, Giovanoli et al., 2014, Giovanoli et al., 2016a, Giovanoli et al., 2016b), whereas
GD14.5 rat MIA only exhibited independent single-hit effects (Yee et al., 2011). This
indicates early MIA affects pathways related to adolescent stress. Additionally, these
studies also found that offspring phenotype changes with age. In adolescence, double-hit
effects included increased hippocampal expression of pro-inflammatory markers, whereas
in adult animals, double-hit symptoms included PPI impairments, increased response to
amphetamine and changes in hippocampal expression of parvalbumin and Reelin were
observed (Giovanoli et al., 2014, Giovanoli et al., 2016a, Giovanoli et al., 2016b).
Studies investigating double-hit effects with cannabinoid exposure utilized the
Cannabinoid Receptor 1 (CB1) agonist HU210 and administered it for two weeks starting
PND 35 (Hollins et al., 2016, 2014; Idrizi et al., 2016). The main findings were changes in
entorhinal cortex gene expression, microRNA profile and striatal epidermal growth factor
receptor expression.
Overall, multiple studies indicate that Poly I:C MIA can interact with other genetic and
environmental risk factors to exacerbate both cellular and behavioural symptoms related to
SCZ in the offspring. The indirect interplay between developmentally relevant genes and
prenatal inflammation is evident in DISC1 and NURR1 studies, where a heterozygous
genotype is sufficient to alter the fetal immune response to Poly I:C, pointing towards a
common basic pathophysiological mechanism. The link with inflammatory signaling is
even more direct in the context of adolescent stress, which itself activates postnatal
inflammatory signaling. Prenatal priming of the immune system might persist postnatally
and is able to interact with adolescent stress to manifest symptoms which otherwise would
not show up. Poly I:C double-hit models therefore have shown considerable face validity
in investigating more complex etiological mechanisms of disorders such as ASD and SCZ.
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1.3

1.3.1

1.3.1.1

Knowledge gaps in Poly I:C literature

Comprehensive investigation of the effects of Poly I:C MIA
timing on sensory processing measured through the acoustic
startle response
Few studies directly study the effects of Poly I:C MIA timing

The epidemiological evidence summarized in section 1.1 highlights the importance of
maternal infection timing with regards to its effects on the risk of ASD or schizophrenia.
In particular, infections in the first or second trimesters carry more risk (Section 1.1.1).
However, a great deal of neurodevelopment can occur even within a trimester (Figure 11). The same MIA occurring 1 month later in humans or 2-3 days later in rodents takes
place in the context of a largely different brain environment and may induce seemingly
disparate effects.
Although Poly I:C MIA has been performed at different gestational times across different
studies, few studies have investigated multiple MIA timings in the same experiment
(Duchatel et al., 2016; Meehan et al., 2017; Urs Meyer et al., 2008; Richetto et al., 2017).
In essence, most of the comparisons concerning Poly I:C MIA timing come from betweenstudy comparisons, and very few come from within-study comparisons. While these
comparisons are important, variations in experimental conditions and design between
studies can greatly influence the effects of Poly I:C MIA (Section 1.1.2). Therefore, more
within-study comparisons are required to fully elucidate the mechanisms of Poly I:C MIA.

1.3.1.2

Analysis of acoustic startle phenotypes in Poly I:C MIA
offspring

The startle response is a motor response to a strong and sudden sensory stimulus. It is a
form of defensive behaviour that is highly conserved across mammals and can occur in
response to acoustic, visual, or tactile stimuli (Yeomans et al., 2002). It has been studied
in humans and rodent models for decades, and much is known about the cellular and
molecular mechanisms that mediate it, especially with acoustic stimuli.
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The acoustic startle response and its modulations can be used as indicators of basic sensory
processing mechanisms in the mammalian brain. The sound threshold required to elicit
startle is determined by the peripheral auditory pathway including the cochlea and cochlear
nucleus (Koch, 1999). Sound information travels to the brainstem’s pontine reticular
formation (PnC), where specialized giant neurons mediate the response (Koch et al., 1992).
Habituation of startle is the reduction in response with repeated stimulation and is a form
of non-associative learning that reduces processing of non-salient stimuli (Geyer and Braff,
1987). On the flipside, sensitization of startle is the increase in response which can often
occur in states of fear and anxiety (Davis, 1992; Davis et al., 1993). Prepulse inhibition
(PPI) of startle is the reduction in response when the startle eliciting stimulus is preceded
by a weaker stimulus. PPI is an operational measure of sensorimotor gating, a process by
which motor responses are inhibited to facilitate processing of stimuli (i.e., the prepulse;
Swerdlow et al., 2016)
One of the most common tests performed in Poly I:C MIA studies is PPI of the acoustic
startle response. This focus is based on the relevance of PPI in neurodevelopmental
disorders with sensory processing disruptions such as ASD and SCZ, where PPI deficits
are seen (Kohl et al., 2013; Swerdlow et al., 2016). Despite frequent startle testing, Poly
I:C MIA studies have not thoroughly characterized the changes in other startle phenotypes.
These include baseline reactivity to different sounds, habituation, sensitization, and PPI
under varying interstimulus intervals (ISIs). These phenotypes are important indicators of
sensory processing and are commonly measured in ASD and SCZ. For instance, Takahashi
et al. (2014) showed that autistic individuals exhibit higher startle to relatively quiet
sounds, but no study yet has investigated whether Poly I:C MIA alters startle at these low
sound levels. Similarly, Meincke et al. (2004) showed that individuals with SCZ exhibit a
PPI deficit with long but not short ISIs. So far, only a few studies have tested PPI with
varying ISIs and have found inconsistent results (Howland et al., 2012; Makinodan et al.,
2008).
The combination of data from the different startle measures can provide valuable
information about cellular and molecular disruptions in various brain circuits (Koch and
Schnitzler, 1997). For example, the sound threshold required to elicit a startle response can
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be influenced by signal processing and conduction in the peripheral auditory system
upstream of the acoustic-mediating Pontine reticular nucleus (PnC; Lingenhohl and Friauf,
1994, 1992; Wagner and Mack, 1998). Alternatively, changes in habituation are indicative
of altered synaptic responses involving potassium channels in the PnC (Zaman et al., 2017),
whereas and sensitization of startle can be caused by increased activity of the amygdaloid
projections to the PnC (Koch and Ebert, 1993). On a similar note, PPI deficits that are
selective to the ISI are linked to different neurotransmitter systems. For example, systemic
muscarinic and GABAB antagonists impair PPI at longer ISIs (~100ms-300; Fendt and
Koch, 1999), whereas systemic dopaminergic agonists decrease PPI at both short
(~30ms)_and long ISIs (Jones and Shannon, 2000).
A comprehensive analysis of startle phenotypes in Poly I:C MIA will not only help in
translating findings to human startle studies, but it can also point to specific underlying
brain mechanisms that can be further investigated in Poly I:C offspring.

1.3.2

Interleukin-15: A potential mediator of Poly I:C MIA’s effects
on the fetus

The immune response is a collective term describing a variety of processes that act in a
concerted effort to defend the body against infection. This immune response is multifaceted
and complex, even in response to a relatively simple innate immune stimulus like Poly I:C
(Mueller et al., 2019; Openshaw et al., 2019).
Currently, only a few cytokines have been studied as potential mediators of Poly I:C MIA’s
effects on the fetal brain. Several studies have shown that administering anti-IL-6 or antiIL-17a antibodies in conjunction with Poly I:C block some of its behavioural effects
(Lammert et al., 2018; Lipina et al., 2013; Pineda et al., 2013; Pratt et al., 2013). A couple
of studies have also shown a less drastic contribution for IL-1β and IFN-γ (Pineda et al.,
2013; Smith et al., 2007). Despite these compelling findings, the role of many other
cytokines and chemokines that are known to increase following Poly I:C MIA is still
unknown.
One of these cytokines that potentially play a major role in Poly I:C MIA but has not yet
been studied in this context is IL-15. IL-15 is a proinflammatory cytokine that can amplify
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immune signaling of other cytokines previously implicated in MIA (e.g IL-6 and IL-8).
Moreover, IL-15 can act as a signaling molecule in various cell types in the fetal brain.
Also, IL-15 is required for the differentiation of Natural Killer (NK) cells, which are the
most abundant lymphocytes in the placenta and can affect fetal development.

1.3.2.1

IL-15 as an immune regulator

IL-15 is a key immune regulator that is widely expressed throughout the body. Its mRNA
can be found in various organs and cell types (Perera et al., 2012). However, IL-15 protein
levels tend to be low except in certain cell types such as dendritic cells and macrophages
(Doherty et al., 1996; Mattei et al., 2001). Dendritic cells are involved in the detection of
pathogens, and they produce IL-15 dendritic cells following exposure to pathogen
associated molecular markers such as Poly I:C and lipopolysaccharides (Mattei et al.,
2001). IL-15 secreted by dendritic cells in the circulation can go on to influence various
cell-types. In macrophages for example, IL-15 plays a key role in regulating the production
of proinflammatory cytokines like IL-6, IL-1 and TNFα (Alleva et al., 1997).
Binding of IL-15 to the IL-15 receptor α (IL-15α) subunit initiates downstream signaling
through the Janus Kinase (JAK) and Signal Transducer and Activator of Transcription
(STAT) pathway (Johnston et al., 1995). Other subunits of IL-15R like the β and γ subunits
are shared by other cytokine signaling mechanisms like IL-2 (Giri et al., 1994). It is these
β and γ chains that recruit JAK1 and JAK3, which go on phosphorylate STAT3 and
STAT5, eventually leading to changes in gene expression that are controlled by the STAT
transcription factors. Despite the shared subunits, IL-15’s effects are still quite distinct
from other cytokines like IL-2, which can be partly attributed to differences in the
distribution of receptor expression throughout the body.
Aside from its immune roles, IL15 signaling can have direct influence on the brain. Firstly,
IL15 gene expression has been detected in human fetal astrocytes, microglia, and various
neural cell lines (Hanisch et al., 1997; Lee et al., 1996; Satoh et al., 1998). IL15 protein has
also been detected throughout the early postnatal and adult mouse brain, with particularly
high levels in the hippocampus and cerebellum (Gómez‐Nicola et al., 2008) and L15Rα

32

has been found in both human fetal brain and adult mouse brain (Hanisch et al., 1997;
Kurowska et al., 2002)

1.3.2.2

IL-15 as a signaling molecule in the brain during and after
development

In further support of IL15’s role in the brain, several studies have shown brain and
behavioural changes in mice lacking IL15 or IL15Rα. For instance, both IL15 and IL15Rα
deficiency reduced anxiety in the elevated plus maze (EPM; Wu et al., 2010). In addition,
IL15Rα-deficient mouse showed alterations in memory, fear conditioning, depressive
behaviour, and activity during the light phase of the circadian cycle (He et al., 2010b,
2010a; Wu et al., 2011, 2010).
In cell culture, treatment with IL15 activates and enhances the survival of microglia and
alters the proliferation and differentiation of neurospheres through JAK-STAT-dependent
mechanisms (Gómez-Nicola et al., 2011; Hanisch et al., 1997; Huang et al., 2009). Studies
have also shown that IL15 deficiency impairs neurogenesis in the adult mouse brain and
IL15Rα deficiency influences GABAergic and serotonergic signaling in the hippocampus
(Hanisch et al., 1997; He et al., 2010a).

1.3.2.3

IL-15 as a driver for Natural Killer cell differentiation

Natural Killer (NK) cells are innate immune cells found in the circulation and in various
organs throughout the body (Shi et al., 2011). The main role of NK cells is to detect and
kill virally infected or neoplastic cells (Sun and Lanier, 2011). However, the various
populations of tissue-resident NK cells can play other non-cytotoxic roles in their
respective organs (Shi et al., 2011).
The development of NK cells requires the presence of IL-15, as evidenced by the lack of
NK cells in IL15 or IL15Rα-deficient mice (Kennedy et al., 2000; Lodolce et al., 1998).
Similarly, NK cells are absent in mice lacking the β subunit of the IL-15/IL-2 receptor
(Suzuki et al., 1997). NK cells derive mainly from hematopoietic stem cells in the bone
marrow. It is thought that IL-15 binds to IL15Rs on the surface of dendritic cells, and this
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complex then interacts with receptors on hematopoietic precursors and induces the
transition to NK cells (Castillo et al., 2009).
After IL-15-dependent development, not all NK cells share the same fate. Some NK cells
remain in the circulation and make up approximately 10% of the total peripheral blood
mononuclear cell population (Mandal and Viswanathan, 2015). Other NK cells reside in
specific organs like the liver, skin, kidney and uterus (Sojka et al., 2019). The latter group
of NK cells remain in their respective organs and express different receptor and
transcription factors compared to their circulating counterparts (Sojka et al., 2019).
During pregnancy, NK cells constitute a large portion of the uterine leukocytes and their
role goes beyond immune regulation. In murine pregnancy, the number of uterine NK cells
increases after implantation, and both mice and rats lacking NK cells have shown changes
in placental structure (Moffett and Colucci, 2014; Renaud et al., 2017). Furthermore, NK
cells may play a role in pregnancy even before implantation by producing growth factors
that enhance fetal growth (Fu et al., 2017).

1.3.3

Interaction with genetic predispositions for ASD:

The data from epidemiological studies of infection during pregnancy show that the ASD
risk increase due to maternal infection is relatively modest. The highest risk increase
reported was around 7-fold (Brown et al., 2004a), but in most studies, the risk hovers
around 1-2 fold after adjusting for potentially confounding variables such as sex, parental
age, parity, and changes in prevalence of ASD over time(Atladóttir et al., 2010; Brucato et
al., 2017; Hornig et al., 2018; Sørensen et al., 2009).
However, family history and genetic variation are known to modify the risk posed by
maternal infection (Clarke et al., 2009; Mazina et al., 2015). These lines of evidence
support the hypothesis that maternal infection is a ‘primer’ rather than a cause of
neurodevelopmental disorders, highlighting the need to investigate its interaction with
other genetic or environmental risk factors for ASD and SCZ (Meyer, 2019).
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1.3.3.1

Contactin Associated Protein-like 2 (Cntnap2)

The human CNTNAP2 gene was first linked with ASD by Strauss et al., (2006), who
identified a homozygous mutation in an Amish population. These children presented with
a syndrome termed cortical dysplasia focal epilepsy (CDFE). Affected individuals
exhibited a variety of symptoms including ASD, seizures, language regression, and
cognitive delays. Following this landmark finding, a wave of studies were conducted
investigating a variety of mutations in the human CNTNAP2 gene and confirmed their
association with epilepsy (Rodenas-Cuadrado et al., 2016; Watson et al., 2014), ASD (Nord
et al., 2011; Poot et al., 2010; Zare et al., 2017; Zhou et al., 2019), and language
development, (Anney et al., 2012; Peter et al., 2011).

1.3.3.2

Function of Cntnap2

Functionally, the role of Cntnap2 was first studied in rodents, where it was identified to
code for a neurexin-like protein called Caspr2 (Poliak et al., 1999). The classical role of
Caspr2 involved the clustering of K+ ion channels at the juxtaparanode of the nodes of
Ranvier that are important structural components of myelinated axons (Horresh et al.,
2008; Poliak et al., 2001). This function is important for the structural organization of the
nodes of Ranvier, and a recent study by Scott et al. (2019) show that lack of Cntnap2 leads
to increased excitability of cortical neurons.
Beyond the juxtaparanode, several studies have confirmed that a loss of Cntnap2 is
associated with neurodevelopmental deficits in neuronal migration and synaptic function.
Loss of Cntnap2 leads to disorganized cortical layering, where projections neurons
destined for upper cortical layers fail to migrate to their target location and are found in
lower cortical layers (Peñagarikano et al., 2011). This finding resembles what is seen in
humans with the deleterious CNTNAP2 mutation (Strauss et al., 2006), and likely relate to
Caspr2’s function as a cell adhesion molecule (Peñagarikano and Geschwind, 2012).
Caspr2, the protein product of Cntnap2, is present in the dendritic spines and axons of
neurons (Varea et al., 2015), where its role likely involves facilitating dendritic arborization
(Anderson et al., 2012).
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The expression CNTNAP2 is widespread, with particular enrichment in areas involved in
sensory and cognitive processing. In humans, high levels of CNTNAP2 expression can be
found in the frontal cortex, striatum, and dorsal thalamus (Abrahams et al., 2007; Alarcón
et al., 2008). The gene is also expressed in brain regions of primary sensory organs, as well
as the auditory brainstem (Gordon et al., 2016; Scott et al., 2018).
Further support for the link between CNTNAP2 and ASD has come from preclinical models
with genetic knockout or knockdown of the Cntnap2 gene. Cntnap2 knockout (Cntnap2-/-)
rodents show ASD-related behavioural phenotypes such as increased repetitive behaviours
(Peñagarikano et al., 2011; Scott et al., 2019; Xing et al., 2019), increased sensory
reactivity (Scott et al., 2020, 2018), and decreased social behaviour (Brimberg et al., 2016;
Scott et al., 2020; Selimbeyoglu et al., 2017).

1.3.3.3

Potential for gene-environment interaction between Poly I:C
MIA and Cntnap2 deficiency

Double-hit gene-environment interaction models using Poly I:C MIA as the environmental
insult have been briefly studied as discussed in Section 1.2.9. Those results showed that
genetic mutations in SCZ risk genes leaves offspring more susceptible to the effects of Poly
I:C MIA. However, no studies have investigated whether Poly I:C MIA also interacts with
genetic mutations in ASD risk genes.
Recently, Schaafsma et al. (2017) combined LPS MIA at GD6.5 with a genetic deficiency
in the ASD risk gene Contactin Associated Protein-like 2 in mice (Cntnap2). Their findings
showed male Cntnap2-knockout mice exposed to LPS MIA showed more social and
repetitive behaviour impairments compared to single hit mice (MIA only or Cntnap2knockout only). These findings suggest that MIA and Cntnap2-knockout may interact to
exacerbate ASD-related symptoms in the offspring. For example, both Poly I:C MIA
offspring and Cntnap2-/- mice show disorganized cortical layering, a sign of abnormal
neuronal migration early on in life (Choi et al., 2016; Coutinho et al., 2017; Peñagarikano
et al., 2011). Furthermore, both Poly I:C MIA offspring and Cntnap2-/- mice show
decreased expression of Parvalbumin, marker of inhibitory interneurons, in the
hippocampus, which may be linked to aberrant synchrony of neuronal activity seen in both
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models (Abazyan et al., 2010; Brunner et al., 2015; Lipina et al., 2013; Peñagarikano et al.,
2011). Changes in neuronal firing may be linked to decreased dendritic arborization
previously reported in the hippocampus and cortex of both Cntnap2-/- mice and Poly I:C
offspring (Brimberg et al., 2016; Fernandes et al., 2019; Li et al., 2014; Xu et al., 2019).
Beyond neuronal phenotypes, both Poly I:C MIA offspring and Cntnap2-/- mice also
exhibit microglial activation measured through microglial morphology (Coutinho et al.,
2017; Hui et al., 2018).
The two models also show substantial overlap in behavioural phenotypes. Social behaviour
deficits are a key diagnostic criteria in ASD, and both Cntnap2-/- mice and Poly I:C
offspring show decreased sociability (Kim et al., 2019a; Richetto et al., 2017; Scott et al.,
2020; Vuillermot et al., 2017; Weber-Stadlbauer et al., 2017). Another hallmark of ASD is
repetitive behaviour, typically measured in mice through grooming activity and the marble
burying task. Both Poly I:C offspring and Cntnap2-/- mice show increased marble burying
(Brimberg et al., 2016; Hui et al., 2018; Xuan and Hampson, 2014). Finally, deficits in
sensory filtering and sensorimotor gating are common in both models (Hao et al., 2019;
Richetto et al., 2017; Scott et al., 2020, 2018), and these changes can be linked to aberrant
reactivity to sensory stimuli, a symptom recognized by the DSM V as an important factor
in autistic individuals.

1.3.4

Thesis aims

The broad aim of this thesis was to investigate offspring phenotypes related to ASD and
SCZ in a rat Poly I:C MIA model. Specifically, my goal was to supplement the literature
with knowledge regarding the influence of Poly I:C MIA timing, the effects of Poly I:C
MIA on acoustic startle phenotypes, the role of IL-15 in Poly I:C MIA, and the potential
synergistic interaction between Poly I:C MIA and an ASD-linked genetic mutation in
Cntnap2.
Aim 1: Investigate the effects of Poly I:C MIA timing on sensory processing phenotypes
measured through the acoustic startle response
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Hypothesis: Poly I:C MIA induced at GD9.5 will produce different offspring sensory
processing phenotypes compared to Poly I:C MIA induced at GD14.5.
Aim 2: Investigate the role of IL-15 in Poly I:C MIA
Hypothesis: The effects of Poly I:C MIA are partially dependent on IL-15.
Aim 3: Investigate the interaction between Cntnap2 deficiency and Poly I:C MIA
Hypothesis: Poly I:C MIA will exacerbate behavioural impairments shown by full
Cntnap2-deficient rats and manifest novel behavioural changes in partial Cntnap2deficient rats.
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2

Sensory filtering disruption caused by Poly I:C - Timing
of exposure and other experimental considerations

A version of Chapter 2 and Appendices C&D are published as:
Haddad, F.L., Lu, L., Baines, K.J., Schmid, S., 2020a. Sensory filtering disruption caused
by poly I:C - Timing of exposure and other experimental considerations. Brain, Behavior,
& Immunity - Health 9, 100156. https://doi.org/10.1016/j.bbih.2020.100156

2.1 Introduction
Maternal infection during pregnancy is a known environmental risk factor for
neurodevelopmental disorders such as schizophrenia (SCZ; Brown et al., 2004; Blomström
et al., 2012), Autism Spectrum Disorder (ASD; Atladóttir et al., 2010; Zerbo et al., 2015),
epilepsy (Sun et al., 2008; Whitehead et al., 2006) and intellectual disability (Lee et al.,
2015). Since multiple types of infection are associated with a similar offspring risk (Nielsen
et al., 2013), it is thought that the disruption of brain development is mediated by maternal
cytokines, the inflammatory molecules of the maternal immune response (Canetta et al.,
2014; Estes and McAllister, 2016; Jones et al., 2017; Koks et al., 2016).
Polyinosinic: polycytidylic acid (Poly I:C) is a synthetic analog of double-stranded RNA
which binds to toll-like-receptor 3 to initiate an acute antiviral-like immune reaction
(Takeda and Akira, 2005). Administration of Poly I:C at distinct time-points during
pregnancy in rodents produces diverse phenotypes related to neurodevelopmental disorders
(Careaga et al., 2017; Haddad et al., 2020; Solek et al., 2018). The Poly I:C model has a
high construct validity, as it closely relates to observations from human epidemiological
studies (Li et al., 2009; Meyer et al., 2008, 2005; Mueller et al., 2018; Richetto et al., 2017;
Shi et al., 2003). It also shows considerable face validity for neurodevelopmental disorders,
as it induces behavioural offspring changes in sensorimotor gating, cognition, social
behavior and stereotypy (Giovanoli et al., 2016; Haddad et al., 2020; Pacheco-López et al.,
2013; Solek et al., 2018; Vuillermot et al., 2010), as well as molecular changes in
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dopaminergic, glutamatergic, and GABAergic neurotransmission (Haddad et al., 2020;
Rahman et al., 2017; Richetto et al., 2014, 2013).
The most commonly investigated phenotype across all Poly I:C studies is the disruption of
sensorimotor gating, which refers to pre-attentive filtering of redundant sensory
information, measured as prepulse inhibition (PPI) of the acoustic startle response (ASR;
Koch, 1999). Disruptions in PPI have been a consistent finding in patients with SCZ for
decades and have also been reported in other psychiatric disorders such as ASD and
Huntington’s Disease, although not as consistently (Kohl et al., 2013; Sinclair et al., 2017;
Swerdlow et al., 2008). Given the direct translatability of ASR measures across species,
PPI testing is a staple preclinical test in many relevant models and PPI deficits may reflect
disruptions along with the cortico-striato-pallido-thalamic circuitry which modulates PPI
(Swerdlow et al., 2016). Beyond PPI, the baseline startle amplitude can be used as a
measure of implicit sensory reactivity. Furthermore, habituation of the startle response
upon repeated stimulation is a form of non-associative memory which may also be
considered a form of pre-attentive sensory filtering (Koch, 1999). Although startle
reactivity and habituation of startle represent valuable measures associated with sensory
processing disruptions in ASD and SCZ, they have received far less attention in Poly I:C
literature in the past.
In this study, we characterize startle reactivity, startle short-term habituation (STH), longterm habituation (LTH) and PPI in the rat Poly I:C model and highlight the extent to which
between- and within-litter variability influences these behavioural measures. Furthermore,
we interpret our data specifically in the context of ASR methodology. For example, we
discuss the influence of habituation on startle reactivity measures and trial-by-trial versus
block-based analysis of habituation. Poly I:C was injected at GD9.5 and GD14.5, the most
commonly studied timepoints across Poly I:C studies. These time points are typically used
because they represent rodent brain developmental equivalents of human first and second
trimesters, which are the gestational periods when maternal infection imposes the greatest
risk (Haddad et al., 2020).
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2.2 Methods
2.2.1

Subjects

This study was conducted using wildtype Sprague Dawley (SD) adult male and female rats
(Charles River Canada). Rats were housed in open cages with corn cob bedding, given ad
libitum food and water, and kept on a 12 h light – 12 h dark cycle with lights turning on at
7:00 a.m. Cages were enriched with polycarbonate huts and wrinkled paper. Cage changes
took place once a week except during behavioural testing procedures, during which cage
changes were carried out at the end of the 5-day startle protocols to ensure LTH was not
influenced by cage change stress. Same-sex animals were housed in groups of 2–4 per
cage. Behavioural testing took place during the light phase (between 7:00 and 19:00 h). All
animal procedures were approved by the Western Animal Care Committee and adhered to
the guidelines of the Canadian Council on Animal Care.

2.2.2

Timed Breeding

Adult male rats were paired with a maximum of two adult females at a time. After pairing
overnight, a vaginal smear was collected from each female at 8 a.m. and inspected under a
light microscope to track the estrus cycle and check for the presence of sperm. If sperm
was detected in the smear, the female was considered pregnant and that day was considered
as GD0.5. Pregnant females were then separated from the male and transferred into a single
cage, where they were left undisturbed until the day of injection (either GD9.5 or GD14.5).
Each female was only bred once in this experiment.

2.2.3

Maternal Immune Activation

Pregnant females were randomly assigned to receive either Poly I:C or saline injections.
maternal immune activation (MIA) was induced using Poly I:C (Sigma Lot#037M4011V),
which had been previously aliquoted and stored at −20° C. Poly I:C aliquots were diluted
in 0.9% saline to obtain a concentration of 4 mg/ml. At around 10 a.m. on GD9.5 or
GD14.5, pregnant females were weighed and had their rectal temperature measured. Then,
they underwent isoflurane anesthesia (5% induction, 2% maintenance), during which they
were injected with either 0.9% saline or 4 mg/kg Poly I:C into the tail vein, as has been
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previously described (REF). The entire injection from anesthesia induction to recovery
procedure took an average of 15 min and rats were returned to their cages afterwards and
were undisturbed besides temperature/weight measurement and weekly cage change.
Temperature measurements were taken 3- and 24-h following injection, whereas maternal
weight was recorded at 6 and 24-h following injection. For 3h temperature monitoring,
data includes GD9.5 and GD14.5 dams used to generate offspring for behavioural testing,
as well as those that were sacrificed for fetal tissue collection. For 24h temperature and
weight monitoring, data includes only dams used for GD9.5 and GD14.5 behavioural
monitoring. The choice of 3 and 24 hours was based on previous Poly I:C studies (Mueller
et al., 2019; Murray et al., 2019; Pratt et al., 2013). 3 hours post injection includes a time
window when maternal serum IL-6 peaks, and 24 hours is when body weight changes due
to sickness behaviours. The number of dams used to quantify the effects of the Poly I:C
injection is described in Table 2-1.
Table 2-1. Number of dams used to quantify the effects of the Poly I:C injection
Saline

Poly I:C

13

12

8

10

10

10

3

3

3 h Temp
24 h Temp
24 h Weight
Fetal extraction (2
pups collected per
dam)

The day of parturition was designated as postnatal day (PND) 0. Offspring were weaned at
PND21, and littermates were separated based on sex and housed in groups of 2–4 rats per
cage. At the end of the experiment, the final number of litters per group was as follows:
GD9.5 saline, 3 litters; GD9.5 Poly I:C, 3 litters; GD14.5 saline, 4 litters; GD14.5 Poly I:C,
4 litters. For the last 2 litters in each group, offspring were culled to 3–5 animals per sex
per litter at 1 week of age, whereas in earlier cohorts all the offspring were tested. We did
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not record the full litter size for the last 2 litters from each group, but previous research
suggests that prenatal Poly I:C treatment similar to ours does not reduce litter size (Gray et
al., 2019; Vernon et al., 2015; Vorhees et al., 2015, 2012). The final number of offspring
included for analysis per group, litter, and sex is included in the statistical analysis section
of the article.

2.2.4

qRT-PCR for quantification of immune response

A total of six dams were used to confirm the efficacy of the batch of Poly I:C used in this
experiment. These dams were injected with either saline or Poly I:C at GD9.5 (3 per group).
They were sacrificed 6 h after maternal saline or Poly I:C injection using mild carbon
dioxide inhalation until respiratory failure, followed by cardiac puncture or decapitation.
Two whole conceptuses (containing decidua, placenta, and embryo) were isolated per dam
and either snap-frozen in liquid nitrogen or fixed in 10% neutral buffered formalin. RNA
was extracted from the tissue by homogenizing in RiboZol (Amresco). The aqueous phase
was then diluted with 70% ethanol, placed on RNeasy columns (Qiagen), treated with
DNase I, and purified. cDNA was generated from purified RNA (50 ng/ml) using High
Capacity cDNA Reverse Transcription kit (Thermo Fisher Scientific), diluted 1:10, and
used for quantitative Reverse Transcriptase-Polymerase Chain Reaction (qRT-PCR). For
qRT-PCR, cDNA was mixed with SensiFast SYBR green PCR Master Mix (FrogtaBio)
and primers described in the supplemental information (Table S1). A CFX Connect RealTime PCR system (Bio-Rad Laboratories) was used for amplification and fluorescence
detection. Cycling conditions were as follows: an initial holding step (95 °C for 3 min),
followed by 40 cycles of two-step PCR (95° for 10 s, 60 °C for 45 s), then a dissociation
step (65 °C for 5 s and a sequential increase to 95 °C). Relative mRNA expression was
calculated using the comparative cycle threshold (Ct; ΔΔCt) method. The geometric mean
of Ct values obtained from the amplification of Ribosomal RNA 18s (Rn18s) was used as
reference RNA. Ct values from each gene of interest (Interleukin-6, Interleukin-10, Tumor
Necrosis Factor-α, and Interferon-γ) were stable among the different replicates for each
animal. Table 2-2 shows the sequence of the primers used for genotyping.
Table 2-2. List of primers used for qPCR
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Gene

Accession #

Forward

Reverse

Size

Il6

NM_012589.2
NM_012854.2

5’
CATTGGAAGTTGGGGTAGGA3’
5’-tggccttgtagacacctttg-3’

99

Il-10

5’GCCAGAGTCATTCAGAGCAA3’
5’-cctgggagagaagctgaaga-3’

Tnfa

NM_012675.3

5’-gaaacacacgagacgctgaa-3’

5’-atccactcaggcatcgaca-3’

121

Ifng

NM_138880.2

5-‘acaacccacagatccagcac-3’

5’-gactccttttccgcttcctt-3’

121

2.2.5

139

Acoustic startle response testing

Behavioural testing was conducted in adolescence (starting PND38-39) and adulthood
(starting PND120-130). The number of offspring used per group for behavioural
experiments is presented in Table 2-3. The same tests were conducted at each time point,
and adolescent animals were handled at least twice before behavioural testing. Startle
testing was performed as described before (Valsamis and Schmid, 2011). In brief, rats were
initially acclimated to the experimental procedure, Plexiglas animal holders, and startle
chambers (Med Associates, Vermont, USA) by undergoing three 5-min acclimation
sessions, at least 6 h apart. During acclimation, the animals were exposed to a 65 dB sound
pressure level (SPL) white noise background sound which is consistently present
throughout all startle testing procedures. After acclimation sessions, startle reactivity in
response to startle stimuli of varying intensities was measured. This startle reactivity test
consisted of 12 white noise startle stimuli, each 20 ms in duration, at intensities ranging
sequentially from 65 dB to 120 dB in 5 dB increments, with a fixed intertrial interval (ITI)
of 15 s. Based on data from the startle reactivity session, platform sensitivity was adjusted
for each rat to optimally detect the startle reflex and the adjusted platform gain for each rat
was used throughout all the remaining testing sessions. Adjusting platform sensitivity
prevents ‘maxing out’ of the startle response, which occurs with high startle responses
where the peak of the response is beyond the limits of the recording software. It also allows
for more accurate detection of low startle responses, where the response is close to
background activity. Startle reactivity data shown below were all normalized by the
platform sensitivity used for each animal, and therefore these data are directly comparable
between animals and groups.
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2.2.6

Habituation and PPI

Following startle reactivity testing, animals underwent 5 consecutive days of startle
habituation and PPI testing to assess startle reactivity, PPI, STH, and LTH. Each day,
animals were exposed to a 5-min acclimation period with background noise, followed by
a habituation block of 20 trials and a PPI block of 50 trials. In the habituation block, each
trial consisted of a 20 ms, 110 dB white noise stimulus. Trials were separated by a fixed
ITI of 15 s. Besides analyzing habituation trials on a trial-by-trial basis, STH score was
calculated from the 20 habituation trials on day 1 by dividing the average startle amplitude
on the first 5 trials by the average startle amplitude on the last 5 trials (a value > 1 indicates
reduced startle at the end of the habituation block and the presence of STH). It is important
to note that initial STH measure across 20 consecutive trials measured at the start of the
session is different from most of the human literature and the few Poly I:C studies that
measured this phenotype. In those studies, habituation was measured as the reduction of
ASR amplitude on a final block of startle-only trials compared to the first block of startleonly trials, and these 2 blocks are usually separated by a PPI block of 30–40 startle and
prepulse trials (Mena et al., 2016; Swerdlow et al., 2014; Takahashi et al., 2017).
In the PPI block, animals were exposed to either startle only trials as described above or
prepulse trials. Prepulse trials included a 4-ms long white noise prepulse of 75 or 85 dB
and preceded the startle stimulus by an interstimulus interval (ISI) of either 30 or 100 ms.
ISI was determined as the time between the onset of the prepulse to the onset of the startle
stimulus. Ten of each of the following prepulse-ISI combinations: 75–30, 75–100, 85–30,
and 85–100 were presented, totaling 40 prepulse/pulse trials and 10 startle alone trials in a
pseudorandomized order. The trials were separated by a 15s ITI. Peak to Peak maximum
startle amplitude was measured. PPI was calculated as the amount of inhibition of startle
in prepulse trials compared to startle-only trials in the PPI block:
%𝑃𝑃𝑃𝑃𝑃𝑃 = �1 − �

𝑎𝑎𝑎𝑎𝑎𝑎𝑎𝑎𝑎𝑎𝑎𝑎𝑎𝑎 𝑠𝑠𝑠𝑠𝑠𝑠𝑠𝑠𝑠𝑠𝑠𝑠𝑠𝑠 𝑚𝑚𝑚𝑚𝑚𝑚𝑚𝑚𝑚𝑚𝑚𝑚𝑚𝑚𝑚𝑚𝑚𝑚 𝑤𝑤𝑤𝑤𝑤𝑤ℎ 𝑝𝑝𝑝𝑝𝑝𝑝𝑝𝑝𝑝𝑝𝑝𝑝𝑝𝑝𝑝𝑝
�� × 100.
𝑎𝑎𝑎𝑎𝑎𝑎𝑎𝑎𝑎𝑎𝑎𝑎𝑎𝑎 𝑠𝑠𝑠𝑠𝑠𝑠𝑠𝑠𝑠𝑠𝑠𝑠𝑠𝑠 𝑤𝑤𝑤𝑤𝑤𝑤ℎ𝑜𝑜𝑜𝑜𝑜𝑜 𝑝𝑝𝑝𝑝𝑝𝑝𝑝𝑝𝑝𝑝𝑝𝑝𝑝𝑝𝑝𝑝 𝑖𝑖𝑖𝑖 𝑃𝑃𝑃𝑃𝑃𝑃 𝑏𝑏𝑏𝑏𝑏𝑏𝑏𝑏𝑏𝑏
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2.2.7

Statistical analysis

For weight and temperature analysis, separate univariate ANOVAs were conducted for
temperature change at 3 h post-injection (GD9.5 saline n = 10, GD9.5 Poly I:C n = 9,
GD14.5 saline n = 3, GD14.5 Poly I:C n = 3), temperature change 24 h post-injection
(GD9.5 saline n = 5, GD9.5 Poly I:C n = 7, GD14.5 saline n = 3, GD14.5 Poly I:C n = 3)
and weight change at 24 h post-injection (GD9.5 saline n = 6, GD9.5 Poly I:C n = 6,
GD14.5 saline n = 4, GD14.5 Poly I:C n = 4). All the Poly I:C injections in these rats were
using the same batch of Poly I:C. Sample size mismatch between analyses is evident
because a) temperature was not collected in one saline and one Poly I:C GD14.5 dam and
b) 24-h weight/temperature could not be collected in dams that were sacrificed for qRTPCR analysis, which was only performed at GD9.5. Some extra dams underwent the same
injection procedure and weight/temperature measurement, but their offspring or tissue
were used in other studies.
Data obtained from the behavioural tests described above were analyzed using IBM SPSS
Statistics version 26 and graphed using GraphPad Prism version 7.00 for Windows. Data
were scanned for extreme outliers (>3 interquartile ranges from the median) using the
explore function in SPSS. The most extreme outlier across multiple behavioural tests was
excluded in a litter-sex-specific manner (e.g the most extreme GD9.5 saline male in litter
1, the most extreme GD9.5 saline male in litter 2, etc.). After the exclusion of litter-sexspecific outliers, the same outlier analysis was performed but this time in a prenatal
treatment-sex specific manner (e.g the most extreme GD9.5 saline male across all litters,
the most extreme GD9.5 Poly I:C male across all litters, etc.). After outlier analysis a total
of 128 rats were included in the results: 24 GD9.5 saline offspring (11 males, 13 females),
37 GD9.5 Poly I:C animals (20 males, 17 females), 32 GD14.5 saline animals (16 males,
16 females) and 35 GD14.5 Poly I:C animals (19 males, 16 females). All data shown for
all the different behavioural measures below represent the same animals per litter, prenatal
treatment, and sex.
For each behavioural test, a three or four-way repeated-measures analysis of variance
(ANOVA) was conducted separately for GD9.5 and GD14.5 offspring because GD9.5 and
GD14.5 testing did not occur at the same time which may affect baseline values in our
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behavioural measures. Additionally, separate ANOVAs were conducted for adolescent and
adult offspring as most of our measures are inherently influenced by weight. Although
weight was not recorded in this experiment and therefore could not be used as a covariate
in the startle reactivity analysis, unpublished data from our lab indicates that within sex/age
groups (e.g adult males), weight fluctuations are not correlated with startle response
amplitude. All ANOVAs included sex and prenatal treatment (saline vs Poly I:C) as
between-subject factors. Additional within-subject factors were included based on the
measure of interest: Stimulus intensity for startle reactivity, trial number for STH of startle,
day of testing for LTH of startle, and prepulse intensity and ISI for PPI.
ANOVAs were inspected for high-level interactions down to main effects. Analyses that
showed high-level interactions were split up into multiple sub-analyses based on which
factors were involved in the interaction (e.g after a high-level interaction of prenatal
treatment, stimulus intensity and sex, males and females were analyzed separately for
effects/interactions of prenatal treatment and stimulus intensity). Main effects were
computed using t-tests with Bonferroni adjustment for multiple comparisons. Data in
Figures 2-1 to 2-9 are shown as mean ± standard error of the mean. In Figure 2-10,
individual data points are represented as dots, with each litter being shown as a different
colour and the combined data from all litters are shown in black. Also in Figure 2-10, the
middle line in each data set indicates the median, and the error bars represent the 25th and
75th percentiles.
Table 2-1. Number of offspring used per group for behavioural experiments
GD9.5
Saline

GD14.5
Poly I:C

Male Female Male
Number
before outlier
exclusion
Sample for all
behavioural
data

Female

Saline

Poly I:C

Male Female Male Female

9

11

18

15

14

14

17

14

11

13

20

17

16

16

19

16
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2.2.8

Variability analysis

Between-litter variability: We quantified between-litter variability by analyzing litter as a
random factor using a variance component analysis. In this case, random refers to the fact
that our 3 or 4 litters are only a sample of infinitely many possible litters exposed to the
same treatment. We measured the extent to which between-litter variability impacts the
total variance in the whole group while taking into account fixed factors of sex and
treatment. For example, Figure 2-10C illustrates how much of the variance in the combined
group shown in black is simply due to differences between the green, purple, and red
subgroups. Specifically, we added the variance attributed to litter only and litter∗treatment
interaction in the GD9.5 and GD14.5 groups and expressed that as a ratio of the total
variance in the dataset. Litter only refers to between-litter variability that was similarly
present in both Poly I:C and saline offspring, whereas litter∗treatment refers to betweenlitter variability that was present to different extents in Poly I:C offspring compared to
saline offspring.
Within-litter variability: To quantify the extent of the sampling bias that can be present in
instances of high within-litter variability, we analyzed data from the first litter of each
experimental group, because those litters were not culled. Additionally, we only used PPI
data, so that males and females could be combined to obtain a bigger sample. PPI data is
normalized for each animal and there were no interactions between prenatal treatment and
sex. Using this data set, we virtually recreated the process of culling, or randomly selecting
offspring from the entire litter to include in the PPI experiment. We generated a thousand
samples using RStudio (version 1.3.595) for every combination of sample size (2–7), age
(adolescent or adult), treatments (GD9.5 control, GD9.5 Poly I:C, GD14.5 control, GD14.5
Poly I:C), and PPI parameters (prepulse-ISI of 75–30, 75–100, 85–30 or 85–100), and
assessed how often the mean of those random samples fell outside the Interquartile (IQ)
range of the full litter (in Figure 2-10, the IQ range is outlined between the top and bottom
error bars), i.e. the sample is not representative of the whole litter.
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2.3 Results
2.3.1

Elevated cytokine gene expression in fetal tissue at 6 h
following Poly I:C injection, but no changes in body weight at
24 h or temperature at 3- or 24-h following Poly I:C injection

Univariate ANOVAs conducted separately for temperature change at 3 or 24 h following
Poly I:C showed no significant main effect of Poly I:C (Figure 2-1A; 3 h: F(1,21) = 0.01,
p = 0.923; 24 h: F(1,14) = 0.131, p = 0.723) and no interaction between Poly I:C and GD
(3 h: F(1,21) = 0.01, p = 0.923; 24 h: F(1,14) = 0.003, p = 0.956), indicating a similar lack
of temperature response following Poly I:C in both groups.
Similarly, a univariate ANOVA conducted for body weight change at 24 h post-injection
revealed no significant effect of injection (Figure 2-1B; F(1,16) = 0.586, p = 0.455) but a
significant GD∗Injection interaction (F(1,19) = 4.931, p = 0.041). However, post-hoc
testing with Bonferroni correction for multiple comparisons showed no significant effect
of injection for either GD14.5 (p = 0.072 with Poly I:C > saline) or GD9.5 (p = 0.267 with
Poly I:C < saline).
In a subset of dams from the animals described above in weight and temperature analysis,
we confirmed the efficacy of the Poly I:C batch used in this experiment using qRT-PCR.
This was performed on fetal tissue collected 6 h after GD9.5 Poly I:C or saline injection,
and involved measuring gene expression of pro and anti-inflammatory cytokines
commonly elevated following Poly I:C. Unpaired t-tests conducted separately for each
cytokine revealed a significant increase in the fetal gene expression of Interleukin-6 (t(10)
= 6.40, p < 0.001), Interleukin-10 (t(10) = 3.40, p = 0.007), Tumor Necrosis Factor-α (t(10)
= 6.26, p < 0.001) and Interferon-γ (t(10) = 3.37, p = 0.007) when compared to salineinjected control animals (Figure 2-1C).
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Figure 2-1. Maternal Poly I:C injection induces a robust cytokine response in
fetal tissue. Maternal temperature was measured at 3 and 24-hours following Poly
I:C or saline injection, whereas maternal body weight was measured 24 hours
following injection. A) Poly I:C did not influence maternal temperature at 3 hours
(left; p=0.923) and 24 hours (right, p=0.723) following injection. B) Poly I:C did not
influence maternal weight at 24 hours (p=0.455) following injection. C) Poly I:C
fetuses exhibited an increase in gene expression of Interleukin-6 (p < 0.001),
Interleukin-10 (p = 0.007), Tumor necrosis factor α (p < 0.001) and Interferon-γ (p
= 0.007) 6 hours after injection. For animal numbers per group, please refer to Table
2-3.

2.3.2

Increased startle reactivity in the adult

Startle reactivity was measured to increasing startle stimulus intensities between 70 and
110 dB in 5 dB increments. Neither GD9.5 nor GD14.5 Poly I:C offspring group showed
changes in startle reactivity in adolescence (Figure 2-2). Three-way repeated-measures
ANOVAs with stimulus intensity as a within-subject factor revealed no significant
interactions between prenatal treatment, sex, and stimulus intensity. Main effects of
prenatal treatment and sex were also not significant, and the only significant effect was that
of stimulus intensity (GD9.5: Greenhouse-Geisser correction applied; F(5.475,627) =
79.897, p < 0.001, partial η2 = 0.584, ε = 0.498; GD14.5: Greenhouse-Geisser correction
applied; F(5.285,682) = 117.262, p < 0.001, partial η2 = 0.654, ε = 0.480).
In contrast, adult offspring of the GD9.5, but not of the GD14.5 Poly I:C group, exhibited
increased startle reactivity independent from sex, particularly at 105- and 110-dB stimulus
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intensities (Figure 2-3). Three-way repeated-measures ANOVAs with stimulus intensity as
a within-subject factor revealed no significant three-way interactions between prenatal
treatment, sex, and stimulus intensity. However, there was a significant interaction between
stimulus intensity and GD9.5 prenatal treatment (Greenhouse-Geisser correction applied;
F(4.112, 627) = 2.607, p = 0.035, partial η2 = 0.044, ε = 0.374). Post-hoc comparison of
startle amplitude between GD9.5 Poly I:C and saline offspring at each stimulus intensity
with Bonferroni correction showed a significant increase in startle reactivity at 105 and
110 dB stimulus intensity for GD9.5 Poly I:C offspring (p = 0.008 and 0.003 respectively).
For GD14.5 offspring, there was no interaction between stimulus intensity and prenatal
treatment (Greenhouse-Geisser correction applied; F(5.074, 693) = 0.250, p = 0.941, partial
η2 = 0.0004, ε = 0.461) and no main effect of prenatal treatment (F(1,63) = 0.141, p =
0.709, partial η2 = 0.002).
G D 1 4 .5

S ta r tle A m p litu d e

G D 9 .5

Figure 2-2. Neither GD9.5 nor GD14.5 Poly I:C treatment change startle
reactivity in adolescent offspring. Data is shown for both males and females from
saline and Poly I:C offspring for each time point. A 3-way repeated measures
ANOVA conducted separately for GD9.5 and GD14.5 adolescent offspring showed
a significant effect of stimulus intensity (p < 0.001) with no interactions or main
effects associated with prenatal treatment. For animal numbers per group, please
refer to Table 2-3.
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Figure 2-3. GD9.5 but not GD14.5 Poly I:C treatment increases startle
reactivity in adult offspring regardless of sex. Data is shown for both males and
females from saline and Poly I:C offspring for each timepoint. For GD9.5 adult
offspring, a 3-way repeated measures ANOVA showed a main effect of prenatal
treatment (p = 0.007), as well as an interaction between stimulus intensity and
treatment (p = 0.035). Post-hoc analysis with Bonferroni correction showed
significant differences for stimulus intensities of 105 and 110 dB. There was no
significant interaction between prenatal treatment and sex (p = 0.808). In contrast, a
3-way repeated measures ANOVA conducted for GD14.5 adult offspring showed no
main effect (p = 0.709) of prenatal treatment or significant interactions associated
with it. For animal numbers per group, please refer to Table 2-3.

2.3.3

No changes in short-term habituation of startle

Short-term startle habituation was measured through the animals’ startle amplitude across
the first 20 habituation trials on day 1 of startle testing. All adolescent offspring showed
STH, and neither GD9.5 nor GD14.5 Poly I:C treatment had an impact on STH (Figure
2-4). Three-way repeated-measures ANOVAs with trial number as a within-subject factor
revealed no significant three-way or two-way interactions when considering the factors of
trial number, prenatal treatment, and sex. However, both GD9.5 and GD14.5 offspring
exhibited a main effect of trial number, indicating STH across trials (GD9.5: GreenhouseGeisser correction applied; F(8.774,1083) = 2.466, p = 0.010, partial η2 = 0.041, ε = 0.452;
GD14.5: Greenhouse-Geisser correction applied; F(11.417,1197) = 4.467, p < 0.001,
partial η2 = 0.066, ε = 0.601). All offspring groups showed STH as measured by STH score
values larger than 1. Univariate ANOVAs were conducted separately for GD9.5 and
GD14.5 offspring on the STH score with sex and prenatal treatment as between-subject
factors. Neither analysis showed significant interactions with or main effects of prenatal
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treatment, indicating that neither GD9.5 nor GD14.5 impact STH score in adolescent
offspring.
In adulthood, all offspring also showed STH across trials (Figure 2-5). Three-way repeatedmeasures ANOVAs with trial number as a within-subject factor revealed a non-significant
trend for an interaction between trial and prenatal treatment in GD9.5 offspring, potentially
pointing towards an impact of prenatal Poly I:C on STH (GD9.5: Greenhouse-Geisser
correction applied; F(8.852,1083) = 1.815, p = 0.064, partial η2 = 0.031, ε = 0.466;
GD14.5: Greenhouse-Geisser correction applied; F(9.697,1197) = 1.480, p = 0.145, partial
η2 = 0.023, ε = 0.510). STH scores were calculated as described in the previous paragraph,
and univariate ANOVAs were conducted separately for GD9.5 and GD14.5 offspring on
the STH score with sex and prenatal treatment as between-subject factors. Once again,
neither analysis showed significant interactions with or main effects of prenatal Poly I:C
treatment, indicating that the trend towards a prenatal treatment and trial interaction in
GD9.5 offspring is likely due to the increased startle reactivity in adult Poly I:C offspring
rather than changes in STH.

Figure 2-4. Neither GD9.5 nor GD14.5 Poly I:C treatment change short-term
habituation of startle in adolescent offspring. Data is shown for both males and
females from saline and Poly I:C offspring for each timepoint. A 3-way repeated
measures ANOVA conducted separately for GD9.5 and GD14.5 offspring showed a
main effect of trial (p < 0.001 for both analyses), but no significant main effect of
prenatal treatment or interactions between prenatal treatment and sex or prenatal
treatment and trial, indicating short-term habituation across all groups and no effects
of either prenatal Poly I:C exposures. Insets show quantification of short-term
habituation using a ratio of startle amplitude on the first 5 trials divided by startle
amplitude on the last 5 trials, with values > 1 indicating short term habituation of
startle. For animal numbers per group, please refer to Table 2-3.
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Figure 2-5. GD9.5 and GD14.5 adult offspring exhibit similar short-term
habituation to controls, but GD9.5 offspring show a strong trend to increased
startle reactivity in the first few trials of the habituation block. Data is shown for
both males and females from saline and Poly I:C offspring for each timepoint. For
GD9.5 offspring, a 3-way repeated measures ANOVA showed strong trends for a
main effect of prenatal treatment (p = 0.074) and an interaction between trial and
prenatal treatment (p = 0.064 with Greenhouse-Geisser correction). In contrast, there
were no significant main effects or interactions associated with prenatal treatment for
GD14.5 offspring. Insets show quantification of short-term habituation using the
ratio of startle amplitude of the 5 first trials divided by the last 5 trials. For animal
numbers per group, please refer to Table 2-3.

2.3.4

Changes of long-term habituation of startle in the adult

LTH was measured through the animals’ startle amplitude on the first 5 trials of startle
testing across 5 days of testing. LTH was not impacted in adolescent offspring (Figure 2-6).
Three-way repeated-measures ANOVAs with day as a within-subject factor revealed no
significant interactions or main effects associated with prenatal treatments for either
timepoint. Interestingly, neither adolescent groups showed a main effect of day (GD9.5:
Greenhouse-Geisser correction applied; F(3.408,228) = 0.416, p = 0.766, partial η2 =
0.007, ε = 0.852; GD14.5: Greenhouse-Geisser correction applied; F(3.438,252) = 1.018,
p = 0.392, partial η2 = 0.016, ε = 0.859), indicating a lack of long-term habituation in all
groups, which may be attributed to the offspring’s age or the nature of protocol used.
In adulthood, startle reactivity was increased in the GD9.5 Poly I:C group (see above), but
there was no change in LTH (Fig. 2-7). In the GD14.5 Poly I:C group, the rate but not
extent of LTH was changed in males. Three-way repeated-measures ANOVAs conducted
for GD9.5 offspring with day as a within-subject factor revealed significant main effects
of prenatal treatment (F(1,57) = 4.616 p = 0.036), sex (F(1,57) = 12.237, p = 0.001) and
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day (F(4,228) = 5.690, p < 0.001) with no interactions between the 3 factors. These results
indicate that while startle amplitude is generally increased across all 5 days in GD9.5 Poly
I:C offspring, LTH is intact, although generally weak LTH in females may be a
confounding factor (Figure 2-7). A similar analysis conducted for GD14.5 offspring
revealed a significant three-way interaction between prenatal treatment, sex, and day
(F(4,232) = 5.627, p < 0.001). Two-way repeated-measures ANOVAs were then conducted
separately for GD14.5 males and females and those revealed a significant interaction
between prenatal treatment and day in male offspring (F(4,112) = 3.321, p = 0.013). Posthoc comparison with Bonferroni correction showed a significant decrease in startle
amplitude for GD14.5 Poly I:C males on day 3 (p = 0.019), potentially indicating faster
LTH, although the total habituation after 5 days of testing was unchanged as evidenced by
a lack of difference in startle amplitude on days 1 and 5.

G D 1 4 .5
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S ta r tle A m p litu d e

G D 9 .5

Figure 2-6. Neither GD9.5 nor GD14.5 Poly I:C treatment change adolescent
startle reactivity or long-term habituation of startle as measured by the first 5
trials of the habituation block. Data is shown for both males and females from
saline and Poly I:C offspring for each timepoint. A 3-way repeated measures
ANOVA conducted separately for GD9.5 and GD14.5 adolescent offspring showed
no significant main effect of prenatal treatment or any interactions with day or sex.
Interestingly, all adolescent offspring failed to show strong long-term habituation (p
= 0.797 and p = 0.399 respectively for main effect of day). For animal numbers per
group, please refer to Table 2-3.
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Figure 2-7.
GD9.5 and GD14.5 adult offspring exhibit similar long-term
habituation to controls, but GD9.5 offspring show higher startle reactivity
across days as measured by the first 5 trials of the habituation block. Data is
shown for both males and females from saline and Poly I:C offspring for each
timepoint. For GD9.5 offspring, a 3-way repeated measures ANOVA revelead
significant main effects of day, prenatal treatment and sex, but no interactions
between them (p < 0.001, p = 0.036 and p = 0.01 respectively).A similar analysis was
conducted and a 3-way interaction followed by post-hoc testing revealed a significant
decrease in startle reactivity only on day 3 for male Poly I:C offspring. For animal
numbers per group, please refer to Table 2-3.

2.3.5

No changes in prepulse inhibition of startle

PPI was measured on day 1 of startle testing with a variety of prepulse intensities and ISI.
Four-way repeated-measures ANOVAs with prepulse intensity and ISI as within-subject
factors revealed no significant interactions with or main effects of prenatal treatment in
adolescent offspring of the GD9.5 or GD14.5 Poly I:C group (Figure 2-8). Higher prepulses
and shorter ISIs were associated with increased PPI across all groups (GD9.5 prepulse main
effect F(1,57) = 22.239, p < 0.001; GD9.5 ISI main effect F(1,57) = 6.110, p = 0.016;
GD14.5 prepulse main effect F(1,63) = 72.062, p < 0.001; GD14.5 ISI main effect F(1,63)
= 12.482, p < 0.001).
Four-way repeated measures ANOVAs conducted for adult GD9.5 offspring with prepulse
intensity and ISI as a within-subject factors revealed a significant three-way interaction
between ISI, prenatal treatment, and sex (F(1,57) = 4.483, p = 0.039). Three-way repeatedmeasures ANOVAs were then conducted separately for GD9.5 males and females and
those revealed a significant interaction between ISI and prenatal treatment in female
offspring (F(1,28) = 6.824, p = 0.014) with a trend for increased PPI in Poly I:C offspring
at 30 ms ISI, but the result did not reach statistical significance after Bonferroni correction
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for multiple comparisons (F(1,28) = 3.740, p = 0.063). A similar analysis for adult GD14.5
offspring revealed no significant interactions or main effects associated with prenatal
treatment (Figure 2-9).
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Figure 2-8. Neither GD9.5 nor GD14.5 Poly I:C treatment change PPI in
adolescent offspring across a variety of prepulse conditions. Data is shown for
both males and females from saline and Poly I:C offspring for each timepoint. A 4way repeated measures ANOVA conducted separately for GD9.5 and GD14.5
adolescent offspring showed main effects of prepulse (PP) intensity and ISI for both
groups but no main effect or interactions associated with prenatal treatment (see text
for detailed statistics). For full animal numbers, please refer to Table 2-3.
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Figure 2-9. Neither GD9.5 nor GD14.5 Poly I:C treatment change PPI in adult
offspring across a variety of prepulse conditions. Data is shown for both males
and females from saline and Poly I:C offspring for each timepoint. A 4-way repeated
measures ANOVA conducted separately for GD9.5 and GD14.5 adolescent offspring
showed main effects of prepulse (PP) intensity and ISI for both groups, but no main
effect or interactions associated with prenatal treatment, besides a significant threeway interaction between ISI, prenatal treatment and sex in GD9.5 offspring (see text
for detailed statistics). For full animal numbers, please refer to Table 2-3.
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2.3.6

Variability analysis

In the process of data analysis, we noticed instances of high variability of some measures
between litters of the same experimental group, and also within specific litters (Figure
2-10). In the next section, we attempt to describe the extent to which between- and withinlitter variability impacted our results.

2.3.6.1

Between-litter variability

To have an estimate on the extent to which between-litter variability impacts the total
variance in the whole group, we performed a variance component analysis. The results are
shown in Table 2-4.. When considering all 7 measures and ages, between-litter variability
accounted for 18% of the variance in GD14.5 offspring data (saline and Poly I:C offspring
combined), but only 9.6% of the variance in GD9.5 offspring data. Between-litter
variability was also more prominent in adolescence in GD9.5 offspring data (11.5%
compared to 7.7% in adulthood) and in adulthood in GD14.5 offspring data (20.4%
compared to 15.7% in adolescence). Splitting up by phenotype, the between-litter effects
do not impact all behavioural measurements to the same extent. For example, betweenlitter variability accounted for approximately 18.6% of all PPI variance (averaged across
ages, treatments, parameter subtypes), but only about 3% of all habituation score data
variance. Even within the same paradigm (PPI), between-litter effects were different across
different testing parameters, most prominently seen in GD14.5 adult offspring, where
almost half of the data’s variance (44%) was attributed to between-litter effects in
conditions with an ISI of 100 ms.
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Table 2-2. Between litter variability in seven startle phenotypes. All values in
the table represent the percent variance component of litter + litter*treatment within
each prenatal exposure group (GD9.5 or GD14.5)

2.3.6.2

Within-litter variability

When looking closely at individual litters, we observed that even within the same
experimental group, one litter’s data could be much more variable compared to another
litter (Figure 2-10B). This has implications when a very small sample of e.g. only two
animals per litter are tested. For example, as depicted in Figure 2-10D, choosing the two
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animals tagged by arrows would provide a biased overestimate of litter 1’s PPI phenotype
at 75 dB prepulse and 100 ms ISI, which we refer to as sampling bias.
Figure 2-11 shows the percentage of samples, drawn from litter 1 of each group, that had
a mean falling outside the IQ range of the full litter (Y-axis, probability of obtaining a
biased sample). It clearly shows that testing more animals per litter reduces the probability
of obtaining biased estimates of the litter’s phenotype. This relationship holds regardless
of age or prenatal treatment. Despite all lines in Figure 2-11 following a similar downward
trajectory with an increased sample size, there is still some variation between different
groups (differences between symbols within the same graph), which could be attributed to
each group’s data distribution. We wanted to see precisely which aspects of a full litter’s
data could explain this variation. For example, perhaps it is more likely to pick biased
samples from a litter whose data has a higher standard deviation, or whose data is not
normally distributed. For this purpose, we split up all the PPI conditions to obtain more
datasets, each with their unique distribution. We found a positive correlation between the
probability of obtaining a biased sample and the kurtosis or absolute skewness of the litter’s
data, regardless of the sample size (Appendix C, Appendix D). Skewness and kurtosis are
both measures of normality and give an idea of the shape of the distribution. For example,
in Figure 2-10D, the litter 3 (green) is relatively non-skewed, with the top and bottom
quartile bars being a similar distance from the median, whereas litters 2 and 4 (red and
purple) are skewed in different directions. To interpret this correlation using our results,
the odds of a sample chosen from litter 2 misrepresenting litter 2’s full data are higher than
the odds of a sample chosen from litter 3 misrepresenting litter 3’s full data.
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Figure 2-10. A representation of between and within litter variability in PPI
measures in our control and Poly I:C offspring. Within each group, litters are
depicted by different colours and each dot represents a single animal. The black
group simply contains the entire group’s data, which was used to calculate effects in
the results section. Error bars represent each group’s 25th and 75th quartiles are
drawn in reference to the group’s median.
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Figure 2-11. The probability of a random sample of 2–7 animals picked out
from litter 1 of each group to produce a biased estimate of the litter’s PPI
phenotype. Data was averaged across all four PPI conditions (prepulse-ISI
combinations) used in our experiment. A biased estimate was considered to be a
sample mean falling outside of the full litter’s IQ range. A thousand random samples
of size 2–7 were generated from each group’s first litter, where animals were not
culled, for each PPI condition. Each sample’s average was compared to the full
litter’s 25th and 75th quartiles for that PPI condition. The number of samples out of
1000 that fell above the 75th or below the 25th quartiles averaged across all four PPISI conditions is represented on the Y-axis.

2.4 Discussion
In this study, we thoroughly investigated phenotypes associated with the baseline startle
reflex and its modulations in animals exposed to GD9.5 prenatal immune activation using
Poly I:C. Acoustic startle reactivity, habituation, and PPI are all common phenotypes
measured in ASD and schizophrenia clinical studies, two disorders that have been
repeatedly linked with an increased risk after maternal infection. We report a robustly
increased startle response amplitude in offspring after an early (GD9.5) MIA, but not after
GD14.5. We did not find any consistent effects on STH or LTH, nor PPI of startle.

2.4.1

Immune response following Poly I:C

In our study, neither GD9.5 nor GD14.5 influenced maternal body weight at 24 h postinjection, which conflicts with previous studies using similar MIA rat models (Chou et al.,
2015; Howland et al., 2012; Murray et al., 2017; Sangha et al., 2014; Zhang et al., 2012).
Similarly, we did not detect changes in maternal temperature at 3 h following Poly I:C,
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which has previously been shown following 5 mg/kg of Poly I:C (Murray et al., 2019).
However, others have also reported no significant changes in body weight gain (Vernon et
al., 2015) or temperature (Murray et al., 2017; Sangha et al., 2014) following Poly I:C
administration, although the latter two studies measured maternal temperature at 8 h.
Overall, we conclude that maternal temperature and body weight gain following Poly I:C
are unreliable measures of the maternal immune response, especially given our
confirmation of a robust gene expression response in fetal tissue 6 h following
administration of the same batch of Poly I:C in GD9.5 dams, which suggests that the Poly
I:C used in this experiment contained sufficient amounts of high molecular weight strands
known to induce a cytokine response at 6 h post-injection (Careaga et al., 2018). Although
we did not conduct a similar gene expression test in GD14.5 dams, there is ample evidence
to support the efficacy of Poly I:C when injected at GD14.5 (Haddad et al., 2020) and little
to suggest that Poly I:C leads to substantially different immune responses when injected at
different gestational time points in rats.

2.4.2

Startle reactivity

Our data show that GD9.5 but not GD14.5 Poly I:C administration increases startle
reactivity in the offspring in adulthood. Previous studies investigating startle reactivity in
adults with ASD have reported an increase in startle reactivity to 110 dB startle stimuli, as
well as an increase in the probability of startle to 80 dB prepulse stimuli (Kohl et al., 2014).
In our study, GD9.5 Poly I:C offspring also exhibited an increase in startle reactivity to
110 dB stimulation. However, startle amplitude was unchanged at lower stimulus
intensities and due to the methods of data acquisition, we were unable to accurately
determine the probability of startle for these stimuli. One limitation of the GD9.5 Poly I:C
model in replicating startle reactivity changes seen in ASD is the relatively late phenotype
manifestation. Startle reactivity is increased in children and adolescents with ASD to
sounds as quiet as 65 dB (Takahashi et al., 2016, 2014) whereas our adolescent GD9.5 Poly
I:C offspring did not exhibit changes in startle reactivity to any sounds in the range of 65–
120 dB.
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The majority of Poly I:C studies that investigated startle reactivity in GD9.5 Poly I:C
offspring report no change in this phenotype (Meyer et al., 2010; Vuillermot et al., 2011;
Meehan et al., 2017), although some conflicting reports of increased reactivity exist (Kim
et al., 2018). Our startle reactivity measurements are more sensitive to detecting changes
in ASR amplitude than previous Poly I:C studies, since we measure the ASR amplitude in
a separate session with a minimum number of trials to avoid any effects of STH on our
readout. Our STH results show that habituation is intact in GD9.5 Poly I:C offspring and
could therefore mask the startle reactivity changes if reactivity is measured using an
average that includes habituated trials. Our STH curves indicate by the 10th trial of our
habituation block, startle reactivity is indistinguishable between GD9.5 Poly I:C and
control offspring. In further support of this notion, ASR amplitude to startle only trials
during the PPI block of our experiment was not significantly different between GD9.5 Poly
I:C and control offspring (data not shown). We also did not detect significant changes in
ASR amplitude at 120 dB, suggesting that a ceiling effect may prevent the detection of
reactivity changes in Poly I:C rodent studies. Furthermore, previous Poly I:C studies almost
exclusively utilize 120 dB startle stimuli that are 40 ms in duration (Kim et al., 2018; Meyer
et al., 2008; Song et al., 2011; Van den Eynde et al., 2014; Wolff and Bilkey, 2010; Zhang
and van Praag, 2015). Our choice of a less intense 20 ms, 110 dB stimulus may therefore
be more suitable to detect changes in startle reactivity.

2.4.3

Startle habituation

Neither GD9.5 nor GD14.5 Poly I:C influenced STH in the offspring, as measured by the
decrease in startle reactivity over 20 consecutive startle-only trials, and this is in line with
the handful of Poly I:C studies that investigated STH (Meyer et al., 2005; O’Leary et al.,
2014; Wolff and Bilkey, 2008; Zhang and van Praag, 2015). These findings are more akin
to normal habituation in ASD (Ebishima et al., 2019; Kohl et al., 2014; Takahashi et al.,
2017) as compared to habituation deficits sometimes observed in patients with
schizophrenia (Meincke et al., 2004; Mena et al., 2016). However, some conflicting
evidence reporting normal habituation in schizophrenia does exist (Oranje and Glenthøj,
2013; Swerdlow et al., 2014). As described in the methods section, we took a different
approach to measure STH compared to previous studies. Our consideration of all trials in
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the habituation block, which occurs at the beginning of the testing session, gives a better
representation of trial-by-trial STH and also more clearly identifies the presence or absence
of startle sensitization, which often occurs in later trials and may confound startle
habituation scores.
In contrast to STH, LTH of startle has been rarely studied in Poly I:C studies. Our results
show that similar to STH, LTH is not influenced by prenatal exposure to GD9.5 or GD14.5
Poly I:C. Typically, LTH is not part of human startle testing protocols, likely due to the
difficulty of bringing in patients for recurrent testing across days. However, one previous
report of normal LTH in individuals with ASD (Ornitz et al., 1993) is in line with our
results. We also found that adolescent animals, regardless of prenatal treatment, did not
exhibit substantial LTH across testing days, which may be related to the developmental
time course of habituation mechanisms. For example, Pletnicov et al. (1995) showed that
pre-weanling rats exhibit STH but not LTH of acoustic startle. In contrast, adult offspring
demonstrated robust LTH across 5 days of testing, as shown by a decrease in startle
baseline amplitude measured as an average of the first 5 trials across test days.
Interestingly, GD14.5 Poly I:C males showed faster LTH than controls, although the
significance of this result is diminished by the observation that controls only required one
more day to reach a similar degree of LTH.

2.4.4

Prepulse inhibition of startle

To our surprise, neither GD9.5 nor GD14.5 Poly I:C treatment showed a consistent impact
on PPI in adolescent or adult offspring. The closest trend to a significant effect was an
increase in PPI at 30-ms ISI in adult GD9.5 Poly I:C females, although the effects were not
significant after adjustment for multiple comparisons. Since startle reactivity was
indistinguishable between groups at the end of the habituation block, we do not assume
that changes in baseline startle reactivity impacted PPI. In the context of ASD and
schizophrenia, the two disorders most commonly linked with MIA, these findings are more
similar to reports of no change in PPI in ASD (Ebishima et al., 2019; Madsen et al., 2014;
Oranje et al., 2013; Takahashi et al., 2016) as opposed to the overwhelming evidence of
PPI disruptions in schizophrenia (Csomor et al., 2009; Hammer et al., 2011; Swerdlow et
al., 2018, 2014).
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The lack of PPI disruption in our study is in contrast to previous reports of decreased PPI
in GD9.5 (Meehan et al., 2017; Meyer et al., 2008; Vuillermot et al., 2011) and GD14.5
(Luchicchi et al., 2016; Wolff and Bilkey, 2010; Zhang and van Praag, 2015) Poly I:C
studies. However, there are also numerous reports of no changes in PPI for either GD
(Abazyan et al., 2010; Ballendine et al., 2015; Chou et al., 2015; Gray et al., 2019; Lipina
et al., 2013; Missault et al., 2014; Vorhees et al., 2012). It is important to note that early
timepoints of Poly I:C exposure such as GD9.5 are not well studied in rats, as discussed in
a recent review that classified studies based on Poly I:C exposure categories of dose,
timing, and route of administration (Haddad et al., 2020). Moreover, contrasting rat data to
mouse data is not straightforward, given the slight but substantial difference in
developmental timeline across the two species (http://translatingtime.org; Haddad et al.,
2020).
We confirmed the efficacy of the Poly I:C we used in eliciting an innate immune response
in a subset of dams injected with Poly I:C at GD9.5. Despite not performing this analysis
in GD14.5 dams, previous studies support the efficacy of Poly I:C administered using
similar procedures at GD14.5 in rats (Clark, 2019; Gray et al., 2019). Similar dosing and
administration methods are followed in virtually all GD14.5 Poly I:C rat literature (see
Haddad, 2020 for review), and we are not aware of literature that suggests different Poly
I:C responses based on gestational timing in rats. Therefore, it is not likely that the Poly
I:C we used was ineffective.
Our PPI protocol contained shorter stimulus durations for both the startle pulse (20 ms
compared to the most commonly used 40 ms) and the prepulse (4 ms compared to the most
commonly used 20 ms). Shorter prepulses produce less intense PPI (Reijmers and Peeters,
1994). As a result, our shorter prepulses may have lowered the baseline PPI values across
all groups, making it more difficult to detect subtle differences in PPI between groups. We
intentionally chose shorter prepulse durations to reduce PPI and avoid ceiling effects when
using shorter ISIs of 30 ms, which typically produce greater PPI compared to longer (and
more commonly used) ISIs of 100 ms (Azzopardi et al., 2018; Schmid et al., 2011;
Valsamis and Schmid, 2011; Yang et al., 2016). Additionally, we did not include an
intermediate prepulse between 75 and 85 dB to avoid a large number of trials, which often
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leads to extensive habituation that makes it difficult to detect the startle response. Some
studies also indicate that PPI phenotypes may differ if the startle stimulus intensity is
changed, which could explain the variability in PPI findings across studies (WeberStadlbauer et al., 2017; Mueller et al., 2018; Luan et al., 2018; Vuillermot et al., 2010).

2.4.5

Variability analysis

Litter variability has been a topic of discussion in toxicology and neurodevelopmental
models for several decades, specifically in relation to models that investigate prenatal
exposures such as Poly I:C (Golub and Sobin, 2020). Within the Poly I:C literature, there
is a trend towards increasing the number of litters and reducing the number of pups used
per litter, typically 1–2 animals are used per litter (e.g see recent Poly I:C literature: Clark
et al., 2019, De Felice et al., 2018, Di Biase et al., 2020, Haida et al., 2019, Kleinmans and
Bilkey, 2018, Purves-Tyson et al., 2019; Zhang et al., 2019). In this case, within-litter
variability has implications for whether the chosen rats are representative of the litter’s
phenotype. Alternatively, between-litter variability has implications for whether the full
group’s phenotype is attributable to the treatment or is simply an artifact of differences
between litters. We therefore attempted to analyze between- and within-litter variability in
our results to highlight important considerations for the Poly I:C MIA field.
Overall, between-litter variability was more evident in GD14.5 data, particularly for PPI
(Table 1). This may have masked our ability to fully decipher the effects of Poly I:C on
PPI and may be the reason why our findings of no change in PPI conflict with some
previous reports of PPI disruption. In support of this notion, the vast majority of Poly I:C
literature measures PPI with 100 ms ISI, which is where we found the biggest betweenlitter variability in GD14.5 offspring (approximately 44%). The high between-litter
variability seems problematic in that it increases the variation of the final outcome. It makes
PPI a relatively unreliable measure, especially when a limited number of litters are tested.
It has been shown that there is a strong genetic component to PPI (Schwabe et al., 2007),
which might cause the large between-litter effects in these outbred rats. Moreover, there
might be a differential susceptibility to Poly I:C, so differences in impact of Poly I:C MIA
on PPI may help uncover factors that exacerbate or protect against MIA. Future studies can
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account for between-litter variability by conducting a similar variance component analysis
to ours or by analyzing data using mixed models that consider litter as a random factor.
In addition to between-litter variability, within-litter variability has many implications for
experimental designs where litters are culled, or only 1–2 animals are used per litter for the
experiment. The most crucial observation from our within-litter analysis is that picking
only two or three pups out of a litter for testing leads to a high probability of a biased
sample (up to 30% for large litters) that are not representative of the full litter’s data,
whereas measuring just over half of the litter (5/9 or 7/13) almost fully eliminates the
probability of the sampled group of animals over or underestimating the full litter’s
phenotype. We also show that litter data with skewness and kurtosis values that indicate
deviation from normality are more likely to produce biased samples (Appendix C,
Appendix D. Therefore, at least half of an average litter should be tested for an accurate
representation of the effects of Poly I:C on the offspring. Additionally, if a behavioural test
is known to produce skewed data in littermates, more animals per litter should be tested to
minimize sampling bias.
In summary, we here show that baseline startle reactivity is the only startle-related
phenotype that is robustly altered in Poly I:C offspring, whereas STH, LTH, and PPI were
unaffected in our study. Moreover, our study supports previous evidence highlighting the
importance of MIA timing (Li et al., 2009; Meyer et al., 2008; Richetto et al., 2017), as
startle reactivity changes were present in offspring exposed to GD9.5 but not GD14.5 Poly
I:C. Finally, our study quantifies the potential impact of between- and within-litter
variability on MIA results, suggesting that at least half the average litter size should be
tested and that litter should be included rather than avoided in statistical analysis to fully
understand the effects of MIA on offspring behavior.
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3

Interleukin-15 modulates the effects of Poly I:C maternal
immune activation on offspring behaviour

Chapter 3 is being prepared for submission as: Haddad, F.L., De Oliveira, D., Patel, S.V.,
Renaud, S.J., Schmid, S., (In prep). “Interleukin-15 modulates the effects of Poly I:C
maternal immune activation on offspring behaviour”

3.1

Introduction

In-utero exposure to maternal infection and the ensuing immune response are linked with
an increased risk for disorders like Autism Spectrum Disorder (ASD) and schizophrenia in
the offspring (Jiang et al., 2016; Khandaker et al., 2013). Since several bacterial and viral
infections show these associations, it is thought that rather than the specific infectious
agent, it is the maternal immune response that disrupts neurodevelopment.
Indeed, some epidemiological findings have shown positive correlations between maternal
cytokine levels and the extent of offspring risk (Abdallah et al., 2013; Allswede et al., 2016;
Brown et al., 2004b; Ellman et al., 2010; Goldstein et al., 2014; Jones et al., 2017; Zerbo
et al., 2014). In addition, preclinical models suggest that maternal immune activation
(MIA) during pregnancy, in the absence of a pathogen, leads to neurodevelopmental
disruption, which is associated with ASD and schizophrenia-related brain and behavioural
changes in the offspring (Haddad et al., 2020b; Solek et al., 2018).
Although preclinical MIA models have shown considerable face and predictive validity,
the mechanisms underlying MIA’s effects on the fetal brain still require further
investigation. Previous reports implicate cytokines such as Interleukin(IL)6, IL-10, and IL17 as important mediators of MIA’s effects on offspring behavioural phenotypes (IL-6:
Lipina et al., 2013; Pineda et al., 2013; Pratt et al., 2013; Smith et al., 2007; IL-17: Kim et
al., 2017; Lammert et al., 2018; Schwartzer et al., 2013; Shin Yim et al., 2017; IL-10:
Meyer et al., 2008). However, these cytokines represent a small part of the maternal
immune response, as evidenced by multiplex assays used to measure the fetal and maternal
immune responses following MIA (Arrode-Brusés and Brusés, 2012; Careaga et al., 2018).
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3.1.1

Interleukin-15

IL-15 is a cytokine that could play a role in Poly I:C MIA’s effects on the fetal brain, given
its role in immune regulation and the antiviral immune response. IL-15 mRNA expression
is widespread throughout the body, but the protein product is found in high concentrations
mainly in immune cells such as dendritic cells, monocytes, and macrophages (Perera et al.,
2012).
In macrophages, IL-15 regulates the production of proinflammatory cytokines such as
Tumor Necrosis Factor (TNF), IL1, and IL-6 (Alleva et al., 1997). Moreover, IL-15 is
elevated after injection of Poly I:C, the most commonly used immune stimulant in MIA
rodent models (Arrode-Brusés and Brusés, 2012; Mattei et al., 2001). IL-15 changes have
been detected in Poly I:C offspring blood as long as two weeks of age (Paraschivescu et
al., 2020).
Beyond its immune regulatory roles, IL-15 is required for the development of Natural
Killer (NK) cells, as shown by the lack of NK cells in IL-15 or IL-15Rα-deficient mice
(Kennedy et al., 2000; Lodolce et al., 1998). NK cells are innate immune cells found in the
circulation and various organs throughout the body (Shi et al., 2011). During pregnancy,
NK cells constitute a large portion of uterine leukocytes and their role goes beyond immune
regulation. In murine pregnancy, the number of uterine NK cells increases after
implantation, and both mice and rats lacking NK cells have shown changes in placental
structure (Moffett and Colucci, 2014; Renaud et al., 2017). Furthermore, NK cells may
play a role in pregnancy even before implantation by producing growth factors that enhance
fetal growth (Fu et al., 2017).

3.1.2

IL-15/NK cells and neurodevelopmental disorders

It is widely accepted that ASD and schizophrenia, the two neurodevelopmental disorders
most commonly linked with MIA, are characterized by immune changes in the brain and
periphery (Thom et al., 2019; Tomasik et al., 2016).
Genetic studies have linked ASD with an increase in Human Leukocyte Antigen (HLA)
polymorphisms associated with NK cell activation (Guerini et al., 2014; Harville et al.,
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2019; Torres et al., 2012) and a decrease in HLA polymorphisms associated with NK cell
inhibition (Guerini et al., 2014). Other findings complement these associations by showing
that NK cells from individuals with ASD are more strongly activated at baseline (Bennabi
et al., 2019), after stimulation with IL-15 (Vojdani et al., 2008) or in response to
Lipopolysaccharides (LPS; Rose et al., 2018). Interestingly, the latter finding with LPS
was seen in a subset of ASD patients that experience gastrointestinal symptoms. Despite
changes in the activation state of NK cells, results have been mixed with regards to the
number of circulating NK cells (Ashwood et al., 2011; Basheer et al., 2018; Vojdani et al.,
2008), while other studies also show no change in blood IL-15 levels (Pecorelli et al., 2016;
Saghazadeh et al., 2019).
In contrast to ASD patients, individuals with schizophrenia exhibit altered levels of IL-15
in their circulation. De Witte et al., (2014) found that IL-15 was elevated in five cohorts of
first-episode schizophrenia patients. In terms of NK cell number, the evidence is mixed
like in ASD (Fernandez-Egea et al., 2016; Karpiński et al., 2016). Furthermore, the
spontaneous activity of NK cells was not elevated in individuals with schizophrenia
(Caldwell et al., 1991; McDaniel et al., 1992; van Venrooij et al., 2012), although this may
be confounded by how NK activity is measured across studies (Yovel et al., 2000).

3.1.3

Rationale and hypothesis

So far, MIA studies have only scratched the surface of understanding the mechanisms
underlying MIA’s effects on the fetus. In particular, only a few cytokines have been studied
as potential mediators of MIA. IL-15, either directly or indirectly, may play an important
role in the effects of MIA on fetal brain development.
Direct mechanisms include its role as a component of the antiviral maternal immune
response and its ability to modulate both the immune system as well as the developing
nervous system. Indirectly, IL-15 is involved in the differentiation of NK cells, which
constitute a crucial part of the maternal-fetal interface (Sojka et al., 2019).
Based on these important roles of IL-15 in fetal brain development, I hypothesized that IL15 deficiency would alter the effects of Poly I:C on offspring behaviour. To test this
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hypothesis, I conducted a similar experiment as in Chapter 2 but using Poly I:C MIA at
GD9.5 in wildtype (WT) or IL-15 knockout dams. Aside from being the first to investigate
the connection between IL-15 and Poly I:C MIA, this study is the first to provide
information on behavioural phenotypes in IL-15-deficient rats. Behavioural results on IL15-deficiency in earlier studies were exclusively reported in mice (IL-15 or IL-15R
knockout models) showed increased fear conditioning, increased working memory,
increased depressive behaviour, and altered activity during the light phase of the circadian
cycle (He et al., 2010b, 2010a; Wu et al., 2011, 2010). Since this novel rat strain was only
established recently (Renaud et al., 2017), its behavioural repertoire has not yet been
thoroughly investigated.
This study is also the first to investigate the Auditory Brainstem Response (ABR) in a Poly
I:C model. The ABR assesses hearing sensitivity, neural responsivity, and speed of
neurotransmission in the auditory brainstem. Auditory disruptions linked to brainstem
processing such as hearing sensitivity and temporal processing are common in ASD
(Sinclair et al., 2017). The auditory brainstem may also be involved in sensory processing
deficits seen in schizophrenia. For example, structures like the inferior colliculus modulate
sensorimotor gating processes such as PPI which is decreased in schizophrenia (GómezNieto et al., 2020; Swerdlow et al., 2018; Yeomans et al., 2006). Furthermore, first
trimester infection with cytomegalovirus, a type of prenatal infection linked with ASD and
schizophrenia, is associated with hearing loss, which can be easily assessed using the ABR
(Foulon et al., 2008).

3.2
3.2.1

Materials and Methods
Animals

This study was conducted using Wildtype (WT) or IL-15 knockout male and female
Holtzman Sprague-Dawley rats. The generation of these rats was described previously by
Renaud et al., (2017). In brief, using zinc finger nuclease-mediated genome editing, a 7
base pair frame shift deletion was created within the second exon of Il5. The frameshift
resulted in a premature stop codon resulting in a truncated protein, and rats homozygous
for this mutation showed a severe lack of NK cells, the survival of which requires
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functional IL-15 Renaud et al., (2017). Rats were housed in open cages with corn cob
bedding, given ad libitum food and water, and kept on a 12 h light – 12 h dark cycle with
lights turning on at 7:00 am. Cages were enriched with polycarbonate huts and wrinkled
paper. Cage changes took place once a week except during behavioural testing procedures,
during which cage changes were carried out at the end of the 5-day startle protocols to
ensure long-term habituation measures were not influenced by cage change stress. All
behavioral testing and cage changes took place during the light phase (between 7:00 and
19:00 h).

3.2.2

Timed Breeding

Adult homozygous WT or IL-15-/- male rats were paired with a maximum of two adult
females of the same genotype at a time (homozygous breeding). After pairing, a vaginal
smear was collected from each female at 8 am every morning and inspected under a light
microscope to track the estrus cycle and check for the presence of sperm. If sperm was
detected in the smear, the female was considered pregnant and that day was considered as
Gestation Day (GD) 0.5. Pregnant females were then separated from the male on GD0.5
and transferred into a single cage, where they were left undisturbed until injection day
(GD9.5). Each female was only bred once in this experiment.

3.2.3

Maternal immune activation

Pregnant wildtype or IL-15-/- females were randomly assigned to receive either Poly I:C or
saline injections. MIA was induced using Poly I:C (Sigma), which had been previously
aliquoted and stored at -20⸰ C. We verified the effectiveness of the same batch of Poly I:C
in a previous study by measuring the expression of proinflammatory cytokines in the fetal
tissue 6 hours after Poly I:C injection, using quantitative reverse transcriptase polymerase
chain reaction (Haddad et al., 2020a). Poly I:C aliquots were diluted in 0.9% saline to
obtain a concentration of 4mg/ml. At around 10 am on GD9.5, pregnant females were
weighed and had their rectal temperature measured. Then, they underwent isoflurane
anesthesia (5% induction, 2% maintenance), during which they were injected with either
0.9% saline or 4mg/kg of Poly I:C into the tail vein. The injection procedure took an
average of 10 minutes after which rats were returned to their cages and were undisturbed
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besides temperature/weight measurement and weekly cage change. Temperature
measurements were taken 6- and 24-hours following injection, whereas maternal weight
was recorded 6, 24- and 48-hours following injection.
The day of parturition was designated as postnatal day (PND) 0. Offspring were weaned at
PND21, and littermates were separated based on sex and housed in groups of 2-4 rats per
cage. At the end of the experiment, the final number of litters per group was as follows:
WT saline, 3 litters; WT Poly I:C, 4 litters; IL-15-/- saline, 3 litters; IL-15-/- Poly I:C, 5
litters. All litters were culled to 3-5 animals per sex per litter at 1 week of age. The final
number of offspring included for analysis per group, litter and sex is included in the
statistical analysis section of the article.

3.2.4

Offspring testing outline

Auditory Brainstem Response (ABR) and behavioural testing occurred in adolescence and
adulthood. Adolescent testing began around PND38-39, and adult testing began around
PND90-100. Animals were weighed and underwent the same tests at each timepoint, with
the whole battery of ABR and behavioural tests taking about 10 days to complete. Tests
were performed in the following order: Startle acclimation and handling (Day 1), ABR
measurements (Days 2&3), social behaviour testing (Days 3 & 4), open field and startle
reactivity testing (Day 5), startle habituation testing (Days 6-9), and finally PPI testing
(Day 10). Due to time restraint, ABR testing was performed on only a subset of animals
that underwent behavioural testing (typically two animals per sex per litter). Adolescent
animals were handled at least twice before behavioural testing to get them acclimated to
the experimenters. The full experimental timeline is shown in Figure 3-1 (Created with
BioRender.com).
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Figure 3-1. Experimental timeline, offspring subgroups, and testing timeline

3.2.5

Acoustic Startle Response

Acclimation: Startle testing was performed as described by Valsamis and Schmid (2011).
In brief, rats were initially acclimated to the experimental procedure, Plexiglas animal
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holders, and startle chambers (Med Associates, Vermont, USA) by undergoing three 5minute acclimation sessions, at least 6 hours apart. During acclimation, the animals were
exposed to a 65dB (SPL) white noise background sound which is consistently present
throughout all startle testing procedures.
Startle Reactivity: After the acclimation sessions, startle reactivity in response to startle
stimuli of varying intensities was measured. This startle reactivity test consisted of 15 white
noise startle stimuli, 13 of which were 20 ms in duration, at intensities ranging from 65dB
to 120dB in 5dB increments, presented in a pseudorandomized order (110dB stimulus was
presented twice because this was the sound level chosen for PPI measurements). The other
two white noise stimuli presented corresponded to the pre-pulses presented in the PPI test
(4ms duration, 75 or 85dB). Based on data from the startle reactivity session, platform
sensitivity was adjusted for each rat to optimally detect the startle reflex. The adjusted
platform gain for each rat was used throughout all the remaining testing sessions.
Habituation: Following startle reactivity testing, animals underwent four consecutive days
of startle habituation testing to assess startle reactivity, STH and LTH. Each day, animals
were exposed to a 5-minute acclimation period with background noise, followed by a
habituation block of 30 trials. In the habituation block, each trial consisted of a 20ms-long,
100dB white noise stimulus after which the Peak to Peak maximum startle amplitude was
measured. Trials were separated by a fixed inter-trial interval (ITI) of 60 seconds. On the
fifth day, both startle habituation and PPI were measured in separate blocks. The
habituation block consisted of 20 startle trials using 110dB stimulus intensity. In the PPI
block, animals were exposed to either startle-only trials, with stimulus parameters the same
as those in the habituation block, or pre-pulse trials. Pre-pulse trials included a 4-ms long
white noise pre-pulse that was either 75 or 85dB loud and preceded the startle stimulus by
an interstimulus interval (ISI) of either 30 or 100ms. ISI was determined as the time
between the onset of the pre-pulse to the onset of the startle stimulus. In total, the 40 prepulse trials were divided into ten of each of the following pre-pulse-ISI combinations: 7530, 75-100, 85-30, and 85-100. The trials were presented in a pseudorandomized order and
separated by a 12-18s randomized ITI. After the presentation of a startle stimulus in each
habituation or PPI trial, the peak to peak maximum startle amplitude was measured. PPI
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was calculated as the amount of inhibition of startle in pre-pulse trials compared to startleonly trials in the PPI block:
%𝑃𝑃𝑃𝑃𝑃𝑃 = �1 − �

𝑎𝑎𝑎𝑎𝑎𝑎𝑎𝑎𝑎𝑎𝑎𝑎𝑎𝑎 𝑠𝑠𝑠𝑠𝑠𝑠𝑠𝑠𝑠𝑠𝑠𝑠𝑠𝑠 𝑚𝑚𝑚𝑚𝑚𝑚𝑚𝑚𝑚𝑚𝑚𝑚𝑚𝑚𝑚𝑚𝑚𝑚 𝑤𝑤𝑤𝑤𝑤𝑤ℎ 𝑝𝑝𝑝𝑝𝑝𝑝𝑝𝑝𝑝𝑝𝑝𝑝𝑝𝑝𝑝𝑝
�� × 100.
𝑎𝑎𝑎𝑎𝑎𝑎𝑎𝑎𝑎𝑎𝑎𝑎𝑎𝑎 𝑠𝑠𝑠𝑠𝑠𝑠𝑠𝑠𝑠𝑠𝑠𝑠𝑠𝑠 𝑤𝑤𝑤𝑤𝑤𝑤ℎ𝑜𝑜𝑜𝑜𝑜𝑜 𝑝𝑝𝑝𝑝𝑝𝑝𝑝𝑝𝑝𝑝𝑝𝑝𝑝𝑝𝑝𝑝 𝑖𝑖𝑖𝑖 𝑃𝑃𝑃𝑃𝑃𝑃 𝑏𝑏𝑏𝑏𝑏𝑏𝑏𝑏𝑏𝑏

Habituation scores were calculated to measure short- and long-term habituation. The shortterm habituation score was calculated based on data from day 1 and using startle baseline
and the trials at which most habituation occurred across groups. Typically, rats habituate
to repeated startle stimulation within a session. However, they sometimes reach a state
where further stimulation causes sensitization as opposed to habituation. Therefore, we
sought to determine the trials during which most habituation occurred using the probability
of each trial having the lowest startle amplitude across the entire 30-trial session on day 1.
For the adolescence time point, we found that rats reached maximal habituation around
trials 17-19. In contrast, adult animals reached maximal habituation around trials 15-17.
Therefore, the habituation score was calculated as follows:
Adolescent STH score =

Adult STH score

=

𝐴𝐴𝐴𝐴𝐴𝐴𝐴𝐴𝐴𝐴𝐴𝐴𝐴𝐴 𝑜𝑜𝑜𝑜 𝑓𝑓𝑓𝑓𝑓𝑓𝑓𝑓𝑓𝑓 5 𝑡𝑡𝑡𝑡𝑡𝑡𝑡𝑡𝑡𝑡𝑡𝑡

𝑎𝑎𝑎𝑎𝑎𝑎𝑎𝑎𝑎𝑎𝑎𝑎𝑎𝑎 𝑜𝑜𝑜𝑜 𝑡𝑡𝑡𝑡𝑡𝑡𝑡𝑡𝑡𝑡𝑡𝑡 17,18,𝑎𝑎𝑎𝑎𝑎𝑎 19
𝐴𝐴𝐴𝐴𝐴𝐴𝐴𝐴𝐴𝐴𝐴𝐴𝐴𝐴 𝑜𝑜𝑜𝑜 𝑓𝑓𝑓𝑓𝑓𝑓𝑓𝑓𝑓𝑓 5 𝑡𝑡𝑡𝑡𝑡𝑡𝑡𝑡𝑡𝑡𝑡𝑡

𝑎𝑎𝑎𝑎𝑎𝑎𝑎𝑎𝑎𝑎𝑎𝑎𝑎𝑎 𝑜𝑜𝑜𝑜 𝑡𝑡𝑡𝑡𝑡𝑡𝑡𝑡𝑡𝑡𝑡𝑡 15,16,𝑎𝑎𝑎𝑎𝑎𝑎 16

Based on the calculations above, a value above 1 indicates habituation, a value below 1
indicates sensitization. This value is not biased by changes in baseline startle as it is
calculated for each animal and therefore compares their baseline to their post-habituation
startle amplitude.
Similarly, a long-term habituation score was calculated using the baseline startle from each
of the first 4 days. Day 5 was excluded as it was the PPI testing paradigm that utilized
higher startle amplitudes. The same calculation was used for both age points, as most longterm habituation occurred by day 4 across groups.
LTH Score

=

𝐷𝐷𝐷𝐷𝐷𝐷 1 𝑏𝑏𝑏𝑏𝑏𝑏𝑏𝑏𝑏𝑏𝑏𝑏𝑏𝑏𝑒𝑒

𝐷𝐷𝐷𝐷𝐷𝐷 4 𝑏𝑏𝑏𝑏𝑏𝑏𝑏𝑏𝑏𝑏𝑏𝑏𝑏𝑏𝑏𝑏
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On each habituation measure and at each age point, a univariate ANOVA was conducted
with genotype, MIA, and sex as between-subject factors. Figure 3-2 (Created with
BioRender.com) shows a summary of the habituation and PPI measures throughout startle
testing.

Figure 3-2. Visual summary of trials in habituation and PPI experiments and
trials used to calculate STH and LTH scores.

3.2.6

Open Field Test

The day following the social behaviour test and before startle testing, rats were placed in a
square open field of 45.7 cm × 45.7 cm dimension for 30 minutes as described previously
(Fulcher et al., 2020). This test was used to determine locomotor activity through the total
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distance travelled throughout the test. Additionally, anxiety-like beheaviour was measured
through the time spent in the centre of the chamber. The animal’s head location was
monitored by an overhead camera as they freely explored the box; the data was collected
and analyzed using ANYMAZE software (V4.99, Stoelting, Wood Dale, IL, USA). The
apparatus was cleaned with 70% ethanol between experiments.

3.2.7

Auditory Brainstem Response

The level of sound-evoked electrical activity in the brainstem was measured using an
established protocol (Scott et al., 2018) to assess hearing sensitivity, neural responsivity,
and speed of neurotransmission in adolescent and adult rats. Rats were anesthetized with
ketamine (80 mg/kg, i.p.) and xylazine (5 mg/kg, i.p.) and placed in a sound-attenuating
chamber. Subdermal electrodes (27 gauge; Rochester Electro-Medical) were positioned at
the vertex (active electrode), over the right mastoid process (reference electrode), and on
the midback (ground electrode). Throughout the electrophysiological assessment, body
temperature was maintained at 37°C using a homeothermic heating pad (507220F; Harvard
Apparatus). A click (0.1 ms) stimulus was used in ABR assessment which was generated
using a Tucker-Davis Technologies RZ6 processing module sampled at 100 kHz. A
magnetic speaker (MF1; Tucker-Davis Technologies) positioned 5 cm from the animal’s
right ear was used to deliver the stimuli and its left ear was blocked with a custom foam
plug. The acoustic stimuli were each presented 1000 times (20 times/s) at decreasing
intensities from 90 to 20 dB sound pressure level (SPL) in 5 dB SPL steps from 90dB to
50dB and 3dB steps from 50dB to 20dB. Consistent with previous studies, each rat’s
hearing sensitivity (i.e., ABR threshold) for the click stimulus was determined using the
criterion of just noticeable deflection of the averaged electrical activity within a 10 ms
window (Popelar et al., 2008; Abitbol et al., 2016; Schormans et al., 2016). Before the
ABR assessment, the acoustic stimuli were calibrated with custom MATLAB software
(The Math-Works) using a 1/4-inch microphone (2530; Larson Davis) and preamplifier
(2221; Larson Davis). The sound-evoked activity associated with the ABR assessment was
collected using a low-impedance head stage (RA4L1; Tucker-Davis Technologies),
preamplified, digitized (RA16SD Medusa preamp; Tucker-Davis Technologies), and sent
to a RZ6 processing module via a fiber-optic cable. The signal was filtered (300–3000 Hz)
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and averaged using BioSig software (Tucker-Davis Technologies). The peak amplitudes
of each of the characteristic positive waves of the rat ABR were measured in microvolts
about the baseline and the latency of each of these peaks was determined from the stimulus
onset. For a wave peak to be analyzed, it must have a preceding and following trough less
than its maximum. This resulted in the consistent presence of peaks for waves I–IV at 90
dB SPL. Hearing threshold was determined as the dB level at which wave IV was no longer
noticeable in the 10ms recording window.

3.2.8

Social Behaviour

Each rat’s preference for a conspecific over an inanimate object (sociability), as well as its
preference for a stranger rat over a familiar rat (social novelty), were assessed using the
previously established 3-chamber assay (Crawley, 2007; Moy et al., 2004; Scott et al.,
2020).
The apparatus was 115cm long, 58cm wide, with transparent walls that were 45m high.
The apparatus was split equally into 3 chambers, and a wall containing a gate in the middle
(10cm) separated the chambers from each other. The gate was always open throughout the
test, and the animal was free to explore and move between chambers at all points during
the test. In each of the side chambers, a plexiglass animal holder was placed, where the
stranger rats would be placed during the sociability and social novelty stages.
The test began by habituating the test rat for 10 minutes to the entire apparatus and the
empty animal holders already positioned in each side chamber. Following habituation,
sociability preference was determined by placing a stranger rat (stranger 1) in one animal
holder in one of the side chambers and video monitoring the test rat’s exploration (10 min).
Then, social novelty preference was determined by placing a novel stranger rat (stranger
2) in the opposing animal holder and side chamber and video monitoring the rat’s
exploration (10 minutes). During social novelty, stranger 1 is considered the familiar rat,
and stranger 2 is considered the novel rat. The test rat was not removed from the apparatus
while placing the strangers during each stage to avoid stressing the test rat and altering its
exploratory behaviour. Between different test rats, the animal holders were washed with
soap, and the entire apparatus was wiped with 70% ethanol.

124

The test rat’s exploration was tracked using a camera and its activity in each chamber was
quantified using ANYMAZE software (V4.99, Stoelting, Wood Dale, IL, USA).
Additionally, the animal’s exploration of the animal holders was tracked, which was
specified as the animal’s nose (as detected by ANYMAZE) being within 3 cm around the
animal holder. A sociability or social novelty score was calculated by subtracting the time
spent in the novel social chamber (stranger 1 – empty animal holder in sociability; stranger
2 – stranger 1 in social novelty). A similar score was also calculated for specific exploration
of animal holders, as opposed to general time spent in each respective chamber.

3.2.9

Statistical analysis

Data obtained from the behavioural tests described above were analyzed using IBM SPSS
Statistics version 26 and graphed using GraphPad Prism version 7.00 for Windows.
Behavioural and ABR data were scanned for extreme outliers (>3 interquartile ranges from
the median) using the explore function in SPSS. There were no outliers when the offspring
results were split based on genotype, MIA, sex, and litter (max n=4). Next, offspring results
were split based on genotype, MIA and sex, and one animal was removed for being a
consistent outlier across multiple tests and having very high startle reactivity (WT Poly I:C
male). Additionally, two extreme outliers were removed from the analysis of short-term
habituation score for showing very extreme values (one WT saline male and one WT Poly
I:C male). Besides these exceptions, all behavioural data shown in this study below
represent the same groups of animals per genotype, MIA, litter and sex.
In total, the ABR data included 85 rats broken down into 16 WT saline offspring (7 males,
9 females), 24 WT Poly I:C offspring (12 males, 12 females), 21 IL-15 knockout saline
offspring (10 males, 11 females), 24 IL-15 knockout Poly I:C offspring (12 males, 12
females). On the other hand, behavioural data included 103 rats broken down into: 16 WT
saline offspring (7 males, 9 females), 27 WT Poly I:C offspring (14 males, 13 females), 22
IL-15 knockout saline offspring (11 males, 11 females), 38 IL-15 knockout Poly I:C
offspring (18 males, 20 females).
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For each behavioural test, a three or four-way repeated-measures analysis of variance
(ANOVA) was conducted separately for adolescent and adult data as most of our measures
are inherently influenced by age (e.g startle amplitude increases with age due to changes
in the animal’s body weight, ABR signal changes with age due to changes in skull thickness
and size of the head).
All ANOVAs included genotype, sex and MIA as between subject factors. Additional
within-subject factors were included based on the measure of interest: Stimulus intensity
for startle reactivity and ABRs, trial number for short-term habituation of startle, day of
testing for long-term habituation of startle, pre-pulse intensity and interstimulus interval
for PPI.
Table 3-1. Number of offspring used per group for ABR and behavioural experiments
IL-15-/-

Wildtype
Saline

Auditory
Brainstem
Response
Number
before outlier
exclusion for
behavioural
analysis
Number for
all
behaviours
except STH
Number for
STH

Poly I:C

Saline

Poly I:C

Male

Female

Male

Female

Male

Female

Male

Female

7

9

12

12

10

11

12

12

7

9

14

13

11

11

18

20

7

9

13

13

11

11

18

20

6

9

12

13

11

11

18

20
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3.3
3.3.1

Results
Body Weight

The animals’ weights were measured before behavioural testing at each experimental
timepoint (adolescence – 6 weeks; adulthood – 3 months), since body weight can influence
startle response amplitude (higher weight leads to increased amplitude). In addition,
previous studies have shown that Poly I:C MIA leads to intrauterine growth restriction
(Baines et al., 2020), which could alter postnatal growth and therefore postnatal body
weight.
A univariate ANOVA was conducted for each timepoint, with genotype, MIA and sex as
between-subject factors. In adolescence, the ANOVA showed a significant MIA*Sex
interaction ( Figure 3-3a; F(1,95)=6.560, p=0.012). Follow-up posthoc testing with
Bonferroni adjustment for multiple comparisons confirmed this effect. Adolescent Poly
I:C male offspring weighed on average 11.6g more than their saline counterparts,
regardless of genotype (p=0.014). In contrast, female body weight was not affected
(p=0.278). Moreover, the original ANOVA also revealed a main effect of genotype
(F(1,95)=6.525, p=0.012), where adolescent IL-15-/- offspring weighed on average 8.2g
more than their WT counterparts, regardless of MIA.
In adulthood, there was also a significant MIA*Sex interaction ( Figure 3-3b;
F(1,94)=8.249, p=0.005) and follow-up posthoc testing confirmed this effect similar to
adolescent body weight data. Adult Poly I:C male offspring weighed on average 29.7g
more than their saline counterparts, regardless of genotype (p=0.004). This effect was
absent in females (p=0.303).
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a) Adolescent
p=0.028

Significance threshold
for comparison = 0.025

b) Adult

Saline male
Poly I:C male

Significance threshold
for comparison = 0.025

*p=0.017

Saline male
Poly I:C male

Figure 3-3. Male offspring body weight is increased in Poly I:C offspring in
adulthood regardless of genotype. a) Adolescent male Poly I:C offspring showed
a trend towards increased body weight compared to saline males. b) By adulthood,
body weight was significantly higher in Poly I:C males compared to saline males.
Data are shown as mean ± standard error. For animal numbers per group, please refer
to Table 3-1.

3.3.2

Auditory Brainstem Response

Different components of the ABR were analyzed to assess hearing and auditory brainstem
processing. Hearing thresholds were assessed as a general indicator of hearing loss, which
has been associated with first trimester cytomegalovirus infections (Foulon et al., 2008).
Amplitude and latency of wave I were assessed as an indicator of activity at the auditory
nerve, which feeds into the main acoustic startle pathway. Amplitude and latency of wave
IV were assessed as an indicator of activity at the lateral lemniscus terminating at the
inferior colliculus.
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Figure 3-4 Representative ABR readout depicting electrical activity at various
brainstem nuclei measured throughout 10ms following stimulus onset. Latency
and amplitude measures for each peak are taken in reference to the stimulus onset.
Peak I represents activity at the auditory nerve, peak II represents activity at cochlear
nucleus, peak III represents activity at the superior olivary complex, peak IV
represents activity at the lateral lemniscus.
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3.3.2.1

Hearing threshold

Hearing thresholds were assessed by inspecting the presence of wave IV across decreasing
stimulus intensities. Each animal’s hearing threshold was determined in adolescence and
adulthood. A univariate ANOVA was conducted for each timepoint, with genotype, MIA,
and sex as between-subject factors. In adolescence, the ANOVA revealed a main effect of
genotype (Figure 3-5a; F1(,78)=4.344, p=0.04). On average, hearing threshold was about
1.2 dB lower in IL-15-/- offspring compared to WT offspring, regardless of MIA. In
adulthood, the ANOVA did not reveal any significant main effects or interactions
associated with either genotype or MIA (Figure 3-5b).
a) Adolescent

b) Adult
#

p=0.04

Figure 3-5. Hearing threshold is decreased in IL-15-/- offspring in adolescence
regardless of MIA. a) Lower hearing threshold in adolescent IL-15-/- offspring
compared to WT. b) No difference in hearing threshold between adult IL-15-/- and
WT offspring. Data are shown as mean ± standard error. For animal numbers per
group, please refer to Table 3-1.

3.3.2.2

Latency to different peaks in the ABR

The latency to ABR peak I represents activity at the auditory nerve which is part of the
startle response pathway. In addition, the interpeak latency between peak I and peak IV
was measured as an indicator of signal conduction velocity in the auditory pathway.
Statistical analysis were conducted for each of these two measures across five stimulus
intensities to assess how signal transduction varies as a function of stimulus intensity in
Poly I:C and IL-15-/- offspring. The five stimulus intensities chosen were 50, 65, 75, 85,
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and 90dB. At each age point, a repeated measures ANVOA was conducted for each
measure (1. wave I latency, 2. interpeak latency between wave I and wave IV) with
genotype, MIA, and sex as between-subject factors and stimulus intensity as a withinsubject factor.

3.3.2.2.1

Wave I peak latency

In adolescence, there was a significant genotype*MIA*sex interaction (F(1,78)=4.090,
p=0.047). Follow-up ANOVAs separated by sex revealed a trend towards a significant
effect of MIA in male offspring, but this was not significant after adjusting for multiple
ANOVAs (F(1,38)=5.165, p=0.029; significance threshold 0.025). However, there was a
main effect of MIA on the latency to wave I. On average, Poly I:C offspring’s wave I
latency was 0.016 ms longer than their saline counterparts regardless of genotype (Figure
3-63a; F(1,78)=7.817, p=0.007). In adulthood, the ANOVA did not reveal any significant
main effects or interactions associated with either genotype or MIA (Figure 3-6b).
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a) Adolescent
*p=0.007

Male

Saline
Poly I:C

Female

Male

Female
-/-

Wildtype

IL15

Saline

b) Adult

Poly I:C

Male

Female

Wildtype

Male

Female
-/-

IL15

Figure 3-6. ABR wave I latency is increased in Poly I:C offspring in adolescence
regardless of genotype. a) Wave I latency was increased in Poly I:C offspring
compared to saline offspring indicating slower signal conduction from the ear to the
auditory nerve. b) There was no difference in wave I latency between Poly I:C and
saline offspring in adulthood. Data are shown as mean ± standard error. For animal
numbers per group, please refer to Table 3-1.

3.3.2.2.2

Interpeak latency between wave I and wave IV

In adolescence, there was a main effect of genotype on I-IV interpeak latency where on
average, IL-15-/- interpeak latency was 0.056ms shorter than in their WT counterparts,
indicating faster conduction in the auditory brainstem (Figure 3-7a; F(1,78)=12.971,
p=0.001). In adulthood, there was a significant stimulus intensity*genotype*MIA*sex
interaction (Greenhouse Geisser adjusted F(2.376,180.538)=3.065, p=0.04). Posthoc
analysis split by sex did not reveal any significant follow-up effects. In the original
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ANOVA for adult data, there was also a significant main effect of genotype, echoing the
genotype effect seen in adolescence (Figure 3-7b; F(1,76)=33.51, p<0.005). On average,
adult IL-15-/- interpeak latency was 0.08ms shorter than their WT counterparts.
Overall, these data show that Poly I:C MIA results in slower ABRs in adolescence, whereas
IL15 deficiency speeds up auditory processing in the brainstem.
a) Adolescent
#

p<0.001

Male

Male

Female

Female
-/-

Wildtype

IL15

Saline

b) Adult

Poly I:C

#

p<0.001

Male

Female

Wildtype

Male

Female
-/-

IL15

Figure 3-7. I-IV interpeak latency is decreased in IL-15-/- offspring in both
adolescence and adulthood regardless of MIA. a,b) the latency from the peak of
wave I to the peak of wave IV is increased across various stimulus intensities in IL15-/- offspring in both adolescence and adulthood, indicating faster signal conduction
in the auditory brainstem. Data are shown as mean ± standard error. For animal
numbers per group, please refer to Table 3-1.

3.3.2.3

Amplitude of different peaks of the ABR

In addition to latency, the amplitude of ABR peak I was analyzed as a measure of the
strength of activity at the auditory nerve following auditory stimulation. Moreover, the
ratio of peaks II and IV to peak I amplitude were analyzed, which measures the signal gains
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at the level of the cochlear nucleus and the inferior colliculus, respectively. Statistical
analysis was conducted for each of these two measures across five stimulus intensities to
assess how peak amplitude varies as a function of stimulus intensity in Poly I:C and IL-15/-

offspring. The five stimulus intensities chosen were 50, 65, 75, 85, and 90dB. At each

age point, a repeated measures ANVOA was conducted for each measure (1. wave I
amplitude, 2. Interpeak ratio of wave II to wave I, and 3. Interpeak ratio of wave IV to
wave I) with genotype, MIA, and sex as between-subject factors and stimulus intensity as
a within-subject factor.

3.3.2.3.1

Wave I amplitude

In adolescence, there were no significant main effects or interactions associated with
genotype or MIA for wave I amplitude (Figure 3-8a). In adulthood, There was a significant
genotype*MIA*Sex interaction (F(1,77)=4.947, p=0.029). Follow-up ANOVAs split by
sex revealed a significant genotype*MIA interaction in females(F(1,40)=6.804, p=0.013),
but no such interaction in males. Posthoc testing with Bonferroni adjustment revealed a
significant effect of MIA in WT female offspring but not IL-15-/- female offspring. On
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average, the wave I amplitude for WT Poly I:C female offspring was 255µV higher than
that of their WT saline female counterparts (Figure 3-8b; p=0.021).

a) Adolescent

Male

Female

Male

Female
-/-

Wildtype

IL15

Saline

b) Adult

Poly I:C

Male

Female

Wildtype

Male

Female
-/-

IL15

Figure 3-8. Wave I amplitude is increased in WT Poly I:C female offspring in
adulthood regardless of genotype. a) Wave I amplitude was not affected by Poly
I:C MIA or IL-15 deficiency in adolescence. b) In adulthood, wave I amplitude was
increased in WT Poly I:C female offspring across various stimulus intensities,
indicating increased sensitivity to sound at the level of the auditory nerve. Data are
shown as mean ± standard error. For animal numbers per group, please refer to Table
3-1.

3.3.2.3.2

Interpeak ratio of wave II to wave I

In adolescence, there was a significant stimulus intensity*genotype interaction for the ratio
of wave II peak amplitude to wave I peak amplitude (Greenhouse Geisser adjusted
F(4,312)=10.043, p<0.005). Posthoc testing with Bonferroni adjustment revealed
significant effects at 65, 85, and 90dB stimulus intensity. On average, wave II to wave I
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ratio was 0.208 higher at 65dB, 0.255 lower at 85dB, and 0.233 lower at 90dB in IL-15-/compared to WT. In other words, the signal gain from wave I to wave II was dependent on
stimulus intensity and was different between IL-15-/- and WT adolescent offspring
regardless of MIA.
The stimulus intensity dependence was absent in adult animals. In adulthood, there was a
main effect of genotype (F(1,77)=9.365, p=0.003), where IL-15-/- animals had on average
lower ratio of wave II to wave I amplitude (by 0.156) across all stimulus intensities.

3.3.2.3.3

Interpeak ratio of wave IV to wave I

In adolescence, there were no significant main effects or interactions associated with
genotype or MIA for the ratio of wave IV amplitude to wave I amplitude, although there
was a trend towards an increase in IL-15-/- offspring (Figure 3-9a; F(1,78)=3.182,
p=0.078). In adulthood, there was a significant genotype*MIA*sex interaction
(F(1,77)=5.293, p=0.024). Follow-up ANOVAs split by sex revealed a significant
genotype*MIA interaction in females (F(1,40)=6.233, p=0.017), but posthoc testing with
Bonferroni adjustment did not reveal any significant comparisons, although there was a
strong trend for the WT Poly I:C ratio in females to be lower than the WT saline female
counterpart (p=0.057).
Besides the 3-way interaction, the main ANOVA also revealed a significant stimulus
intensity*genotype interaction (Figure 3-9b; Greenhouse Geisser adjusted F(4,308)=4.266,
p=0.023). On average, IL-15-/- adult offspring had a wave IV to wave I ratio that is 0.156
lower at 85dB (p=0.027) and 0.140 lower at 90dB (p=0.049) compared to their WT
offspring.
Overall, these data show that in adolescent IL15-/- offspring exhibit increased gain in the
auditory brainstem, indicated by higher wave IV to wave I ratio across stimulus intensities.
In adulthood, the effect reverses and IL15-/- offspring exhibit decreased gain but only at
higher stimulus intensities.
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a) Adolescent

Male

Female

Male

Female
-/-

Wildtype

IL15

Saline

b) Adult

Poly I:C
#

p<0.001, WT>IL15-/- at 85 and 90dB

Male

Female

Wildtype

Male

Female
-/-

IL15

Figure 3-9. The ratio of wave IV to wave I is decreased in IL-15-/- offspring in
adulthood at high stimulus intensities, regardless of Poly I:C injection. a) There
was a trend towards an increase in the amplitude ratio of wave IV to wave I in IL-15/offspring in adolescence. b) In adulthood, there was a significant decrease in the
amplitude ratio of wave IV to wave I in IL-15-/- offspring at 85 and 90dB. Data are
shown as mean ± standard error. For animal numbers per group, please refer to Table
3-1.

3.3.3

Startle Reactivity

Startle reactivity in our experiment was measured in two ways. Firstly, reactivity was
measured in response to varying stimulus intensities during the initial experiment used to
determine startle platform gain. For this measure, a repeated-measures ANOVA was
conducted at each age point with stimulus intensity as a within-subject factor (12 levels,
65dB to 120dB in 5dB increments) and genotype, MIA, and sex as between-subject factors.
Next, the animals underwent 4 days of habituation testing, where the stimulus intensity was
100dB. There, the baseline reactivity was determined as the average startle amplitude in
the first five trials, before significant short-term habituation had occurred. For this measure,
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a univariate ANOVA was conducted at each age point with genotype, MIA, and sex as
between-subject factors.

3.3.3.1

Reactivity to varying stimulus intensities

In adolescence, there was a significant interaction between stimulus intensity and genotype
(Figure 3-10a; Greenhouse Geisser adjusted F(3.863, 366.981)=4.928, p=0.001). Posthoc
testing with Bonferroni adjustment revealed significantly reduced startle amplitude in IL15-/- adolescent offspring at 80dB (p=0.002) and significantly increased startle amplitude
in IL-15-/- adolescent offspring at 100dB (p=0.019), 110dB (p=0.001), 115dB (p=0.039)
and 120dB (p=0.01). There was also a trend to a main effect of MIA (F(1,95)=2.889,
p=0.092), suggesting that Poly I:C adolescent offspring show reduced startle reactivity
across stimulus intensities.
In adulthood, there was a significant stimulus intensity*genotype*MIA interaction
(Greenhouse Geisser adjusted F(4.541, 426.850)=2.620, p=0.028). Follow-up ANOVAs
split by genotype showed a significant stimulus intensity*MIA interaction in WT but not
IL-15-/- adult offspring (Figure 3-11a; Greenhouse Geisser adjusted F(11,429)=3.095,
p=0.017). Posthoc testing with Bonferroni adjustment showed that IL-15-/- offspring had
higher startle amplitude than their WT counterparts at 85dB (p=0.031), 110dB (p=0.006),
and 115 dB (p=0.037).
In addition, the main ANOVA in adult offspring showed a significant stimulus
intensity*genotype interaction (Figure 3-11a; F(4.541,1034)=3.6, p=0.005). Posthoc
testing with Bonferroni adjustment showed that IL-15-/- offspring regardless of MIA had
reduced startle amplitude compared to their WT offspring at lower stimulus intensities
(significant for 75dB p=0.049 and trends for 85 dB p=0.063 and 90dB p=0.051), and
increased startle amplitude at higher stimulus intensities (significant for 115dB p=0.038).
Overall, these data show that IL-15-/- offspring exhibited increased startle reactivity.
Moreover, WT but not IL-15-/- Poly I:C offspring showed decreased startle reactivity in
adulthood.
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3.3.3.2

Startle baseline on day 1 of habituation testing

In adolescence, there was a main effect of MIA on startle baseline regardless of genotype
or stimulus intensity (Figure 3-10b; F(1,95)=5.420, p=0.022). On average, Poly I:C
offspring regardless of sex or genotype had a startle amplitude reduction of 180 units
compared to their saline counterparts. In adulthood, there were no significant effects or
main interactions associated with genotype or MIA.

3.3.4
3.3.4.1

Startle Habituation
Short-term Habituation

In adolescence, there was a significant main effect of MIA (Figure 3-10b; F(1,93)=4.686,
p=0.033), whereby Poly I:C offspring showed less short-term habituation compared to
saline offspring regardless of genotype or sex.
In adulthood, there was a significant Genotype*MIA*Sex interaction (F(1,92)=4.374,
p=0.039). Follow-up ANOVAs split by sex revealed a trend towards a main effect of MIA
in females (F(1,49)=4.635, p=0.036; significance threshold adjusted to 0.025). The main
ANOVA for adult data also revealed a significant main effect of genotype (Figure 3-11b;
F(1,92)=4.047, p=0.047), where IL-15-/- offspring showed less short-term habituation
compared to their WT counterparts.

3.3.4.2

Long-term Habituation

In adolescence, there was a significant genotype*MIA*sex interaction on LTH score
(Figure 3-10c; F(1,95)=6.262, p=0.014). However, follow-up ANOVAs did not reveal any
significant main effects or interactions associated with either genotype or MIA.
In adulthood, there was a significant genotype*sex interaction (F(1,94=4.76, p=0.032).
Posthoc comparisons with Bonferroni adjustment showed that IL-15-/- females had less
long-term habituation compared to WT females.
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Figure 3-10. Adolescent startle reactivity and habituation data shows that IL15-/- offspring show increased startle reactivity regardless of MIA, whereas Poly
I:C offspring show decreased startle reactivity and decreased short-term
habituation of startle regardless of genotype. a) IL-15-/- offspring show an increase
in startle reactivity at higher stimulus intensities (100, 110, 115, 120dB), whereas
Poly I:C offspring show a trend towards a decrease in startle reactivity. b) Poly I:C
offspring showed decreased startle baseline and short-term habituation compared to
saline offspring. c) Despite the decrease in baseline startle, Poly I:C offspring did not
show changes in long-term habituation compared to saline offspring. Data are shown
as mean ± standard error, *p<0.05. For animal numbers per group, please refer to
Table 3-1.
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Figure 3-11. IL-15-/- offspring show increased startle reactivity and decreased
short-term habituation regardless of MIA, whereas Poly I:C WT but not IL-15/- offspring show decreased startle reactivity, and Poly I:C female offspring
regardless of genotype show increased short-term habituation of startle. a)
Startle reactivity is significantly increased in IL-15-/- offspring at 115dB stimulus
intensity. In contrast, Poly I:C WT but not IL-15-/- offspring show decreased startle
reactivity at 110 and 115dB. b) IL-15-/- offspring have significantly decreased shortterm habituation. c) A trend towards a significant increase in habituation in Poly I:C
female offspring, but this was not significant after adjusting for multiple
comparisons. d) No changes in long-term habituation between Poly I:C and saline
offspring. Data are shown as mean ± standard error, *p<0.05. For animal numbers
per group, please refer to Table 3-1.
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3.3.4.3

Pre-pulse Inhibition

Similar to chapter 2, PPI was assessed using a combination of two different prepulse levels
and interstimulus intervals (ISIs). The choice of 75 and 85dB pre-pulses helps avoid floor
and ceiling effects. 75dB is a relatively quiet pre-pulse and would be ideal for comparing
groups with inherently high PPI values. Alternatively, 85dB is a relatively loud pre-pulse
and would be suitable for comparing groups with inherently low PPI values. On the other
hand, the use of different ISIs is based on evidence suggesting that PPI involving different
ISIs implicates different neural mechanisms. Therefore, it is an advantage to test PPI at
short (30ms ISI) and long (100ms ISI) intervals and changes in either or both can lead to
more concrete hypotheses about relevant brain structures.
To analyze PPI, a repeated-measures ANOVA was conducted with pre-pulse and ISI as
within-subject factors and genotype, MIA, and sex as between-subject factors.
In

adolescence,

there

was

a

significant

pre-pulse*genotype*MIA

interaction

(F1,96)=5.774, p=0.018). Follow-up ANOVAs split by genotype revealed a significant
pre-pulse*MIA interaction in IL-15-/- offspring (F(1,56)=9.078, p=0.004) and posthoc
testing with Bonferroni adjustment for multiple comparisons showed that IL-15-/adolescent Poly I:C offspring had less PPI compared to their IL-15-/- saline counterparts
(Figure 3-12a).
In adulthood, there was a main effect of MIA (Figure 3-12b; F(1,94)=8.381, p=0.005),
where Poly I:C offspring had higher PPI across pre-pulse and ISI conditions regardless of
genotype or sex. Additionally, there was a significant pre-pulse*genotype*sex interaction
(F(1,94)=4.930, p=0.029). Follow-up ANOVAs split by sex revealed a main effect of
genotype in males (F(1,45)=6.13, p=0.017), where IL-15-/- male offspring had higher PPI
compared to WT male offspring (Figure 3-12b).
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Figure 3-12. PPI elicited with 75dB pre-pulses is decreased in Poly I:C IL-15-/but not Poly I:C WT offspring in adolescence, whereas adult PPI is increased
across all pre-pulse parameters in Poly I:C offspring regardless of genotype and
increased in IL-15-/- male offspring across all pre-pulse parameters. a)
Adolescent Poly I:C IL-/- but not WT offspring showed decreased PPI at the 75dB
pre-pulse level regardless of ISI compared to their saline counterparts. b) In
adulthood, Poly I:C offspring showed increased PPI across all parameters regardless
of genotype compared to saline offspring (left figure), whereas IL-15-/- male
offspring showed increased PPI across all pre-pulse parameters compared to their
WT male offspring (right top figure). Data are shown as mean ± standard error,
individual dots represent individual animals. For animal numbers per group, please
refer to Table 3-1.

3.3.5

Locomotor Activity and Anxiety

The open field test was used to assess levels of activity by measuring the total distance
traveled and levels of anxiety by measuring the total time spent in the centre of the open
field chamber. A univariate ANOVA was conducted on each of these 2 measures at each
age point with genotype, MIA, and sex as between-subject factors.
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3.3.5.1

Total Distance

In adolescence, there were main effects of genotype (F(1,95)=18.015, p<0.005) and MIA
(F(1,95)=9.163, p=0.003) but no interaction between the two (Figure 3-13a). In summary,
IL-15-/- offspring showed hyperactivity compared to WT offspring, whereas Poly I:C
offspring showed hypoactivity compared to saline offspring.
In adulthood, there was a significant genotype*MIA interaction (F(1,94)=6.695, p=0.011).
Follow-up ANOVAs split by genotype revealed a main effect of MIA in IL-15-/- offspring
F(1,55)=6.184, p=0.016) where IL-15-/- Poly I:C offspring showed hyperactivity compared
to IL-15-/- saline offspring (Figure 3-13b). In addition to this interaction, the main ANOVA
revealed a significant main effect of genotype (F(1,94)=8.632, p=0.004) where IL-15-/offspring showed hyperactivity compared to WT offspring (Figure 3-13b).

3.3.5.2

Centre time

In adolescence, there was a main genotype*MIA interaction (F(1,95)=9.341, p=0.003).
Follow-up ANOVAs split by genotype revealed a main effect of MIA (F(1,56)=12.062,
p=0.001) where Poly I:C IL-15-/- offspring showed reduced time spent in the centre
compared to saline IL-15-/- offspring (Figure 3-13a). Additionally, the main ANOVA
showed a main effect of genotype (F(1,95)=4.128, p=0.045) where IL-15-/- offspring spent
more time in the centre compared to WT offspring (Figure 3-13a).
In adulthood, there was a main effect of genotype (F(1,94)=8.512, p=0.004) where IL-15/-

offspring spent more time in the centre compared to WT offspring (Figure 3-13b). There

were no main effects or interactions associated with MIA (Figure 3-13b).
Overall, these data show that IL-15-/ - offspring exhibit hyperactivity and reduced anxiety
at both adolescence and adulthood. Poly I:C MIA increases adolescent hyperactivity
regardless of genotype but increases adolescent anxiety and adult hyperactivity in IL-15-/ but not WT offspring.
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Figure 3-13. Anxiety is increased in adolescence and hyperactivity is increased
in adulthood in Poly I:C IL-15-/- offspring compared to their saline IL-15-/counterparts. In general, IL-15-/- offspring are hyperactive compared to WT
offspring. a) IL-15-/- offspring were significantly hyperactive compared to WTs as
measured by the total distance traveled. Additionally, Poly I:C offspring were
significantly hypoactive compared to saline offspring (# indicates a main effect of
Poly I:C). Poly I:C IL-15-/- offspring showed decreased centre time compared to their
saline IL-15-/- counterparts. b) In adulthood, the IL-15-/- animals were still
hyperactive compared to WT animals regardless of MIA. However, this
hyperactivity was further increased in Poly I:C IL-15-/- offspring compared to their
saline IL-15-/- counterparts. Data shown as mean± standard error, individual dots
represent individual animals. For animal numbers per group, please refer to Table
3-1.

3.3.6

Social behaviour

Social behaviour was assessed via the commonly used 3-chamber test. As stated in the
methods, sociability and social novelty scores were calculated for each rat. Sociability
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difference scores were calculated as the time spent interacting with an animal compared to
time spent in an empty chamber. Social Novelty difference scores were calculated as the
time spent interacting with a novel animal compared to a familiar animal. For each of these
scores at each of the age points, a univariate ANOVA with genotype, MIA, and sex as
between-subject factors was carried out. None of the ANOVAs revealed any significant
main effects or interactions associated with genotype or MIA (Figure 3-14). However, at
both age points, the hyperactivity profile of IL-15-/- offspring as observed in the locomotor
box (see above) was evident by a main effect of genotype (not shown in figures;
adolescence: F(1,95)=7.466, p=0.007; adulthood: (F(1,95)=4.395, p=0.039).
a) Adolescent

b) Adult

Figure 3-14. Neither Poly I:C MIA nor IL-15 deficiency altered social
behaviour in adolescence or adulthood. Social behaviour data is shown as
sociability and social novelty scores, which are measured as outlined in the methods
section. a) Neither genotype, Poly I:C MIA, nor an interaction between them
influenced sociability and social novelty scores in adolescence. b) Adult data shows
similar results as in adolescence with no significant differences between any of the
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groups. Data shown as mean ± standard error, individual dots represent individual
animals. For animal numbers per group, please refer to Table 3-1.

3.4

Discussion

In this study, I showed that Poly I:C MIA and IL-15 deficiency are two factors that can
alter offspring sensory processing and auditory brainstem signaling. Each factor on its own
had distinct effects, but in some cases, the effects of Poly I:C were dependent on whether
animals were WT or IL-15-deficient. These latter findings suggest that the presence of IL15 mediates some of Poly I:C’s effects while protecting against others.

3.4.1

Genotype effects independent of Poly I:C MIA

IL-15 deficiency led to behavioural and auditory brainstem changes regardless of whether
offspring were exposed to Poly I:C MIA. In adolescence, these effects included reduced
hearing thresholds, faster signal conduction in the auditory brainstem, increased startle
reactivity, and locomotor hyperactivity. The faster auditory brainstem signal conduction
and locomotor hyperactivity persisted in adulthood. Additionally, IL-15-/- adult offspring
exhibited a reduction in signal amplification across the auditory brainstem, decreased
short-term habituation of startle, and increased PPI in males.
Combined, these data support the involvement of IL-15 in neurodevelopment, be it directly
through its role in the brain, or indirectly through its requirement for the survival of NK
cells which influence the maternal-fetal environment.
A previous study by Wu et al., (2010) reported reduced anxiety in the elevated plus maze
in IL-15-/- mice. These are similar to our findings of increased hyperactivity and increased
centre time in the open field, with the latter indicative of reduced anxiety, as animals that
are more anxious in the open field tend to move less frequently away from the walls and
avoid crossing the centre of the chamber. It is worth noting, however, that rats that are
simply hyperactive without experiencing increased anxiety have a higher chance of
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crossing the centre of the chamber, which is a limitation of the open field test as a marker
of anxiety compared to other behavioural measures, such as the elevated plus maze.
One of the consistent findings in IL-15-/- offspring was the reduced ABR interpeak latency,
pointing towards an involvement of IL-15 in peripheral auditory processing. Overall, the
magnitude of latency change was quite small, around 0.08ms long. Compared to the
average 0.5-1ms needed for synaptic transmission (Holz and Fisher, 1999), this change
likely reflects subtle alteration in presynaptic neurotransmitter release or the excitability of
postsynaptic terminals across the auditory brainstem, as opposed to major changes in
circuitry or neuronal connections. Whether this difference is biologically significant for
behaviour is unclear and would likely depend on whether IL-15 knockout also alters
transmission between the brainstem and the thalamus, or the thalamus and the cortex.
The precise mechanisms by which IL-15 is involved in hearing have not been investigated,
but the involvement of other cytokines in the cochlea and inner ear has been studied in
context of noise trauma. IL-8 is a cytokine that is induced by IL-15 (Badolato et al., 1997;
McDonald et al., 1998) and perfusion of the inner ear with IL-8 is related to inflammatory
activity and increased hearing threshold similar to those seen following exposure to noise
(Iguchi and Anniko, 1998). TNFα is another proinflammatory cytokine that has been
linked with inflammation in the inner ear following noise exposure in mice, and is also a
cytokine commonly elevated following Poly I:C MIA (Katsumi et al., 2020; Landegger et
al., 2019). Given that our IL-15-/- rats exhibit opposite changes to those seen in noise trauma
studies (e.g. decreased hearing threshold), it is possible that the lack of IL-15 leads to a
general anti-inflammatory environment in the inner ear that alters its baseline function or
its susceptibility to noise throughout life.

3.4.2

Poly I:C effects independent of genotype

Several Poly I:C effects were present in both WT and IL-15-/- offspring. In adolescence,
these effects included increased latency to wave I of the ABR and decreased startle
baseline, short-term habituation of startle, and distance traveled in the open field. In
adulthood, Poly I:C offspring showed increased PPI and male body weight. Since these
effects were present regardless of genotype, their mechanism is likely independent of IL-

148

15, suggesting that IL-15 is not necessary for some Poly I:C effects on fetal
neurodevelopment.
Poly I:C male offspring exhibited increased body weight compared to saline offspring
regardless of genotype. An increase in body weight is potentially indicative of catch-up
growth, a phenomenon through which individuals experience accelerated growth following
a period of stunted growth. Catch-up growth is common in individuals who experienced
intrauterine growth restriction and is associated with low birth weight and increased risk
for type 2 diabetes and obesity later in life (Longo et al., 2013; Morrison et al., 2010).
Although intrauterine growth and birth weights were not measured, a previous study
showed that following Poly I:C MIA at GD8.5, fetal weight was decreased at GD13.5 and
GD18.5 (Baines et al., 2020). Another study by Arsenault et al., (2014) found decreased
early postnatal weight (PND3-10) in offspring exposed to Poly I:C at GD14.5-GD16.5,
which is indicative of low birth weight and potentially intrauterine growth restriction.
Interestingly, low birth weight is associated with the risk of developing ASD or
schizophrenia later in life (Cannon et al., 2002; Gardener et al., 2011).
In terms of auditory processing, adolescent Poly I:C offspring showed an increase in the
latency to ABR wave I, which has previously been shown in individuals with ASD
(Rosenhall et al., 2003). Wave I corresponds to neural activity at the level of the auditory
nerve and an increase in latency suggests peripheral auditory dysfunction before auditory
signals reach the auditory nerve. Interestingly, the latency to waves II and IV was not
altered, indicating potential neuronal adaptation between the auditory nerve and the
cochlear nucleus.
The startle-mediating giant neurons are also downstream of the auditory nerve, and our
results showed decreased adolescent startle baseline and short-term habituation and
increased adult PPI. Our previous experiment from Chapter 2 did not find any startle
changes in adolescent offspring, suggesting that the effects of GD9.5 Poly I:C varied
between experiments. This may be attributed to differences in startle testing protocols. For
instance, the habituation stimuli in Chapter 2 were presented at a faster rate, which may
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produce inherently more habituation and make it harder to detect subtle differences
between groups.
Lastly, Poly I:C offspring regardless of genotype or sex showed decreased adolescent open
field exploration indicated by a decrease in total distance traveled. Although we did not
quantify freezing and immobility specifically, reduced total distance travelled could be
associated with increased freezing which is indicative of increased anxiety. A previous
study by Hao et al. found that rat offspring from GD8.5 Poly I:C MIA showed decreased
distance traveled at PND60 (Hao et al., 2019). In contrast, most GD9.5 Poly I:C studies are
conducted in mice and test their offspring in adulthood and report no change in spontaneous
locomotion.

3.4.3

Poly I:C effects present in WT but not IL-15-/- offspring

All of these effects occurred only in adulthood and included decreased startle reactivity
and increased amplitude of ABR wave I in females. Since these results were present only
in WT offspring, their mechanism likely involves the presence of IL-15, but the precise
structures and processes involved are difficult to pinpoint without further experiments.
The significantly decreased startle reactivity follows a similar direction to the statistically
nonsignificant trend seen in adolescence, which suggests a late manifestation of symptoms
similar to what is seen in schizophrenia and what was reported in Chapter 2, as well as
being a common characteristic of Poly I:C MIA findings (Haddad et al., 2020b). However,
the direction of change is opposite to Chapter 2. This could be attributed to the strain
differences between the rats used in each Chapter, which correspond to the Sprague
Dawley strain in Chapter 2 and the Holtzman strain in Chapter 3.
Mouse studies have shown strain differences in susceptibility to Poly I:C and its influence
on offspring behavioural phenotypes (Morais et al., 2018; Schwartzer et al., 2013). More
broadly, differences between the Sprague Dawley and Holtzman strains have previously
been reported in neuropathic pain sensitivity (DeLeo and Rutkowski, 2000). Furthermore,
rat strain differences have been shown to influence the antibody response to commensal
bacterial antigens and the activation state of NK cells in the experimental autoimmune
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encephalopathy model of multiple sclerosis (Djuretić et al., 2019; Kovačević-Jovanović et
al., 2013). Therefore, it is possible that the same Poly I:C immune challenge produced
different effects in experiments from Chapter 2 compared to those in Chapter 3.
The decrease in ABR wave I amplitude indicates decreased activity at the auditory nerve
which was present throughout various stimulus intensities. Given the involvement of the
auditory nerve in relaying signals that induce the startle response, these findings suggest
that the mechanism of altered startle reactivity may be different between males and
females. Increased input to the startle pathway could have resulted in compensatory
changes that in turn decreased startle amplitude in adult female offspring.

3.4.4

Poly I:C effects present in IL-15-/- but not WT offspring

Some Poly I:C effects were present only in IL-15-/- offspring. These included decreased
adolescent PPI at 75dB pre-pulses and altered open field exploration in both adolescence
and adulthood. Since these results were only present in IL-15-/- offspring, their mechanism
is likely mediated by the absence of IL-15, suggesting a protective role for IL-15 against
some of the effects of Poly I:C.
The decreased PPI seen in adolescent offspring is contrary to previous reports of PPI
deficits in Poly I:C studies, which only report PPI changes in adulthood. In addition, the
stimulus intensity dependence of this phenotype suggests a subtle deficit that is absent
when pre-pulses get louder.
The results from the open field test suggest an intricate interplay between genotype and
Poly I:C. Firstly, Poly I:C offspring showed reduced total distance traveled in adolescence
regardless of genotype. However, only Poly I:C IL-15-/- offspring showed decreased time
spent in the centre of the chamber. The combination of these results suggests that changes
in locomotor activity due to Poly I:C regardless of genotype are separate from potential
effects on anxiety behaviour that only manifests in IL-15-/- animals. In adulthood, Poly I:C
resulted in hyperactivity only in IL-15-/- offspring. These results suggest that IL-15-/- is
protective against anxiety-like effects but not locomotor hypoactivity effects in the open
field test.
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3.4.5
3.4.5.1

Potential mechanisms of IL-15 in context of Poly I:C MIA
IL-15 in neurodevelopment

Aside from its immune roles, IL-15 signaling can have a direct influence on the brain.
Firstly, IL-15 gene expression has been detected in human fetal astrocytes, microglia, and
various neural cell lines (Hanisch et al., 1997; Lee et al., 1996; Satoh et al., 1998). IL-15
protein has also been detected throughout the early postnatal and adult mouse brain, with
particularly high levels in the hippocampus and cerebellum (Gómez‐Nicola et al., 2008).
The results presented here show that IL-15-/- offspring exhibit increased startle reactivity
compared to WT animals, and that Poly I:C WT but not IL-15-/- offspring exhibit a decrease
in startle reactivity/baseline. A potential mechanism through which IL-15 can influence
startle reactivity is by altering the number of startle-mediating giant neurons in the pontine
reticular nucleus (PnC), since Gómez-Nicola et al., (2011) previously showed that IL-15
can increase the proliferation of adult neural stem cells in culture and their differentiation
into astrocytes. If this effect is similar in the prenatal period, then IL-15 may decrease the
number of cells fated to become neurons, thereby reducing the number of giant neurons
and reducing startle amplitude. This effect may be elicited by increased levels of IL-15 in
the circulation following Poly I:C and contribute to the mechanism of reduced startle
amplitude seen in WT but not IL-15-/- offspring. On the other hand, lack of baseline levels
of IL-15 may result in more stem cells fated to become neurons at early stages of
development and lead to an increase in startle amplitude as seen in our IL-15-/- offspring.

3.4.5.2

IL15 modulation of microglia

Another potential mechanism by which IL-15 can modulate the Poly I:C effect on startle
reactivity is through microglia. Hanisch et al. (1997) showed that IL-15 is overexpressed
in activated microglia, and that IL-15 blockade reduces microglial proinflammatory gene
expression. Increased activation of microglia could increase their synaptic pruning abilities
and reduce glutamatergic input onto PnC neurons, thereby reducing startle reactivity.
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Given that IL-15 is important for the activation of microglia, this mechanism would explain
why Poly I:C would change reactivity in WT but not IL-15-/- offspring.

3.4.4.3 Role of IL-15 in uterine NK cells
As mentioned in the introduction, NK cells constitute a large portion of the uterine
leukocyte population, with roles in spiral artery remodeling and growth factor secretion
(Fu et al., 2017; Renaud et al., 2017). To elicit its immune-stimulating effects, Poly I:C
activates toll-like-receptor 3 (TLR3) which known to be expressed in NK cells and in the
placenta (Guillerey et al., 2015; Koga and Mor, 2010).
Evidence suggests that Poly I:C may act on placental NK cells and influences prenatal
development. For instance, Bao et al., (2012) discovered that TLR3 expression was
increased in decidual cells in patients with recurrent unexplained miscarriage. Preclinical
support for these findings comes from a study by Zhang et al., (2007) who showed that
Poly I:C injected at GD6.5 increased fetal loss at mid-gestation in mice and also altered
spiral artery remodeling. Lastly, a study by Hsiao and Patterson (2012) investigated
placental changes in response to Poly I:C and found that Poly I:C dams exhibited an
increase in uterine NK cells as well as behavioural changes in PPI and open field
exploration.

3.4.6

A caveat for translating IL-15 findings in the context of MIA to
humans

As discussed, there are several links to support the involvement of IL-15 and NK cells in
neurodevelopment and Poly I:C MIA. However, one caveat in relating findings from this
study to human studies is that IL-15 and NK cells play extensive roles in the response to
specific viral infections as opposed to general infections by viruses or bacteria (Perera et
al., 2012). Therefore, it is likely that IL-15 and NK cells would have more substantial
contributions in a maternal viral infection model compared to our Poly I:C MIA model.

3.4.7

Fetal versus maternal contributions

Based on the results of the current study, it can be concluded that IL-15 and/or NK cells
are involved in some of the effects of Poly I:C MIA. However, one major knowledge gap
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in the current study is that it cannot answer the question of whether the effects seen are due
to maternal IL-15 or fetal IL-15. For example, the study by Hsiao and Patterson, (2012)
clearly outlined that maternal but not fetal IL-6 are likely involved in the mechanisms of
Poly I:C MIA.
In the future, similar Poly I:C MIA studies need to be conducted for IL-15 using different
heterozygous breeding schemes. For example, IL-15+/- dams paired with IL-15-/- males to
give birth to IL-15-/- pups. Alternatively, IL-15-/- dams paired with IL-15+/- males to give
birth to IL-15+/- pups. The first condition tests the involvement of maternal IL-15, and
places more emphasis on the role of IL-15 in the maternal immune response and placental
NK cells. The second condition tests the involvement of fetal IL-15, and places more
emphasis on the expression of IL-15 in fetal tissue and how that can be induced by the
maternal immune response.

3.5

Conclusion

In summary, our findings suggest a role for IL-15 in a subset of phenotypes resulting from
Poly I:C MIA. That is, Some Poly I:C phenotypes, like decreased startle reactivity seem to
be mediated by IL-15, while other phenotypes, like decreased PPI, seem to be prevented
by IL-15. On the other hand, changes like increased latency in the ABR were completely
independent of IL-15. These findings suggest that the role of IL-15 in Poly I:C MIA is
multifaceted and could influence different brain regions underlying these phenotypes in
different ways. Moreover, our study further supports the notion that IL-15 is crucially
involved in fetal development and that a deficiency in IL-15 can lead to locomotor
hyperactivity, increased startle reactivity, and faster signal conduction in the auditory
brainstem.
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4

Investigating neurodevelopmental gene-environment
interactions in a double-hit model of Poly I:C maternal
immune activation and Cntnap2 genetic deficiency

Chapter 4 is being prepared for submission as: Haddad, F.L., De Oliveira, D., Schmid, S.,
(In prep). “Investigating neurodevelopmental gene-environment interactions in a doublehit model of Poly I:C maternal immune activation and Cntnap2 genetic deficiency”

4.1

Introduction

The pathophysiology of neurodevelopmental disorders such as ASD has been difficult to
decipher largely due to the existence of numerous genetic and environmental risk factors
that are associated with them.
Genetic factors are highlighted by various reports of substantial heritability including those
from twin studies. For example, Hallmayer (2011) reported that the monozygotic twin
concordance rate for ASD was 77% compared to 31% in dizygotic twins. Similarly, Deng
et al., (2015) showed an 80% concordance rate for monozygotic twins and 13.6% for
dizygotic twins. Another study by Lichtenstein et al., (2010) estimated a lower
monozygotic concordance rate at 47%. Even in the absence of an ASD diagnosis, nonautistic twins of autistic individuals scored lower on the Autism Diagnostic InterviewRevised (ADI-R) instrument compared to non-autistic monozygotic twins (Hu et al., 2019).
This suggests that genetic factors can influence ASD-related behaviours, even if the
symptom severity does not warrant a diagnosis of ASD. On the other hand, the evidence
from twin studies suggests a role for environmental factors, given that the monozygotic
concordance rate is never 100%. However, environmental factors alone are not sufficient
to cause ASD. For example, exposure to valproic acid during pregnancy, one of the most
well-established environmental risk factors for ASD, only increases the absolute risk for
ASD by 4% (Harden, 2013). Similarly, exposure to maternal infection during pregnancy
does not necessitate that the offspring develop ASD. Instead, this exposure increases the
risk by about 2 to 3-fold (Section 1.1).
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Taken together, the lack of full heritability of ASD and the insufficiency of environmental
factors to cause ASD suggest a role for gene-environment interactions in the etiology of
ASD. In support of this hypothesis, (Mazina et al., 2015) found a significant interaction
between the presence of ASD-associated copy number variations (CNVs) in the genome
and maternal infection during pregnancy in individuals with ASD. Specifically, ASD
individuals with CNVs and maternal infection history showed increased social
impairments and restricted behaviours. Schizophrenia is another neurodevelopmental
disorder with similarly complex etiology to ASD, and a study by (Clarke et al., 2009)
showed that the risk of schizophrenia associated with maternal infection was five times
greater in those with a family history of psychosis.
Preclinical models also support the gene-environment interaction hypothesis for ASD.
Recently, a study by Schaafsma et al. (2017) showed that maternal immune activation
(MIA) using Lipopolysacchrides (LPS) at GD6.5 interacts with male sex and a deficiency
in the autism risk gene contactin associated protein-like 2 (Cntnap2) to exacerbate autismrelated behaviours in mice. The study found that Cntnap2 knockout males that were also
exposed to MIA showed the most severe behavioural changes. These included decreased
ultrasonic vocalizations, impaired social behaviour, and locomotor hyperactivity.
Human studies have linked various CNTNAP2 mutations with ASD, epilepsy and impaired
language development. Deletions rendering CNTNAP2 protein product CASPR2
nonfunctional result in a severe syndrome characterized by ASD, intellectual disability,
focal epilepsy, and severe language impairment (Jackman et al., 2009; Rodenas-Cuadrado
et al., 2016; Strauss et al., 2006; Zweier, 2011). Less severe mutations such as single
nucleotide polymorphisms in CNTNAP2, although not typically associated with autism
(Sampath et al., 2013; Zhang et al., 2019), have been associated with altered or impaired
language development (Riva et al., 2018), decreased grey matter volume (Li et al., 2021;
Uddén et al., 2017), and speech disorders (Zhao et al., 2015).
In rodents, homozygous deletions of Cntnap2 produce various brain and behavioural
changes linked to autism, which are similar to those shown in GD9.5 Poly I:C MIA models.
These include deficits in social behaviour (Richetto et al., 2017; Vuillermot et al., 2017;
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Weber-Stadlbauer et al., 2017; Brimberg et al., 2016; Peñagarikano et al., 2015, 2011),
sensorimotor gating (Meyer et al., 2005; Richetto et al., 2017; Shi et al., 2003; Scott et al.,
2020, 2018), repetitive behaviour (Hui et al., 2018; Brimberg et al., 2016) and changes in
learning and memory (MacDowell et al., 2017; Willi et al., 2013; Brunner et al., 2015;
Peñagarikano et al., 2011).
In the brain, both models have exhibit changes in cortical layering (Soumiya et al., 2011;
Peñagarikano et al., 2011), decreased dendritic arborization (Xu et al., 2019; Brimberg et
al., 2016), and dysfunctional cortical inhibition (Anderson et al., 2012; Bridi et al., 2017;
Canetta et al., 2016)
Given the overlap in phenotypes produced by Cntnap2 deficiency and GD9.5 Poly I:C
MIA, a double-hit model incorporating both of these factors has the potential to exacerbate
ASD-related symptoms and to shed light on the convergence of these two impacts. In this
study, I investigated this gene-environment interaction in the context of acoustic startle
phenotypes, open field exploration, and social behaviour, since both models have
previously been shown to alter acoustic startle phenotypes like startle reactivity and PPI
(Haddad et al., 2020a; Scott et al., 2020, 2018). In this study, I used a heterozygous
breeding scheme to investigate whether early gestation Poly I:C MIA would influence
offspring differently based on their sex, Cntnap2 genotype, and age.

4.2
4.2.1

Materials and Methods
Animals

This study was conducted using Wildtype (WT) and Cntnap2 homozygous and
heterozygous knockout rats on a Sprague Dawley background. The Cntnap2 rat model
contains a 5 base pair frame shift deletion in exon 6 of the Cntnap2 gene, resulting in total
functional loss of the Cntnap2 protein CASPR2, as confirmed via Western blot (ENVIGO).
Original breeders were purchased from Horizon Discovery and then bred in house
(https://rgd.mcw.edu/rgdweb/report/strain/main.html?id=11568646).
Rats were housed in open cages with corn cob bedding, given ad libitum food and water,
and kept on a 12 h light – 12 h dark cycle with lights turning on at 7:00 am. Cages were
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enriched with polycarbonate huts and wrinkled paper. Cage changes took place once a
week except during behavioural testing procedures, during which cage changes were
carried out at the end of the 5-day startle protocols to ensure long-term habituation
measures were not influenced by cage change stress. All behavioral testing and cage
changes took place during the light phase (between 7:00 and 19:00 h).

4.2.2

Timed Breeding

To reduce variability in the offspring, the same male was used to generate all the litters in
this study in the span of 6 months. In each breeding round, the Cntnap2+/- breeding male
was paired with 2-3 Cntnap2+/- females. Additionally, one litter in this experiment was
generated by pairing a Cntnap2-/- female with a Cntnap2+/- male, but offspring from this
litter were not different from those obtained by full heterozygous breeding and were
included in all the results. Breeding rounds were at least one week apart. There were six
breeding rounds total, with five rounds containing at least one saline and one Poly I:C dam.
Females in each round were typically siblings, but an equal number of females were used
from four different backgrounds that were all unrelated to the breeding male. At the end of
these breeding rounds, the WT saline group was the smallest, and so an extra breeding
round containing only saline-treated dams (n=3) was performed to increase the sample size
for this group.
After pairing, a vaginal smear was collected from each female at 8am every morning and
inspected under a light microscope to track the estrus cycle and check for the presence of
sperm. If sperm was detected in the smear, the female was considered pregnant and that
day was considered as Gestation Day (GD) 0.5. Pregnant females were separated from the
male on GD0.5 and transferred into a single cage, where they were left undisturbed until
injection day (GD9.5). One female was bred twice, all other females were bred only once
in this experiment.

4.2.3

Maternal immune activation

Pregnant females were randomly assigned to receive either Poly I:C or saline injections.
MIA was induced using Poly I:C (Sigma lot #118M4035V), which had been previously
aliquoted and stored at -20⸰ C. Poly I:C aliquots were diluted in 0.9% saline to obtain a
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concentration of 4mg/ml. At around 10am on GD9.5, pregnant females were weighed and
had their rectal temperature measured. Then, they underwent isoflurane anesthesia (5%
induction, 2% maintenance), during which they were injected with either 0.9% saline or
4mg/kg of Poly I:C into the tail vein. The injection procedure took an average of 5 minutes
and rats were returned to their cages afterwards and were left undisturbed besides blood
collection, temperature/weight measurement, and weekly cage change. Temperature
measurements were taken 3, 24 and 48-hours following injection, whereas maternal weight
was recorded 24 and 48-hours following injection. There were no significant differences
for these data between the Poly I:C and saline dams (data not shown). On the day of
injection, maternal blood was also collected from the dams 3 hours following injection.
Under isoflurane anesthesia 0.5-1mL of blood was drawn from the tail vein and stored in
serum separation tubes (SARSTEDT Microvettes). The blood was allowed to clot for 30
minutes and then spun at 2000g and 20⸰ C for 10 minutes. Serum was then collected and
stored at -20⸰ C to later be used in the ELISA cytokine experiment to assess cytokine
expression.
The day of parturition was designated as postnatal day (PND) 0. Offspring were weaned at
PND21, and littermates were separated based on sex and housed in groups of 2-4 rats per
cage. At the end of the experiment, the final number of litters per group was as follows:
nine litters born from saline Cntnap2+/- dams, one litter born from a saline Cntnap2-/- dam,
eight litters born from Poly I:C Cntnap2+/- dams. In total, the number of offspring used for
behavioural testing was as follows: 24 saline WT offspring (10 males, 14 females), 48
saline Cntnap2+/- offspring (23 males, 24 females), 33 saline Cntnap2-/- offspring (19
males, 4 females), 19 Poly I:C WT offspring (9 males, 10 females), 36 Poly I:C Cntnap2+/offspring (19 males, 17 females), 34 Poly I:C Cntnap2-/- offspring (16 males, 18 females).
Nine rats were euthanized after adolescent testing for brain collection and piloting of
immunostaining techniques, including one Cntnap2+/- Poly I:C male, four Cntnap2+/saline females, two Cntnap2+/- saline males, and two Cntnap2-/- Poly I:C females (see Table
4-1)
Table 4-1. Total number of offspring included for the study.
Adolescent Adult
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Cntnap2+/+
Wildtype (WT)

Cntnap2

+/-

Cntnap2-/-

4.2.4

Saline
Poly I:C
Saline
Poly I:C
Saline
Poly I:C

10
14
9
10
23
25
19
17
19
14
16
18

10
14
9
10
21
21
18
17
19
14
16
16

Quantification of the immune response – Enzyme linked
Immunosorbant Assay (ELISA)

Collected serum was used to quantify the maternal immune response to Poly I:C using
DuoSet IL-6 (Lot P216627) and TNF-alpha (Lot P237489) ELISAs supplemented with the
ELISA ancillary kit (LotP240500; R&D Systems). The procedure was conducted
according to manufacturer’s instructions with a minor modification. Due to the presence
of matrix effects in the serum that could disrupt the signal produced by the cytokines of
interest, samples were diluted 10-fold as opposed to the 2-fold dilution recommended by
the manual (10% serum, 90% buffer solution). Additionally, 10% control serum was
obtained from a control rat to establish the cytokine standards used to generate the standard
curve, so that the curve is representative of a signal containing 10% serum and would help
more accurately determine the concentration of IL-6 in the samples.
A standard curve was generated using linear regression of the log concentration plotted
against the log optical density for positive and negative controls. This curve was then used
to interpolate cytokine concentrations in the serum samples tested. Data shown represents
serum collected from all Poly I:C dams and all but 3 saline dams.

4.2.5

Offspring testing outline

Ultrasonic vocalization testing occurred at PND8 (data not included). Startle, open field
and social behaviour testing occurred in adolescence and adulthood. Adolescent testing
began around PND38-39, and adult testing began around PND90-100. Animals were
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weighed and underwent the same tests at each timepoint, with the whole battery of tests
taking about eight days to complete. Tests were performed in the following order: Startle
acclimation and handling (Day 1), social behaviour (Days 2 & 3), open field and startle
reactivity (Day 4), startle habituation (Days 5-8), PPI (Day 9) Adolescent animals were
handled at least twice prior to behavioural testing to get them acclimated to the
experimenters. After these tests, animals underwent testing for a cognitive attentional task
in touch screen boxes (data not included). Food restriction and touchscreen training started
one week after adult tests were complete, around PND100-110. Touchscreen training lasted
a maximum of 40 days, after which testing was completed over 1-2 weeks. After this,
animals were perfused and brains were harvested for post mortem analysis (data not
included in this thesis). The full experimental timeline is shown in Figure 4-1 (Created with
BioRender.com).
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Figure 4-1. Experimental timeline, offspring subgroups, and testing timeline.

4.2.6

Acoustic Startle Response

Acclimation: Startle testing was performed as described by Valsamis and Schmid (2011).
In brief, rats were initially acclimated to the experimental procedure, Plexiglas animal
holders, and startle chambers (Med Associates, Vermont, USA) by undergoing three 5-
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minute acclimation sessions, at least six hours apart. During acclimation, the animals were
exposed to a 65dB (SPL) white noise background sound which is consistently present
throughout all startle testing procedures.
Startle Reactivity: After the acclimation sessions, startle reactivity in response to startle
stimuli of varying intensities was measured. This startle reactivity test consisted of 15 white
noise startle stimuli, 13 of which were 20 ms in duration, at intensities ranging from 65dB
to 120dB in 5dB increments, presented in a pseudorandomized order (110dB stimulus was
presented twice because this was the sound level chosen for PPI measurements). The other
two white noise stimuli presented corresponded to the pre-pulses presented in the PPI test
(4ms duration, 75 or 85dB). Based on data from the startle reactivity session, platform
sensitivity was adjusted for each rat to optimally detect the startle reflex. The adjusted
platform gain for each rat was used throughout all the remaining testing sessions.
Habituation: Following startle reactivity testing, animals underwent four consecutive days
of startle habituation testing to assess startle reactivity, Short-term habituation (STH) and
Long-term habituation (LTH). Each day, animals were exposed to a 5-minute acclimation
period with background noise, followed by a habituation block of 30 trials. In the
habituation block, each trial consisted of a 20ms-long, 100dB white noise stimulus after
which the peak-to-peak maximum startle amplitude was measured. Trials were separated
by a fixed inter-trial interval (ITI) of 60 seconds. On the 5th day, both startle habituation
and PPI were measured in separate blocks. The day 5 habituation block consisted of 20
startle trials using 110dB stimulus intensity. In the PPI block, animals were exposed to
either startle-only trials, with stimulus parameters the same as those in the habituation
block, or pre-pulse trials. Pre-pulse trials included a 4ms long white noise pre-pulse that
was either 75, 80, or 85dB loud and preceded the startle stimulus by an interstimulus
interval (ISI) of either 30 or 100ms. ISI was determined as the time between the onset of
the pre-pulse to the onset of the startle stimulus. In total, the 60 pre-pulse trials were divided
into 10 of each of the following pre-pulse-ISI combinations: 75-30, 75-100, 80-30, 80-100,
85-30, and 85-100. The trials were presented in a pseudorandomized order and separated
by a 12-18s randomized ITI. After the presentation of a startle stimulus in each habituation
or PPI trial, the peak-to-peak maximum startle amplitude was measured. Figure 4-2
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(Created with BioRender.com) shows a summary of the habituation and PPI measures
throughout startle testing. PPI was calculated as the amount of inhibition of startle in prepulse trials compared to startle-only trials in the PPI block:
%𝑃𝑃𝑃𝑃𝑃𝑃 = �1 − �

𝑎𝑎𝑎𝑎𝑎𝑎𝑎𝑎𝑎𝑎𝑎𝑎𝑎𝑎 𝑠𝑠𝑠𝑠𝑠𝑠𝑠𝑠𝑠𝑠𝑠𝑠𝑠𝑠 𝑚𝑚𝑚𝑚𝑚𝑚𝑚𝑚𝑚𝑚𝑚𝑚𝑚𝑚𝑚𝑚𝑚𝑚 𝑤𝑤𝑤𝑤𝑤𝑤ℎ 𝑝𝑝𝑝𝑝𝑝𝑝𝑝𝑝𝑝𝑝𝑝𝑝𝑝𝑝𝑝𝑝
�� × 100.
𝑎𝑎𝑎𝑎𝑎𝑎𝑎𝑎𝑎𝑎𝑎𝑎𝑎𝑎 𝑠𝑠𝑠𝑠𝑠𝑠𝑠𝑠𝑠𝑠𝑠𝑠𝑠𝑠 𝑤𝑤𝑤𝑤𝑤𝑤ℎ𝑜𝑜𝑜𝑜𝑜𝑜 𝑝𝑝𝑝𝑝𝑝𝑝𝑝𝑝𝑝𝑝𝑝𝑝𝑝𝑝𝑝𝑝 𝑖𝑖𝑖𝑖 𝑃𝑃𝑃𝑃𝑃𝑃 𝑏𝑏𝑏𝑏𝑏𝑏𝑏𝑏𝑏𝑏

Figure 4-2. Visual summary of trials in habituation and PPI experiments and
trials used to calculate STH and LTH scores.
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4.2.7

Open Field Test
The day following the PPI test, rats were placed in a square open field of

45.7 cm × 45.7 cm dimension for 30 minutes as described previously (Fulcher et al., 2020).
This test was used to determine locomotor activity through the total distance travelled
throughout the test. Additionally, anxiety-like behaviour was measured through the time
spent in the centre of the chamber. The animal’s head location was monitored by an
overhead camera as they freely explored the box; the data was collected and analyzed using
ANYMAZE software (V4.99, Stoelting, Wood Dale, IL, USA). The apparatus was cleaned
with 70% ethanol between experiments.

4.2.8

Social Behaviour

Each rat’s preference for a conspecific over an inanimate object (sociability), as well as its
preference for a stranger rat over a familiar rat (social novelty), were assessed using the
previously established 3-chamber assay (Crawley, 2007; Moy et al., 2004; Scott et al.,
2020).
The apparatus was 115cm long, 58cm wide, with transparent walls that were 45m high.
The apparatus was split equally into 3 chambers, and a wall containing a gate in the middle
(10cm) separated the chambers from each other. The gate was always open throughout the
test, and the animal was free to explore and move between chambers at all points during
the test. In each of the side chambers, a plexiglass animal holder was placed, where the
stranger rats would be placed during the sociability and social novelty stages.
The test began by habituating the test rat for 10 minutes to the entire apparatus and the
empty animal holders already positioned in each side chamber. Following habituation,
sociability preference was determined by placing a stranger rat (stranger 1) in one animal
holder in one of the side chambers and video monitoring the test rat’s exploration (10 min).
Then, social novelty preference was determined by placing a novel stranger rat (stranger
2) in the opposing animal holder and side chamber and video monitoring the rat’s
exploration (10 minutes). During social novelty, stranger 1 is considered the familiar rat,
and stranger 2 is considered the novel rat. The test rat was not removed from the apparatus
while placing the strangers during each stage to avoid stressing the test rat and altering its
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exploratory behaviour. Between different test rats, the animal holders were washed with
soap, and the entire apparatus was wiped with 70% ethanol.
The test rat’s exploration was tracked using a camera and its activity in each chamber was
quantified using ANYMAZE software (V4.99, Stoelting, Wood Dale, IL, USA).
Additionally, the animal’s exploration of the animal holders was tracked, which was
specified as the animal’s nose (as detected by ANYMAZE) being within 3 cm around the
animal holder. A sociability or social novelty score was calculated by subtracting the time
spent in the novel social chamber (stranger 1 – empty animal holder in sociability; stranger
2 – stranger 1 in social novelty). A similar score was also calculated for specific exploration
of animal holders, as opposed to general time spent in each respective chamber.

4.2.9
4.2.9.1

Statistical analysis
ELISA

A one-tailed independent t-test was conducted for each cytokine. These tests were adjusted
to account for the violation of the assumption of equal variance since there was substantial
variability in the levels of serum cytokines in Poly I:C dams but not saline dams.

4.2.9.2

Behaviour

Before conducting analysis, outliers were systematically removed to exclude extreme
values and to allow the data distributions to better approximate to a normal distribution that
is required for the parametric statistical tests described later in this section.
Data were scanned using the SPSS explore function on each genotype-MIA-sex group in
each age to detect outliers (12 groups total: 3 genotypes x 2 sexes x 2 MIA groups). Within
each group, outliers were defined as either moderate or extreme: Moderate outliers were
those that had a value of 1.5 interquartile ranges above the 75th percentile or below the 25th
percentile; Extreme outliers were those that had a value of 3 interquartile ranges above the
75th percentile or below the 25th percentile.
Within each test (open Field, sociability, social novelty, startle), animals that were extreme
outliers at any of different measures or were moderate outliers in two or more measures
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were excluded from the analysis, since many measures within each test are interdependent
(e.g presence in one zone of the 3-chamber social apparatus changes values for presence in
the other zones).
In the startle test, additional outlier exclusion was conducted for separate measures which
were influenced by trial-to-trial variability. For example, animals that did not startle on
trial 1 would have an extremely high sensitization scores that are not representative of the
group. These animals were excluded for sensitization score statistics, but not necessarily
for habituation score analysis. This resulted in slightly different groups of animals for
different measures, but all analyses were performed using at least nine animals per group.
For each behavioural test, a three or four-way repeated-measures analysis of variance
(ANOVA) was conducted separately for adolescent and adult data. All ANOVAs included
genotype, sex and MIA as between subject factors. Additional within-subject factors were
included based on the measure of interest: Stimulus intensity for startle reactivity and
ABRs, trial number for short-term habituation of startle, day of testing for long-term
habituation of startle, pre-pulse intensity and interstimulus interval for PPI.

Figure 4-3. Visual representation of moderate and extreme outliers.
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Table 4-2. Number of offspring used per group for behavioural experiments
Cntnap2+/-

Wildtype
Saline

Poly I:C

M

F

M

F

Number before
outlier exclusion
OFT

10

14

9

10

9

14

9

Sociability

10

14

Social Novelty

9

Startle curves

Saline
M

Cntnap2-/-

Poly I:C

F

M

F

23

25

19

17

10

22

23

19

8

8

23

25

13

8

10

22

8

11

8

8

Sensitization

8

11

8

Habituation

8

11

PPI

6

Number before
outlier exclusion
OFT

Saline
M

Poly I:C

F

M

F

19

14

16

18

15

18

14

16

18

19

13

19

14

14

18

23

16

16

18

14

16

17

23

24

18

14

17

11

15

16

8

22

23

17

14

17

11

14

16

8

8

23

23

18

13

17

11

15

15

10

8

8

23

24

18

13

17

11

14

15

10

14

9

10

21

21

18

17

19

14

16

16

9

13

8

10

20

20

17

16

19

14

16

16

Sociability

10

13

8

10

21

18

18

16

17

14

15

14

Social Novelty

9

11

6

10

20

18

17

16

16

14

15

16

Startle curves

8

11

8

8

21

20

17

14

17

11

15

14

Sensitization

7

10

8

8

17

19

16

14

16

10

15

13

Habituation

8

11

7

8

20

20

16

14

16

11

15

14

PPI

8

10

8

7

20

18

16

12

15

11

14

14

Adolescent

Adult

4.3
4.3.1

Results
Maternal serum cytokine response

To confirm the efficacy of the Poly I:C MIA, the maternal serum cytokine response was
measured three hours following Poly I:C administration. The cytokines of interest were
proinflammatory cytokines IL-6 and TNFα, commonly elevated following Poly I:C
exposure (Esslinger et al., 2016; Mueller et al., 2019; Openshaw et al., 2019). There was a
significant increase in serum IL-6 (t=3.065; df=7, p=0.0091) and TNFα (t=4.186; df=7,
p=0.002) following Poly I:C administration, confirming that the protocol was successful in

178

inducing a strong maternal immune response (Figure 4-4). Cytokine levels in saline dams
were all similar just above detection threshold of the ELISA. Poly I:C dam cytokine levels
were variable, but even the least responsive Poly I:C dam had an elevated level of IL-6 and
TNFα compared to all saline dams.

Figure 4-4. Poly I:C MIA significantly increases circulating levels of
proinflammatory cytokines Interleukin-6 (IL-6) And Tumor Necrosis Factor α
(TNF) in maternal serum. Serum samples were collected three hours following
Poly I:C injection and quantified using ELISAs for IL-6 and TNFα. Both IL-6 and
TNF were significantly elevated in serum from Poly I:C-treated dams compared to
saline-treated dams. Data are shown as mean ± standard error, *p<0.05. individual
dots represent individual dams.

4.3.2
4.3.2.1

Open field exploration
Total distance travelled

Locomotor hyperactivity is commonly reported in Cntnap2-/- mice and may be related to
ASD core symptoms or comorbidities. ASD is characterized by repetitive movements and
patterns of behaviour, a common comorbidity associated with ASD is attention deficit
hyperactivity disorder (ADHD). This may also be linked to impaired processing of
environmental stimuli and failure to habituate to novel environments.
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Locomotor hyperactivity was measured in the open field test by calculating the total
distance travelled throughout a 30-minute session. A separate univariate ANOVA was
conducted for each age with genotype, MIA, and sex as between subject factor. In
adolescence, there was a main effect of genotype (F(2,175)=18.363, p<0.001), and posthoc testing revealed a significant increase in total distance travelled in Cntnap2-/- rats
compared to both Cntnap2+/- (p<0.001) and WT (p<0.001) rats (Figure 4-5A).
In adulthood, the same ANOVA revealed a significant main effect of genotype
((F(2,159)=31.767, p<0.001; Figure 4-5B) and a significant genotype*MIA*sex
interaction (F(2,159)=5.346, p=0.006). To further investigate this interaction, two followup ANOVAs for each sex revealed a significant genotype*MIA interaction in females only
(F(2,82)=6.218, p=0.003), whereby Cntnap2+/- Poly I:C females had lower distance
travelled compared to Cntnap2+/- saline females (p=0.019) and Cntnap2-/- Poly I:C females
had higher distance travelled compared to Cntnap2-/- saline females (p=0.013; Figure
4-5B). In contrast, there was only a main effect of genotype in males (F (2,83)=25.346,
p<0.001) where Cntnap2-/- males showed higher distance travelled compared to both
Cntnap2+/- (p<0.001) and WT (p<0.001) males (Figure 4-5B).

4.3.2.2

Centre time

Anxiety is one of the comorbidities commonly associated with ASD and time spent in the
centre of the open field is a common measure of anxiety in rodents, since more anxious
rodents prefer to spend time near the walls of the chamber. The time spent in the centre of
the open field was measured throughout the 30-minute open field test session.
A separate univariate ANOVA was conducted for each age with genotype, MIA, and sex
as between subject factors. In adolescence, there were no significant main effects or
interactions associated with genotype or MIA (Figure 4-5C). In adulthood, there was a
significant genotype*MIA interaction (F(2,159)=3.302, p=0.039) and post-hoc testing
revealed that WT Poly I:C animals spent less time in the centre of the open field compared
to WT saline animals (p=0.008; Figure 4-5D). Additionally, there was a main effect of
genotype (F(2,159)=6.040, p=0.003), where Cntnap2-/- animals spent significantly less
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time in the centre of the open field compared to Cntnap2+/- (p=0.049) and WT (p=0.004)
animals (Figure 4-5D).

S - Saline

A

C

S - Saline

P - Poly I:C

Wildtype

Cntnap2+/-

Cntnap2-/-

Male Female

Male Female

Male Female

Wildtype

Cntnap2+/-

Cntnap2-/-

*

Male Female

Male Female

*

Male Female

B

Wildtype

Male Female

D

Wildtype

*

P - Poly I:C

Cntnap2+/-

Cntnap2-/-

Male Female

Male Female

Cntnap2+/-

Cntnap2-/-

Male Female

Male Female

*

Male Female

Figure 4-5. Poly I:C MIA influences open field locomotor activity and anxiety
in the open field in a sex and genotype dependent manner, whereas full Cntnap2
deficiency induces changes in open field exploration in both adolescence and
adulthood. A) Cntnap2-/- offspring show hyperactivity measured by total distance
travelled in the open field compared to WT and Cntnap2+/- offspring at 6 weeks of
age. B) Anxiety as measured by time spent in the centre is not altered by either
Cntnap2 deficiency or Poly I:C MIA in adolescence. C) In adulthood, Cntnap2-/hyperactivity persists, but Poly I:C MIA leads to reduced activity in Cntnap2+/females and increased activity in Cntnap2-/- females. D) Poly I:C WT offspring show
reduced centre time in adulthood compared to WT saline offspring, but Poly I:C MIA
has no effects on Cntnap2+/- or Cntnap2-/- offspring. Additionally, Cntnap2-/offspring show significantly decreased centre time compared to WT offspring. Data
are shown as mean ± standard error, *p<0.05. For animal numbers per group, please
refer to Table 4-2.
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4.3.3

Social behaviour in the 3-chamber test

One of the core symptoms of ASD is the deficit in social communication and social
behaviour. In rodents, the 3-chamber test is used as a basic measure of social approach,
social memory, and preference for social contexts. This test consisted of 3 phases:
habituation, sociability, and social novelty. Data from the habituation phase was not
included here as this phase meant to acclimatize the animals to the chamber. However, the
locomotor hyperactivity phenotype of Cntnap2-/- animals that was evident in the open field
test was also replicated in this test at all 3 phases.

4.3.3.1

Sociability

To measure sociability, a repeated measures ANOVA was conducted at each age for each
measure (chamber time, sniff time) with side as a repeated factor and genotype, MIA, and
sex as between subject factors. The social side is one where a stranger rat is placed in an
animal holder and is shown in Figure 4-6. and Figure 4-7. as the left bar, coloured in green.
The non-social side contains an empty animal holder and is the right bar, shown in purple.
In adolescence, there was a significant side*genotype*MIA interaction (F(2,173)=3.377,
p=0.036) for the time spent in each side chamber. To follow up this interaction, a separate
analysis was conducted for each genotype which showed a significant side*MIA
interaction for Cntnap2+/- offspring (F(1,76)=12.474, p=0.001), where Poly I:C Cntnap2+/offspring spent less time in the social chamber compared to saline Cntnap2+/- offspring
(p=0.002; Figure 4-6A). A similar analysis was conducted for the time spent sniffing each
animal holder, which also revealed a significant side*genotype*MIA interaction
(F(2,173)=4.443, p=0.003) and significant side*MIA interaction in Cntnap2+/- offspring
(F(1,76)=5.305, p=0.024), where Poly I:C Cntnap2+/- offspring spent less time sniffing the
social animal holder compared to saline Cntnap2+/- offspring (p=0.013; Figure 4-6B).
In adulthood, there were no significant main effects or interactions associated with either
genotype or MIA for both chamber time (Figure 4-6C) and time spent sniffing the social
versus non-social animal holders (Figure 4-6D). Overall, these data show that Poly I:C
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MIA reduces but does not abolish sociability preference in Cntnap2+/- offspring, which can
be considered a relatively mild social deficit.

S - Saline

S - Saline

P - Poly I:C

A

Wildtype

Cntnap2+/-

Cntnap2-/-

C

Wildtype

Cntnap2+/-

Cntnap2-/-

*

*

P - Poly I:C

B

Wildtype

Cntnap2+/-

Cntnap2-/-

D

Wildtype

Cntnap2+/-

Cntnap2-/-

*

*

Figure 4-6. Poly I:C reduces sociability exploration in Cntnap2+/- offspring, but
neither Poly I:C MIA nor Cntnap2 deficiency abolish sociability preference.
A,B) Poly I:C MIA reduced time spent in the social chamber and sniffing the social
stimulus (green) in adolescent Cntnap2+/- but not WT or Cntnap2-/- offspring. C,D)
In adulthood, neither Poly I:C MIA nor genotype influence time spent exploring the
different social/non-social chambers/animal holders. In all groups at both ages, time
spent in the social chamber/exploring the social animal holder was significantly more
than the time spent in the non-social chamber/exploring the non-social animal holder,
indicating that all groups showed strong preference for the social side/stimulus. Data
are shown as mean ± standard error, *p<0.05. For animal numbers per group, please
refer to Table 4-2.

4.3.3.2

Social Novelty

To measure social novelty preference, a repeated measures ANOVA was conducted at each
age for each measure (chamber time, sniff time) with side as a repeated factor and
genotype, MIA, and sex as between subject factors. The social side is the one that was
previously empty and has a novel stranger rat placed in it at the end of the social novelty
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test (shown in green). The non-social side contains the initial stranger from the sociability
experiment which is now designated as familiar (shown in purple).
In adolescence, there were no significant main effects or interactions associated with
genotype or MIA with regards to time spent in the social versus non-social chamber (Figure
4-7A). However, there was a significant genotype*MIA effect (F(2,170)=3.445 p=0.034)
on the total time spent sniffing both animal holders. Post-hoc tests revealed that Poly I:C
Cntnap2-/- offspring spent less time sniffing both the novel stranger animal holder and the
familiar animal holder compared to saline Cntnap2-/- offspring (p=0.003; Figure 4-7B).
In adulthood, there were no significant main effects or interactions associated with either
Genotype or MIA for both chamber time (Figure 4-7C) and time spent sniffing the social
versus non-social animal holders (Figure 4-7D). Overall, these data show that Poly I:C
MIA reduces social novelty exploration time but not preference in adolescent Cntnap2-/offspring, which can be considered a relatively mild social deficit.

S - Saline

A

Wildtype

S - Saline

P - Poly I:C
Cntnap2+/-

Cntnap2-/-

B
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Cntnap2+/-

Cntnap2-/-

*

C

Wildtype

Cntnap2+/-

Cntnap2-/-

D

Wildtype

Cntnap2+/-

*

Cntnap2-/-

Figure 4-7. Neither Poly I:C MIA nor Cntnap2 deficiency alter social novelty
preference in adolescence or adulthood, but Poly I:C reduces the time spent
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sniffing both familiar and novel animals in Cntnap2-/- adolescent offspring. A,B)
In adolescent offspring, all groups show significantly more time spent in the social
chamber and sniffing the novel animal (green) compared to the non-social chamber
and familiar animal. However, Cntnap2-/- Poly I:C offspring spend significantly less
time exploring or sniffing both the novel and familiar animals compared to their
Cntnap2-/- saline offspring. C,D) Neither Poly I:C MIA nor genotype influence time
spent exploring the different social/non-social chambers/animal holders in
adulthood. Data are shown as mean ± standard error, *p<0.05. For animal numbers
per group, please refer to Table 4-2.

4.3.4

Acoustic Startle phenotypes

The acoustic startle protocol allowed for the testing of sensory reactivity, sensory filtering
and sensorimotor gating of the acoustic startle response, all of which are relevant
phenotypes that can be related to sensory processing phenotypes commonly found in
individuals with ASD. Clinical studies have shown that startle reactivity is increased in
ASD. However, increased reactivity can be an outcome of increased sensitization or
decreased habituation to repeated stimulation. In addition, human studies have also
reported decreased PPI in ASD (Perry et al., 2007; Takahashi and Kamio, 2018).

4.3.4.1

Age, sex and gene-dose-related changes in startle reactivity
and startle sensitization across stimulus intensities and days

Previous studies in our lab have confirmed the Cntnap2-/- model’s validity in replicating
the increased startle reactivity typically found in individuals with ASD (Scott et al., 2020,
2018; Takahashi et al., 2014). The previously reported Cntnap2-/- reactivity changes
manifested in adulthood and affected both males and females. In addition, Cntnap2+/- rats
exhibited a moderate increase in startle reactivity compared to WT animals but only to loud
stimulus intensities. In this study, the Cntnap2-/- reactivity phenotype was replicated, in
addition to revealing a Cntnap2+/- increased reactivity phenotype that manifests in adult
males.

4.3.4.1.1

Reactivity to various stimulus intensities

The basic startle reactivity test was conducted before all other startle testing and consisted
of various stimuli of increasing intensity from 65dB to 120dB in 5dB steps. A separate
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repeated measures ANOVA was conducted at each age with stimulus intensity as a within
subject factor and genotype, MIA, and sex as between subject factors.
In adolescence, the ANOVA revealed a significant main effect of genotype (F(2,161) =
77.791, p<0.001) and a stimulus intensity*genotype interaction (F(13.1,1053)=10.096,
p<0.001). Overall, Cntnap2+/- animals were not different from WTs, but Cntnap2-/- showed
significantly increased startle compared to both Cntnap2+/- and WT offspring, regardless
of MIA status, at all stimulus intensities except 70dB and 85dB (Figure 4-8A).
In adulthood, there was also a significant main effect of genotype (F(2,152) = 57.377,
p<0.001) and a significant stimulus intensity*genotype interaction (F(15.0,1143)=10.096,
p<0.001). Post-hoc testing revealed that Cntnap2-/- startled more than Cntnap2+/- and WT
offspring at all stimulus intensities, whereas Cntnap2+/- offspring startled more than WT
offspring at all decibels louder than 95dB (Figure 4-8B). The curves shown in Figure 4-8B
suggest that males were influenced differently from females, but this did not reach
statistical significance in the form of a genotype*sex interaction (F(2,152)=1.890, p=0.155)
or a stimulus intensity*genotype*sex interaction (F(15.03,1143)=1.163, p=0.295).
Overall, these data show that Cntnap2-/- offspring regardless of Poly I:C MIA or sex exhibit
increased reactivity to a broad range of stimulus intensities in both adolescence and
adulthood.

4.3.4.1.2

Reactivity and sensitization to repeated stimulation with
100dB stimulus

The next startle experiment was the short-term habituation experiment which exposed the
animals to thirty 100dB stimuli separated by an intertrial interval of 1 minute. This protocol
maximizes sensititazion and reduces short-term habituation. A separate repeated measures
ANOVA was conducted at each age with trial number as a within subject factor and
genotype, MIA, and sex as between subject factors.
In adolescence, the ANOVA revealed a significant genotype*MIA*sex interaction that will
be discussed in the next results section. In addition, there was a significant main effect of
genotype (F(2,161)=38.452, p<0.001) and a significant trial*genotype interaction (F(31.1,
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2505)=4.013, p<0.001). Post-hoc testing revealed that Cntnap2-/- animals startled to the
same degree as Cntnap2+/- and WT offspring at trial 1, but startled significantly higher on
the next 20 trials from 2 to 21 (Figure 4-8C). This suggests a sharp and substantial
sensitization effect in Cntnap2-/- animals following trial 1, which was seen in both male
and female offspring.
In

adulthood,

the

(F(2,152)=5.833,

ANOVA

p=0.004)

revealed

but

no

a

significant

significant

genotype*sex

interaction

genotype*trial*sex

interaction

(F(32,2431)=0.839, p=0.725). Post-hoc testing revealed that across trials, Cntnap2-/females startled higher than both Cntnap2+/- and WT females (p=0.001; Figure 4-8D).
Across trials, Cntnap2-/- males startled higher than both WT (p<0.001) and Cntnap2+/males (p<0.001), whereas Cntnap2+/- rats startled higher than WT offspring (p=0.015).
This represents the first report of an age, sex and gene dose-specific effect in Cntnap2
reactivity phenotypes. Taken together with the trial-specificity, it seems that baseline startle
(at trial 1) is not altered in Cntnap2-/- animals in adolescence but is altered in adulthood.
Moreover, this suggests sensitization as a major factor in determining the overall increased
startle reactivity of Cntnap2+/- and Cntnap2-/- animals.
Overall, these data also show that across a 30-trial session Cntnap2+/- male offspring
develop an intermediate reactivity phenotype in adulthood that falls between WT and
Cntnap2-/- offspring

4.3.4.1.3

Average reactivity over days

To summarize the total reactivity for each day throughout the course of the 4-day startle
habituation protocol, the average startle amplitude from all 30 trials was measured. This
measure provides an indication of overall reactivity without specifically exploring the
baseline, habituation and sensitization of startle within each day, the combined effects of
which all influence the average daily reactivity. A separate repeated measures ANOVA
was conducted at each age with day as a within subject factor and genotype, MIA, and sex
as between subject factors.
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In adolescence, there was a significant day*genotype interaction (F(4.86, 442)=6.301
p<0.001) and a main effect of genotype (F(2,182)=33.03, p<0.001). Post-hoc testing
revealed that Cntnap2-/- animals had a higher average startle amplitude across all 4 days
compared to Cntnap2+/- and WT offspring (Figure 4-8E). Additionally, Cntnap2-/offspring showed long-term habituation over the 4 days whereas Cntnap2+/- and WT
offspring did not.
In adulthood, there was a significant day*Genotype*sex interaction (F(5.6, 484)=5.342,
p<0.001), a main effect of genotype (F(2,173)=24.468, p<0.001), and a significant
genotype*sex interaction (F(2,173)=6.482, p=0.002). To further clarify these interactions,
separate analyses were conducted for each sex. In females, there was a significant
day*genotype interaction (F(5.334,229)=6.09, p<0.001), and post-hoc testing revealed that
Cntnap2-/- females startled higher on days 1 and 2 compared to Cntnap2+/- and WT females,
but only higher than Cntnap2+/- females on days 3 and 4 (Figure 4-8F). In males, there was
a main effect of genotype (F(2,87)=18.0, p<0.001), but no interaction with day. Post-hoc
testing revealed that Cntnap2-/- males startled higher across all four days compared to
Cntnap2+/- and WT males, but the difference between Cntnap2+/- and WT males was not
significant after adjustment for multiple comparisons (p=0.133; Figure 4-8F).
Overall, startle data across days suggest that in adolescence, startle reactivity undergoes a
form of long-term habituation in adolescent Cntnap2-/- male and female offspring and in
adult Cntnap2-/- female offspring. These findings were not present in WT or Cntnap2+/offspring, which suggests that animals with higher reactivity are more likely to undergo
long-term habituation, or that long-term habituation circuits are strengthened in Cntnap2-/offspring.
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Figure 4-8. Cntnap2 sex and gene dose effects on startle reactivity manifest in
adulthood. A) Cntnap2-/- adolescent animals show a general increase in startle
reactivity compared to Cntnap2+/- animals at all stimulus intensities except at 70dB.
B) In adulthood, Cntnap2+/- males show an intermediate reactivity phenotype
between WT and Cntnap2-/- males. Cntnap2-/- males startled significantly higher than
Cntnap2+/- and WT males at all intensities, whereas Cntnap2+/- males startled
significantly higher than WT offspring at 100dB or higher intensities. C) Adolescent
Cntnap2-/- males and females show increased reactivity across repeated stimulation
with a 100dB stimulus on the first day of startle testing, likely due to strong
sensitization after trial 1. D) Adult Cntnap2+/- males show an intermediate phenotype
compared to WT and Cntnap2+/- males, whereas only Cntnap2-/- offspring show
increased reactivity compared to their WT and Cntnap2+/- counterparts. E) Over four
days of startle testing, Cntnap2-/- adolescent males and females show increased
reactivity measured by the average amplitude of all 30 trials on each day compared
to Cntnap2+/- and WT offspring. F) In adulthood, Cntnap2+/- males show a trend to
having an intermediate phenotype between WT and Cntnap2-/- males. Cntnap2-/females only show increased reactivity at days 1 and 2. Data are shown as mean ±
standard error, *p<0.05. For animal numbers per group, please refer to Table 4-2.

4.3.4.2

Habituation, sensitization and the effect of Poly I:C MIA on
adolescent Cntnap2-/- males on day 1 of testing

The previous analyses showed that startle reactivity differences involve a complex
interplay between baseline reactivity, sensitization, and habituation of startle over the
course of the testing session. Here, the interaction effect between Poly I:C MIA and
Cntnap2-/- genotype alters reactivity, and each factor alone also affects habituation and
sensitization on Day 1 of testing.
For these purposes, the 29 trials following trial 1 were binned (Figure 4-9). Each bin was
an average of either 3 or 4 trials. Bins 1 was the average of the first 4 trials after trial 1,
whereas bin 9 was the average of the last 4 trials. Bins 2-8 each consisted of the average of
3 trials and encompassed trials 6-26.
A sensitization score (Bin 1 / Trial 1) or a habituation score (Bin 9 / Bin 1) were calculated
for each animal. A sensitization score above 1 signifies sensitization following trial 1,
whereas a habituation score below 1 signifies habituation at the end of session’s Bin 9
compared to Bin 1.
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4.3.4.2.1

Poly I:C-Cntnap2-/- interaction in adolescent male
offspring

A repeated measures ANOVA was conducted with bin number as a repeated measures
factor (including Bin 0) and genotype, MIA, and sex as between subject factors.
In adolescence, there was a significant genotype*MIA*sex interaction (F(2,161)=3.453,
p=0.034). To follow up this interaction, a separate ANOVAs were conducted for each sex.
In males, there was a significant genotype*MIA interaction (F(2,83)=5.308, p=0.007) but
no significant bin*genotype*MIA interaction. Post-hoc testing revealed that Poly I:C
Cntnap2-/- males startled significantly higher throughout the session compared to saline
Cntnap2-/- males (Figure 4-9A).
In adulthood, there were no significant effects associated with Poly I:C MIA (Figure 4-9B)
and the only effect was that of genotype reported in Figure 4-8.

4.3.4.2.2

Sensitization Score

A separate univariate ANOVA was conducted for the sensitization score at each age with
genotype, MIA, and sex as between subject factors. In adolescence, there was a significant
genotype*sex interaction (F(2,157)=7.695, p=0.001), a significant MIA*sex interaction
(F(1,157)=9.1, p=0.003), as well as a main effect of genotype (F(2,157)=6.583, p=0.002).
Post-hoc testing showed that Cntnap2-/- males sensitized significantly more than
Cntnap2+/- (p<0.001) and WT males (p<0.001), and this effect was absent in females
(Figure 4-9C). Moreover, Poly I:C females sensitized significantly more than saline
females regardless of genotype, and this effect was absent in males (Figure 4-9C).
In adulthood, the ANOVA showed a significant main effect of Poly I:C MIA
(F(1,141)=4.019, p=0.047) where Poly I:C offspring showed higher sensitization compared
to saline offspring regardless of genotype (Figure 4-9D). In contrast, there were no
genotype-related effects on sensitization in adulthood.
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4.3.4.2.3

Habituation Score

A separate univariate ANOVA was conducted for the habituation score at each age with
genotype, MIA, and sex as between subject factors. In adolescence, there was a main effect
of genotype (F(2,170)=4.463, p=0.013), and post-hoc testing showed that Cntnap2-/animals had a lower score and therefore more habituation compared to WT offspring
(Figure 4-9E). In adulthood, there were no main effects or interactions associated with
either Genotype or MIA (Figure 4-9E).
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Figure 4-9. Habituation and sensitization changes because Poly I:C MIA or
Cntnap2 deficiency occur independently of each other. A, B) Habituation curves
from previous figure but separated into bins as opposed to individual trials. C) In
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adolescence, Cntnap2-/- male offspring show increased sensitization (Bin 1/ Trial 1)
compared to WT and Cntnap2+/- males, whereas Poly I:C females show increased
sensitization compared to saline females regardless of genotype. D) In adulthood,
Poly I:C increases sensitization in both males and females, whereas genotype had no
significant effects on sensitization score. E) Adolescent Cntnap2-/- offspring show
better habituation as indicated by a smaller habituation score. F) In adulthood, neither
genotype nor Poly I:C MIA (not shown) influence habituation score on day 1 of
startle testing. Data are shown as mean ± standard error, *p<0.05. For animal
numbers per group, please refer to Table 4-2.
Overall, these data show that Poly I:C MIA increases reactivity over 30 trials in Cntnap2/-

males, but this increase is not associated with significant changes in habituation and

sensitization. Moreover, Cntnap2-/- offspring regardless of MIA showed increased
sensitization and habituation in adolescence, whereas Poly I:C MIA offspring regardless
of genotype showed increased sensitization in adulthood, indicating that the mechanisms
that impact sensitization may differ between Cntnap2 and Poly I:C MIA.

4.3.4.3

Prepulse Inhibition – Effect of Poly I:C on adolescent
Cntnap2-/- males

PPI is a measure of sensorimotor gating, a process that prevents brain circuits from being
overwhelmed with too much sensory information. PPI is commonly decreased in
psychiatric disorders like schizophrenia and some studies have suggested that individuals
with ASD experience PPI impairments.
PPI was tested on the last day of startle testing and used a combination of prepulse
intensities (75, 80, and 85dB) and interstimulus intervals (30 or 100 ms ISI), which allowed
a comprehensive analysis of the PPI phenotype of. A similar repeated measures ANOVA
was conducted at each age with prepulse intensity and ISI as within subject factors, and
genotype, MIA, and sex as between subject factors.
In adolescence, there was a significant ISI*genotype*MIA interaction (F2,155=4.447,
p=0.013). To further investigate this interaction, 2 follow-up ANOVAs were conducted for
each ISI. For 30 ms ISI (Figure 4-10A), there were significant main effects of genotype
(F(2,155)=30.001 p<0.001; Cntnap2-/- < Cntnap2+/- and WT) and MIA (F1,155)=6.247,
p=0.013; Poly I:C < saline), as well as a significant genotype*MIA interaction
(F(2,155)=6.054, p=0.003). Post-hoc testing revealed that Poly I:C Cntnap2-/- offspring
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have decreased PPI compared to saline Cntnap2-/- offspring. For 100 ms ISI (Figure
4-10B), there was a main effect of genotype (F(2,155)=13.873), where Cntnap2-/- offspring
showed decreased PPI to Cntnap2+/- and WT offspring regardless of MIA.
In adulthood, there was a significant ISI*genotype interaction (F(1,141)=41.149, p<0.001)
where Cntnap2-/- offspring showed decreased PPI compared to Cntnap2+/- and WT
offspring at both ISIs, but the extent of the decrease was much higher at 30 ISI
(approximately 28% less PPI; Figure 4-10C) compared to 100 ISI (approximately 7% less
PPI Figure 4-10D). Similarly, there was a significant genotype*sex interaction
(F(2,141)=4.637, p=0.011), whereby both sexes showed decreased PPI in Cntnap2-/animals compared to Cntnap2+/- and WT animals, but the extent of decrease in females
was higher than that in males (data not shown, approximately 21% decrease in females
compared to 13.5% in males)
Overall, PPI data show that Poly I:C MIA and Cntnap2-/- genotype both independently and
synergistically decrease PPI in adolescent male offspring. The Cntnap2-/- genotype effect
persists into adulthood, whereas the independent and synergistic Poly I:C MIA effects do
not. In females, Cntnap2-/- genotype but not Poly I:C MIA decrease PPI in both adolescence
and adulthood.
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S - Saline
P - Poly I:C
M - Male
F - Female
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Figure 4-10. Full Cntnap2 deficiency impairs PPI at all stimulus parameters,
but Poly I:C MIA leads to further reduction in PPI in Cntnap2-/- adolescent
offspring with 30ms ISIs. A) Adolescent Cntnap2-/- offspring show significantly
reduced PPI at 30ms ISI compared to both WT and Cntnap2+/- animals, and Poly I:C
MIA leads to further reduction of PPI in a synergistic manner. B) In adulthood, Poly
I:C MIA has no influence on PPI, but Cntnap2-/- offspring still show greatly reduced
PPI at 30ms ISI. C,D) At 100ms ISI, Cntnap2-/- offspring show reduced PPI in both
adolescence and adulthood, and Poly I:C MIA does not influence PPI in any of the
genotype groups. Data are shown as mean ± standard error, *p<0.05. For animal
numbers per group, please refer to Table 4-2.

4.4

Discussion

This study revealed sex and age-dependent gene-environment interactions between MIA
and Cntnap2 deficiency. These interactions were seen in phenotypes related to core
symptoms of autism including locomotor hyperactivity, sensory reactivity, and social
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behaviour. The synergistic effects of MIA and Cntnap2 deficiency were prominent in
adolescence but not in adulthood.
There were also independent effects of Poly I:C MIA and Cntnap2 deficiency on sensory
filtering of the acoustic startle response. Similar to the interaction effects, these
independent effects were age and sex-dependent, highlighting the importance of studying
the developmental timeline and sex-specificity in ASD animal models.
Crucially, the study design allowed for the comprehensive assessment of sensory filtering
changes of the acoustic startle. The strong sensitization that occurred after the first trial in
the habituation experiment highlights the limitation of a commonly used method, which is
measuring startle reactivity using an average of multiple trials. Using such an average may
be problematic in cases of high sensitization similar to those shown in our model.

4.4.1

Immune response variability

An important consideration in Poly I:C experiments is the extent of the maternal immune
response that is elicited by the mother. This immune response was quantified by measuring
two key proinflammatory cytokines: IL-6 and TNFα. The immune response was highly
variable between the different dams despite receiving the same dose of Poly I:C. Variability
in the maternal immune response following Poly I:C injection has risen to attention in
recent years (Mueller et al., 2019).
These findings are likely due to slight variations in Poly I:C administrations as opposed to
Poly I:C efficacy, since the same Poly I:C lot number was used for all of the experiments.
Indeed, every Poly I:C dam showed an elevation in both IL-6 and TNFα compared to all
saline dams.
These results are limited in that they provide a brief snapshot of the immune response three
hours after the Poly I:C injection. Individual immune variability could slightly delay or
quicken the peak of the Poly I:C immune response which may have been missed by the
serum collection at three hours following injection. For instance, a peak occurring later
than three hours is possible given that previous studies have shown significant elevations
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in maternal serum IL-6 at 6 hours and up to 24 hours following Poly I:C administration
(Goeden et al., 2016; Openshaw et al., 2019).
The design of this study and analysis of the results minimizes the potential for this
variability to greatly skew the results. Multiple dams were used for each MIA condition
and each genotype-MIA-sex group in the study contained subjects from at least five
different dams. This design combined with comprehensive outlier analysis would have
minimized the potential for minimally or maximally affected offspring to be included in
the study.

4.4.2

Sensitization of startle in Cntnap2-deficient rats: implications
for studying sensory reactivity

One of the unique characteristics of this study and its design is the ability to detect not only
changes to reactivity to various sound levels, but also being able to detect sensitization and
habituation of startle. This was achieved by analyzing data on a trial-by-trial basis, as
opposed to looking at changes by averaging blocks of trials. Based on the data, sharp and
sudden sensitization after trial 1 plays a major role in determining the startle reactivity in
the following trials in Cntnap2-/- offspring.
Although not as clear as the 30-trial short-term habituation curves, further support for this
point can be drawn from the multiple stimulus intensity experiments. Our experimental
design was such that the order of stimulus presentation was randomized within animals but
not between animals. Therefore, all animals received the same sequence of trials. In total
there were 15 trials, and the first 5 trials contained the following stimuli: 4ms 75dB
(excluded from analysis, shorter duration to check for lack of startle to prepulses), 20ms
110dB, 20ms 85dB, 20ms 70dB, 20ms 115dB, and 20ms 75dB.
The curves in Figure 4-8A and Figure 4-8B show the presence of dips in the Cntnap2-/curve. These dips coincide with the first few trials of the experiment and do not follow the
general trend of the line. For example, dips at 85 and 110dB are present in almost all curves.
Similarly, dips at 70 and 115dB can be seen in adolescent animals. Cntnap2-/- animals even
startled substantially at 65dB stimulus intensity which is the same as the background noise
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but elicited from a different speaker. This 65dB sound was presented as the last trial in the
15-trial experiment, which would be after the animals had already potentially sensitized.
The studies that reported increased startle reactivity in individuals with ASD used an
average of multiple trials spread across the entire session (Takahashi et al., 2017, 2014). It
is therefore difficult to distinguish whether their observed effects were due to increased
baseline reactivity or increased sensitization. The distinction between baseline reactivity
and sensitization has important implications for inferring which underlying brain structures
are affected in ASD.
On one hand, an increase in baseline reactivity to low level stimuli (e.g 70 dB) prior to
sensitization indicates a decrease in startle threshold. Startle threshold is determined by
peripheral auditory system activity, which is upstream of the startle-mediating nucleus, the
pontine reticular formation (PnC). On the other hand, an increase in sensitization without
a change in baseline reactivity is most likely controlled by startle modulating projections
onto the PnC from other brain regions that increase its excitability (Koch, 1999).

4.4.3

Interaction effects

Our study confirmed the potential for gene-environment interaction between MIA and
Cntnap2 deficiency, which is consistent with a previous report by Schaafsma et al (2017).
Interestingly, most of the interaction effects except those in the open field were seen in
adolescence. Age-related changes have been previously reported in both genetic and
environmental models of ASD including Cntnap2 (Bridi et al., 2017; Scott et al., 2018)
and Poly I:C MIA (Esslinger et al., 2016; Giovanoli et al., 2016; O’Leary et al., 2014;
Vuillermot et al., 2010). This may be related to age-related phenotype change such as the
general decrease in sociability preference and PPI, which could mask subtle interaction
effects seen earlier in life. Alternatively, the brain may adapt and compensate for early-life
changes as it matures into adulthood. A similar age dependency is seen in other models of
ASD such as the Fmr1 mouse model of Fragile X Syndrome (Gauducheau et al., 2017).
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4.4.3.1

Social behaviour

Poly I:C Cntnap2+/- offspring showed reduced time spent with the social stimulus in the
sociability experiment compared to their saline counterparts. There have not been previous
reports of altered social behaviour in Cntnap2+/- adolescent offspring, suggesting that
partial deficiency in Cntnap2+/- could make animals susceptible to further hits such as MIA.
A similar but not statistically significant change was also seen in Poly I:C Cntnap2-/animals. This lack of Poly I:C MIA effect in Cntnap2-/- animals compared to Cntnap2+/animals may have been the result of Cntnap2-/- hyperactivity. This persistent phenotype
(see open field data and Scott et al., 2020) which generally reduced social exploration time,
masking any subtle effects like that described in Cntnap2+/- offspring.
In the social novelty test, Poly I:C Cntnap2-/- offspring did not exhibit changes in social
novelty preference but instead spent less total time sniffing in the vicinity of both the
familiar and novel animals compared to saline Cntnap2-/- offspring. Similar to these
findings, Brunner et al. (2015) reported a decrease in time spent in both the novel and
familiar chambers and exploring the novel and familiar animals but no change in preference
when normalized by the total exploration time.
Overall, the social behaviour changes reported here are relatively mild, particularly
compared to mouse Cntnap2 knockout studies where social preference is completely
abolished (Kim et al., 2019b; Peñagarikano et al., 2015, 2011). Therefore, this model may
not be well suited to studying the social communication deficits associated with ASD.

4.4.3.2

Open field exploration

The two main interaction effects seen in the open field test were related to adult female
locomotor activity. Adult Poly I:C Cntnap2+/- females had reduced activity compared to
their saline counterparts, whereas Poly I:C Cntnap2-/- females had increased activity
compared to their saline counterparts. These changes occurred without alterations in centre
time and can therefore be attributed to locomotor activity as opposed to increased anxiety
and freezing in a novel environment.
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Poly I:C MIA studies have produced conflicting results with regards to its effect on
spontaneous activity in the open field test in mice (No change: Meyer, 2006; Meyer et al.,
2008; increased: da Silveira et al., 2017; Tang et al., 2013; Zhu et al., 2014; decreased Li
et al., 2014; Shi et al., 2003). One explanation for this variability is genetic variation
between strains used at different labs which can influence the effects of Poly I:C MIA as
has been previously reported in Poly I:C MIA literature (Morais et al., 2018; Schwartzer et
al., 2013).
The results in this study indicate that Cntnap2 may be one of the genes that influences the
effects of Poly I:C MIA on locomotor activity in a gene-dependent manner. The effects of
Poly I:C were absent in WT rats and were dependent on the gene-dose of Cntnap2.
The female specificity of the results is rarely reported in either Poly I:C MIA or Cntnap2
literature, suggesting that gene-environment interactions can manifest novel phenotypes
beyond what each individual model shows. It is unclear why the direction of change in
Cntnap2+/- would be opposite to that seen in Cntnap2-/- females. Cntnap2+/- animals have
not received much attention beyond studies from our lab, perhaps due to their mostly
normal behavioural phenotype (Scott et al., 2020) and it is not yet known which brain
processes are altered with only 1 copy of the gene.
Results from the open field experiment also showed that Poly I:C MIA reduced time spent
in the centre of the open field in adult Poly I:C WT offspring compared to saline WT
offspring. Time spent in the centre is thought to reflect an increase in anxiety which is one
of the comorbidities associated with ASD (van Steensel et al., 2011). Similar effects have
been reported in Poly I:C studies (Kim et al., 2018; Meyer, 2006; Meyer et al., 2005) and
the lack of a similar change in Cntnap2+/- and Cntnap2-/- offspring may be in part due to
their already reduced centre indicated by a main genotype effect. This strong genotype
influence can produce a floor effect that masks the effects of Poly I:C MIA.

4.4.3.3

Startle phenotypes

The startle-related interaction effects seen in this study were in the same phenotypes that
are disrupted in Cntnap2-/- animals: PPI and startle reactivity upon repeated stimulation in
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the short-term habituation protocol. Similar to other interaction effects, these occurred only
in adolescence, highlighting the early-life susceptibility or the later-life adaptability of the
brain.

4.4.3.3.1

Reactivity and sensory filtering

The first interaction effect was in adolescent male Cntnap2-/- reactivity on day 1. Poly I:C
Cntnap2-/- males overall reacted more strongly to the 30 trials of repeated stimulation
compared to saline Cntnap2-/- males. The short-term habituation curve indicates that the
effect is very likely driven by stronger sensitization in Poly I:C Cntnap2-/- males.
Interestingly, a similar interaction was not present in the sensitization score measure, and
this was not due to the method of outlier exclusion. The discrepancy suggests that the
sensitization score changes were subtle but still sufficient to cause consistent differences
across the entire session.

4.4.3.3.2

PPI

The second interaction between genotype and MIA was in adolescent PPI at 30ms ISI. An
ISI-dependent change in PPI helps to specifically locate which of the many brain nuclei
that can modulate PPI are disrupted (Gómez-Nieto et al., 2020). Cntnap2-/- Poly I:C
offspring regardless of sex showed reduced PPI at 30ms ISI compared to Cntnap2-/- saline
offspring.
Our data support a synergistic hypothesis for this effect several reasons. Firstly, although
Poly I:C WT offspring showed reduced PPI compared to saline WT offspring (~5%
reduction), this effect was not statistically significant. Secondly, the magnitude of PPI
reduction in Poly I:C Cntnap2-/- offspring (~10% reduction) was higher than the general
main effect of Poly I:C MIA (~5% reduction), and was present despite the already
decreased PPI in Cntnap2-/- offspring compared to WT animals. Combining the lack of
adolescent PPI changes in both previous chapters with the results from this chapter further
supports the idea that Poly I:C MIA does not alter adolescent PPI without an additional
risk factor like Cntnap2 deficiency to increase susceptibility.
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4.4.4

Potential mechanisms and future directions

Based on several lines of evidence from this study and previous studies involving Cntnap2,
Poly I:C, and ASD, the amygdala may be a mechanistic link for future studies to investigate
with regards to changes in anxiety and acoustic startle phenotypes.
Firstly, human studies have consistently found links between the amygdala and ASD.
Several studies have shown age-dependent changes in amygdala volume. Enlarged
amygdala has been reported in children aged 2-4 years, and toddlers with enlarged
amygdala were found to have more severe symptoms (Nordahl, 2012; Schumann et al.,
2009). These volumetric changes seem to dissipate by adolescence and adulthood (BarneaGoraly et al., 2014).
Functionally, less activity in the amygdala has also been found in individuals with ASD
during social tasks related to eye fixation to faces or processing of facial emotional stimuli
(Critchley et al., 2000; Dalton et al., 2005; Kliemann et al., 2012). Moreover, the amygdala
is heavily involved in anxiety disorders which are a common comorbidity in autism
(Hofvander et al., 2009; Mattila et al., 2010).
From a startling perspective, the amygdala is involved in both sensitization and prepulse
inhibition of startle. Amygdala activity is strongly implicated in the fear potentiation of
startle with both conditioned and unconditioned aversive stimuli, which is a form of
sensitization (Koch, 1999). Although this experiment did not use an inherently aversive
stimulus, the startle stimuli themselves can be considered aversive and can cause a fear
association to occur with the experimental context (Leaton and Cranney, 1990). Indeed,
the acoustic startle response is associated with electrical activity in the basolateral
amygdala (BLA; Ebert and Koch, 1997), and electrical stimulation of the amygdala
potentiates sound-evoked responses in the pontine reticular nucleus (PnC; Koch and Ebert,
1993) .
In context of PPI, lesions and pharmacological inhibition of the amygdala decrease PPI
(Wan and Swerdlow, 1996). Recently, it has even been suggested that this role in PPI is
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due to direct connections from the amygdala to the pontine reticular nucleus that mediates
PPI (Cano et al., 2021).
Preclinically, the amygdala has been studied in Poly I:C MIA models but not in Cntnap2
knockout models to date. Weber-Stadlbauer et al. (2017) found decreased PPI and
increased cued fear expression in GD9.5 Poly I:C mouse offspring which were associated
with genome-wide transcriptomic changes in the amygdala. Also in GD9.5 adult Poly I:C
offspring, Abazyan et al. (2010) reported decreased amygdala volume but behavioural
deficits were only present in mice with a mutation in the schizophrenia risk gene DISC1.
Another study by Li et al., (2018) found that GD12.5 Poly I:C MIA adult mice exhibited
stronger glutamatergic projections from the medial prefrontal context to the BLA which
affected both excitatory and inhibitory activity in the BLA.
Several findings from this study provide support for investigating the amygdala as a brain
region involved in this particular gene-environment interaction. Firstly, the main startle
interaction effects were increased reactivity and decreased PPI, both related to dysfunction
in the amygdala. These interactions were prominent in adolescence and faded in adulthood,
mirroring the developmental time course of ASD-related amygdala changes. Moreover,
both Cntnap2-/- and Poly I:C separately increased anxiety measured by time spent in the
centre of the open field, and it is likely that Poly I:C did not influence Cntnap2-/- offspring
due to their severe baseline phenotype. In addition, this study provides evidence that
sensitization of startle is an important factor to consider for Poly I:C MIA and Cntnap2
deficiency, both of which increased sensitization in an age and sex-dependent manner.
Future studies should investigate structural and functional changes in amygdala circuits
related to the acoustic startle response, such as projections from the central amygdaloid
nucleus that influence the PnC and increase startle reactivity (Koch and Ebert, 1993), or
projections from the BLA that modulate PPI (Forcelli et al., 2012). In addition, it is known
that postnatal development requires the expansion of dendritic arbors and myelination of
projections arriving to the amygdala from other regions (Chareyron et al., 2012; Ryan et
al., 2016). Given that Cntnap2-deficiency is associated with both white matter
abnormalities and a reduction in dendrite formation (Anderson et al., 2012; Zerbi et al.,
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2018), it would be interesting to investigate whether these abnormalities are prominent in
amygdala circuits.

4.5

Conclusion

Our study’s findings support the double-hit gene-environment interaction hypothesis of
ASD. It also provides insight into the specific sensory processing changes related to two
risk factors associated with ASD and suggests important considerations for measuring and
analyzing the acoustic startle response in animal models. Future studies can explore the
structural and functional brain correlates of these behavioural findings to locate vulnerable
brain networks or molecular pathways impacted simultaneously by multiple ASD risk
factors.
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5

General discussion

The findings from experimental chapters 2-4 add to the growing literature of Poly I:C MIA
studies and provide new avenues for investigation. In particular, they address knowledge
gaps on the effect of Poly I:C MIA timing, cytokine-mediated mechanisms, and
interactions with genetic predispositions for neurodevelopmental disorders. In this section,
I will focus on key takeaways when considering all 3 chapters together, as opposed to the
more specific discussion sections included in each Chapter.

5.1

General summary of major behavioural findings

In Chapter 2, GD9.5 but not GD14.5 Poly I:C MIA offspring exhibited higher startle
amplitude across various stimulus intensities regardless of sex. In contrast, GD14.5 Poly
I:C MIA offspring showed no changes in any of the startle phenotypes measured including
reactivity, habituation, and PPI.
In Chapter 3, Poly I:C WT but not Poly I:C IL-15-/- offspring exhibited decreased startle
reactivity. In contrast, Poly I:C IL-15-/- but not Poly I:C WT offspring showed deficits in
adolescent PPI and increased adult locomotor hyperactivity. Neither IL-15-/- genotype nor
Poly I:C MIA altered sociability or social novelty behaviours.
In Chapter 4, GD9.5 Poly I:C exacerbated the decreased PPI and increased startle reactivity
phenotypes already exhibited by Cntnap2-/- offspring. Moreover, Poly I:C MIA manifested
changes in otherwise unaffected social preference and social exploration phenotypes in
Cntnap2+/- and Cntnap2-/- offspring, respectively.

5.2

Comparison of effects across Chapters 2-4

The common factor between all of Chapters 2 to 4 was the Poly I:C MIA conducted at
GD9.5, which consisted of a 4mg/kg intravenous injection of Poly I:C. Table 5-1
summarizes the findings from all 3 chapters. The columns in grey represent the GD9.5 Poly
I:C offspring from Chapter 2, and the GD9.5 Poly I:C WT offspring from Chapters 3 and
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4. The full behavioural phenotype including open field and social behaviour tests was not
assessed in Chapter 2.
The summary in Table 5-1 shows that the baseline phenotypes between the 3 studies is
highly variable. The most consistent phenotypes across all Chapters were those where no
change was seen, such as no change in social behaviour or long-term habituation of startle
at either ages. The observed phenotypical changes in Chapter 2 GD9.5 offspring were
either reversed in the WT offspring in Chapter 3 (adult startle reactivity) or affected only
females compared to both males and females in Chapter 3 (adolescent open field). Neither
of these phenotypes were altered in Chapter 4 WT offspring. Furthermore, none of the
phenotypes altered in Chapter 3 WT offspring were altered in Chapter 4 WT offspring.
Here, I will offer some explanations for the observed differences in baseline phenotypes.
One explanation is that the immune response induced by Poly I:C was different across the
different studies, and therefore its effect on the fetal brain was different from one study to
another. This is possible because each experiment used a different Poly I:C Lot# which
was unavoidable due to the timeline of the experiments.. Previous studies have shown that
different Lots of Poly I:C obtained from Sigma can have different efficacies with regards
to their influence on the immune response measured in dams and fetuses (Mueller et al.,
2019). Although I confirmed that MIA induced an immune response in each experiment
separately, it is not possible to directly compare the results because they were all conducted
in different experimental settings with their own controls.
Another potential explanation is that the immune response differentially influenced
animals derived from different strains and obtained from different sources. Previous studies
also show strain-specific effects in mice Poly I:C MIA studies (Morais et al., 2018;
Schwartzer et al., 2013). In other cases, same-strain mice obtained from different sources
were differentially influenced by Poly I:C MIA, and this was attributed to the differential
intestinal microbiome in each group (Choi et al., 2016).
In Chapter 2, Sprague Dawley rats were used that were ordered from Charles River. In
Chapter 3, the IL-15 transgenic rat was created on the background of a slightly different
strain, Sprague Dawley Holtzman. Differences between Charles River and Holtzman

215

Sprague Dawley rats have been previously reported in both behavioural and
pharmacological contexts, supporting the hypothesis that baseline strain differences might
uniquely interact with the effects of Poly I:C MIA (Helmstetter and Fanselow, 1987;
Kuribara et al., 1976; Padilla et al., 2009). In Chapter 4, the transgenic Cntnap2 colony was
rederived six months prior to the beginning of breeding experiments by the CHUM
research Centre in Montreal using sperm from the original transgenic rats from Horizon
and their Sprague Dawley rats. Since Sprague Dawley rats are an outbred rat strain, genetic
differences between these cohorts can be considerable.
In addition to largely genetic strain differences influencing the effects of Poly I:C,
differences in environmental conditions such as housing may also play a role. A study by
Buschert et al., (2016) showed that environmental enrichment may protect the offspring
against the effects of Poly I:C MIA, whereas Bronson et al., (2011) found that dams may
exhibit weight loss following Poly I:C if they were single but not if they were double
housed. In our case, all pregnant dams were single housed following confirmation of
pregnancy. However, housing conditions in Chapter 4 were substantially altered compared
to the previous two studies, as all animals were kept in a different animal facility with
different cages (larger colony cages), bedding (sawdust compared to corncob in Chapters
2 & 3), and enrichment (different material of plastic shelters and wooden blocks compared
to only plastic or PVC shelters in Chapters 2 & 3).
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Table 5-1. Summary of findings from Chapters 2-4. Grey columns represent the
groups that can be directly compared across studies. (N/A) Data not available. (-)
no change in phenotype, (↑) increase in the phenotype, and (↓) decrease in the
phenotype.
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5.3

Comparison to previous Poly I:C studies and future

directions for the Poly I:C field
The startle findings from Chapter 2 and their contrast to Poly I:C studies from other groups
which often report reductions in PPI in Poly I:C offspring and were previously discussed
in this thesis. In a similar manner, normal sociability preference results from Chapters 3
and 4 also contrast to previous reports of decreased sociability in GD9.5 and GD12.5 mice
(Abazyan et al., 2010; Hsiao et al., 2013; Meehan et al., 2017; Shi et al., 2003; WeberStadlbauer et al., 2017; Weiser et al., 2016).
Overall, the rat model characterized in this thesis seems to be less susceptible to Poly I:CMIA induced behavioural changes than previous models. This is supported by findings of
reduced PPI and impaired social behaviour only in IL-15 and Cntnap2-deficient but not
WT offspring. Many of the factors discussed in previous sections such as strain, housing,
and Poly I:C efficacy may be the reason behind this discrepancy. However, I would like to
shift the focus from these factors that are difficult and often unreasonable to control for
across studies to another factor that can be more easily controlled: the immune stimulant.
Poly I:C is a widely used immune stimulant, with various applications particularly in the
field of immunology. Although induction of MIA with Poly I:C has served a great purpose
in confirming the validity of the MIA hypothesis, it remains unclear which aspects of the
Poly I:C immune response are responsible for which offspring changes. The effects of Poly
I:C are variable, and they are also relatively broad as they elicit changes in numerous
cytokines and chemokines as discussed earlier.
To tackle the issue of variability, the Poly I:C MIA field should pay closer attention to the
molecular properties of Poly I:C such as its molecular weight, which are known to
influence its efficacy (Mueller et al., 2019). Doing so would help in between-study
comparisons, and any differences due to Poly I:C efficacy can be disentangled from
differences due to other factors like housing or animal strain. Moreover, by monitoring the
molecular properties, researchers can more accurately study the effect of Poly I:C dosage.
Neuroscience Poly I:C studies almost exclusively used a single dose of Poly I:C and rarely
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tracked its molecular properties (Haddad et al., 2020b). However, human studies have
shown that more severe infections lead to greater offspring risk. Therefore, future studies
should attempt to vary the dosage or efficacy of Poly I:C in the same experiment to
determine how MIA severity impacts offspring phenotypes.
To tackle the issue of the breadth of the immune response, the MIA field should emphasize
studies that use specific cytokines as immune stimulants, or those that block the action of
certain cytokines during Poly I:C exposure. For example, a study by Hsiao and Patterson,
(2011) administered Poly I:C and IL-6 during pregnancy in separate experiments and
noticed that the behavioural effects were highly similar. In the same experiment, they also
noted that Poly I:C failed to produce offspring effects in maternal but not fetal IL-6
deficient mice. The only other cytokine investigated in a similar comprehensive manner is
IL-17 (Choi et al., 2016; Shin Yim et al., 2017). These types of studies must be conducted
for other important cytokines elevated following Poly I:C such as IL-1β, TNFα, and IL-10
if MIA mechanisms are to be elucidated to the level required for the development of
treatments or interventions.

5.4

Future

directions

for

the

study

of

sensory

processing using the startle response in animal models
of brain disorders
The startle phenotypes described Chapters 2-4 have important implications for preclinical
studies of sensory processing. Startle and PPI are usually assessed using standard
experimental and analysis protocols that limit the conclusions that can be made from the
results. A major conclusion from our study is to inform the design of startle experiments
to better identify the potential mechanisms behind the observed phenotypes.
In the context of startle reactivity, studies typically report this as the average startle
amplitude across a number of start-only trials throughout the entire experiment (Kim et
al., 2018; Meyer et al., 2008a; 2008b) or from blocks of trials at the beginning and end of
a testing session (Zhang and van Praag, 2015).
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The first limitation of this method is the lack of information with regards to reactivity in
response to lower intensity startle stimuli, since these experiments usually use one startle
stimulus intensity. Reactivity to low intensity stimuli is increased in individuals with ASD
and this change seems more robust than any changes related to PPI, which is usually
disrupted in schizophrenia (Sinclair et al., 2017; Swerdlow et al., 2018; Takahashi et al.,
2014). Therefore, testing reactivity to various stimulus intensities would help clarify which
disorder the particular model is most relevant to, since both disorders are associated with
MIA.
Another limitation of inferring reactivity using blocks of trials or in the middle of the PPI
block is the confound of sensitization and habituation. Our results from Chapter 4 highlight
the limitation of averaging the startle amplitude across the first few trials, which can be
heavily influenced in animals that experience a large degree of sensitization after trial 1
(Figure 4-8). Along the same lines, calculating the startle amplitude from the PPI block
also uses trials after the animals have already sensitized or habituated, and would therefore
be confounded if the different groups of animals have varying levels of habituation or
sensitization. To address this limitation, a separate experiment assessing sensitization and
habituation as performed across Chapters 2-4 is beneficial. Alternatively, a habituation
block can be included in the PPI experiments that lack this feature (Wu et al., 2015; Zhang
and van Praag, 2015), or if already present, should be extended to 10 or 20 trials as opposed
to often used 4-6 trial blocks (e.g Esslinger et al., 2016).
In context of PPI, our results from Chapter 4 highlight the importance of testing more than
one ISI. We saw an interaction between Poly I:C MIA and Cntnap2 deficiency but only
with 30 ms ISI. These changes are informed by previous studies that show differential
mechanisms mediating PPI at short versus long ISIs (Gómez-Nieto et al., 2020). Short ISI
PPI is presumably mediated by projections from the ventral nucleus of the trapezoid body
or the locus coeruleus to the cochlear root neurons, whereas longer ISI PPI is mediated by
a more comprehensive circuit involving multiple brainstem nuclei that integrate
multimodal prepulses (Gómez-Nieto et al., 2020). The findings of ISI-dependent PPI
impairments can also point to specific molecular mechanisms underlying the changes. For
example, Jones and Shannon (2000) showed that the muscarinic receptor antagonist
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scopolamine alters PPI at 100 but not 30 ms ISI, which gives rise to the hypothesis that PPI
with short ISI is more dependent on the activation of ionotropic receptors, whereas PPI
with longer ISIs depend on metabotropic neurotransmitter receptors (Yeomans et al.,
2010).

5.5
5.5.1

Limitations
Chapters 2&3: Immune response quantification in behavioural
cohorts

One of the limitations of the thesis is that the immune responses measured in Chapter 2
was not in the same dams that were used to generate the offspring used to obtain the
behavioural data. Therefore, I am unable to precisely identify how variable the immune
response was in those dams and if it could have impacted our behavioural results. However,
in Chapter 2, the Poly I:C used in the separate immune quantification experiment and in
the behavioural experiment was from the same Lot # and stored under similar conditions.

5.5.2

Chapter 3: Fetal versus maternal effects of IL-15

A limitation of our experimental approach to Chapter 3 is the inability to disentangle
maternal IL-15 from fetal IL-15 effects. The importance of this distinction is shown in
other cytokine-mediated Poly I:C mechanisms. Hsiao and Patterson's (2011) study showed
that maternal, but not fetal, IL-6 knockout in mice protected against the effects of Poly I:C
MIA. In our case, the homozygous breeding scheme meant that IL-15 was knocked out in
both mothers and offspring, and this distinction could not be made.
To address this issue, future studies can use different breeding schemes such as IL-15-/females paired with IL-15+/+ males. In that case, all offspring would have one functional
copy of IL-15 but the mother would be lacking IL-15, which can help uncover the fetal IL15 contribution to the Poly I:C MIA phenotype. Alternatively, IL-15+/- dams could be
paired with IL-15-/- males, and in that case half of the offspring would have no functional
copies of IL-15, and those can be investigated for the maternal IL-15 involvement in Poly
I:C MIA.
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5.5.3

Litter effects and their contribution to the Poly I:C MIA
phenotypes

An important factor to consider in prenatal exposure studies like Poly I:C MIA is related
to litter effects. This topic is addressed in Chapter 2 where within and between-litter
variability within the experiments were analyzed. However, it is important to further
elaborate on some relevant points.
Although Chapter 2 showed considerable between-litter effects, offspring from the same
litter were still treated as independent subjects within our experiments. This approach is
widely implemented across Poly I:C MIA literature, and the high within-litter variability
across treatments seems to justify this approach (Figure 2-10). The analysis clearly
supported the argument that littermate behaviour is highly variable and littermates could
be considered as independent. Many factors could be related to this including postnatal
maternal care, litter size, and the genotype of littermates that influence the postnatal
environment, all of which may alter the developmental environment a pup experiences
early in life.
A potential way to account for litter effects is to designate litter as a random factor in a
mixed model approach. However, this statistical method requires a large number of dams
as well as a large number of pups per litter to be tested to give valid conclusions (Singmann
and Kellen, 2019). Designing such an extensive experiment comes with several challenges,
including those related to generating sufficient numbers of transgenic animals.

5.6

Conclusion

Taken together, these studies inform the Poly I:C MIA field with respect to MIA timing,
IL-15 influence, and Cntnap2 interactions. They provide further support for the importance
of MIA timing and how it can influence offspring phenotypes. They show that the
relationship between the proinflammatory cytokine IL-15 and the effects of Poly I:C are
not straightforward and that IL-15 deficiency can both mediate and protect against the
effects of Poly I:C, depending on the phenotype in question. Finally, the results provide
further evidence to support the multiple-hit hypothesis for ASD, hoping that these results
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motivate future studies to consider this approach to obtain more holistic models of complex
brain disorders like ASD.

References
Abazyan, B., Nomura, J., Kannan, G., Ishizuka, K., Tamashiro, K.L., Nucifora, F.,
Pogorelov, V., Ladenheim, B., Yang, C., Krasnova, I.N., Cadet, J.L., Pardo, C., Mori, S.,
Kamiya, A., Vogel, M.W., Sawa, A., Ross, C.A., Pletnikov, M.V., 2010. 18. Prenatal
Interaction of Mutant DISC1 and Immune Activation Produces Adult Psychopathology.
Biological Psychiatry 68, 1172–1181. https://doi.org/10.1016/j.biopsych.2010.09.022
Bronson, S.L., Ahlbrand, R., Horn, P.S., Kern, J.R., Richtand, N.M., 2011. 107. Individual
differences in maternal response to immune challenge predict offspring behavior:
Contribution of environmental factors. Behavioural Brain Research 220, 55–64.
https://doi.org/10.1016/j.bbr.2010.12.040
Buschert, J., Sakalem, M.E., Saffari, R., Hohoff, C., Rothermundt, M., Arolt, V., Zhang,
W., Ambrée, O., 2016. 36. Prenatal immune activation in mice blocks the effects of
environmental enrichment on exploratory behavior and microglia density. Progress in
Neuro-Psychopharmacology
and
Biological
Psychiatry
67,
10–20.
https://doi.org/10.1016/j.pnpbp.2016.01.005
Choi, G.B., Yim, Y.S., Wong, H., Kim, S., Kim, H., Kim, S.V., Hoeffer, C.A., Littman,
D.R., Huh, J.R., 2016. 223. The maternal interleukin-17a pathway in mice promotes
autism-like
phenotypes
in
offspring.
Science
351,
933–939.
https://doi.org/10.1126/science.aad0314
Esslinger, M., Wachholz, S., Manitz, M.P., Plumper, J., Sommer, R., Juckel, G., Friebe,
A., 2016. 216. Schizophrenia associated sensory gating deficits develop after adolescent
microglia
activation.
Brain
Behav
Immun
58,
99–106.
https://doi.org/10.1016/j.bbi.2016.05.018
Gómez-Nieto, R., Hormigo, S., López, D.E., 2020. Prepulse Inhibition of the Auditory
Startle Reflex Assessment as a Hallmark of Brainstem Sensorimotor Gating Mechanisms.
Brain Sciences 10, 639. https://doi.org/10.3390/brainsci10090639
Haddad, F.L., Patel, S.V., Schmid, S., 2020. Maternal Immune Activation by Poly I:C as a
preclinical Model for Neurodevelopmental Disorders: A focus on Autism and
Schizophrenia.
Neuroscience
&
Biobehavioral
Reviews
113,
546–567.
https://doi.org/10.1016/j.neubiorev.2020.04.012
Helmstetter, F.J., Fanselow, M.S., 1987. Strain differences in reversal of conditional
analgesia by opioid antagonists. Behavioral Neuroscience 101, 735–737.
https://doi.org/10.1037/0735-7044.101.5.735

223

Hsiao, E.Y., McBride, S.W., Hsien, S., Sharon, G., Hyde, E.R., McCue, T., Codelli, J.A.,
Chow, J., Reisman, S.E., Petrosino, J.F., Patterson, P.H., Mazmanian, S.K., 2013. 62.
Microbiota Modulate Behavioral and Physiological Abnormalities Associated with
Neurodevelopmental
Disorders.
Cell
155,
1451–1463.
https://doi.org/10.1016/j.cell.2013.11.024
Hsiao, E.Y., Patterson, P.H., 2011. 227. Activation of the maternal immune system induces
endocrine changes in the placenta via IL-6. Brain, Behavior, and Immunity 25, 604–615.
https://doi.org/10.1016/j.bbi.2010.12.017
Jones, C.K., Shannon, H.E., 2000. Effects of scopolamine in comparison with apomorphine
and phencyclidine on prepulse inhibition in rats. Eur J Pharmacol 391, 105–12.
https://doi.org/S0014-2999(00)00055-8 [pii]
Kim, H.-J., Won, H., Im, J., Lee, H., Park, J., Lee, S., Kim, Y.-O., Kim, H.-K., Kwon, J.T., 2018. 166. Effects of Panax ginseng C.A. Meyer extract on the offspring of adult mice
with
maternal
immune
activation.
Mol
Med
Rep
18,
3834–3842.
https://doi.org/10.3892/mmr.2018.9417
Kuribara, H., Ohashi, K., Tadokoro, S., 1976. Rat Strain Differences in the Acquisition of
Conditioned Avoidance Responses and in the Effects of Diazepam. The Japanese Journal
of Pharmacology 26, 725–735. https://doi.org/10.1254/jjp.26.725
Meehan, C., Harms, L., Frost, J.D., Barreto, R., Todd, J., Schall, U., Shannon Weickert,
C., Zavitsanou, K., Michie, P.T., Hodgson, D.M., 2017. 12. 137. Effects of immune
activation during early or late gestation on schizophrenia-related behaviour in adult rat
offspring.
Brain,
Behavior,
and
Immunity
63,
8–20.
https://doi.org/10.1016/j.bbi.2016.07.144
Meyer, U., Murray, P.J., Urwyler, A., Yee, B.K., Schedlowski, M., Feldon, J., 2008. 6.
Adult behavioral and pharmacological dysfunctions following disruption of the fetal brain
balance between pro-inflammatory and IL-10-mediated anti-inflammatory signaling. Mol.
Psychiatry 13, 208–221. https://doi.org/10.1038/sj.mp.4002042
Meyer, Urs, Nyffeler, M., Yee, B.K., Knuesel, I., Feldon, J., 2008. 16. 132. Adult brain
and behavioral pathological markers of prenatal immune challenge during early/middle and
late fetal development in mice. Brain, Behavior, and Immunity 22, 469–486.
https://doi.org/10.1016/j.bbi.2007.09.012
Morais, L.H., Felice, D., Golubeva, A.V., Moloney, G., Dinan, T.G., Cryan, J.F., 2018. 71.
Strain differences in the susceptibility to the gut–brain axis and neurobehavioural
alterations induced by maternal immune activation in mice: Behavioural Pharmacology 1.
https://doi.org/10.1097/FBP.0000000000000374
Mueller, F.S., Richetto, J., Hayes, L.N., Zambon, A., Pollak, D.D., Sawa, A., Meyer, U.,
Weber-Stadlbauer, U., 2019. 222. Influence of poly(I:C) variability on thermoregulation,
immune responses and pregnancy outcomes in mouse models of maternal immune
activation. Brain, Behavior, and Immunity. https://doi.org/10.1016/j.bbi.2019.04.019

224

Padilla, E., Barrett, D., Shumake, J., Gonzalez-Lima, F., 2009. Strain, sex, and open-field
behavior: Factors underlying the genetic susceptibility to helplessness. Behavioural Brain
Research 201, 257–264. https://doi.org/10.1016/j.bbr.2009.02.019
Schwartzer, J.J., Careaga, M., Onore, C.E., Rushakoff, J.A., Berman, R.F., Ashwood, P.,
2013. 53. Maternal immune activation and strain specific interactions in the development
of autism-like behaviors in mice. Translational Psychiatry 3, e240–e240.
https://doi.org/10.1038/tp.2013.16
Shi, L., Fatemi, S.H., Sidwell, R.W., Patterson, P.H., 2003. 9. Maternal influenza infection
causes marked behavioral and pharmacological changes in the offspring. J. Neurosci. 23,
297–302.
Shin Yim, Y., Park, A., Berrios, J., Lafourcade, M., Pascual, L.M., Soares, N., Yeon Kim,
J., Kim, S., Kim, H., Waisman, A., Littman, D.R., Wickersham, I.R., Harnett, M.T., Huh,
J.R., Choi, G.B., 2017. 68. Reversing behavioural abnormalities in mice exposed to
maternal inflammation. Nature 549, 482–487. https://doi.org/10.1038/nature23909
Sinclair, D., Oranje, B., Razak, K.A., Siegel, S.J., Schmid, S., 2017. Sensory processing in
autism spectrum disorders and Fragile X syndrome—From the clinic to animal models.
Neuroscience
&
Biobehavioral
Reviews,
SI:IBNS-2015
76,
235–253.
https://doi.org/10.1016/j.neubiorev.2016.05.029
Singmann, H., Kellen, D., 2019. An Introduction to Mixed Models for Experimental
Psychology, in: Spieler, D., Schumacher, E. (Eds.), New Methods in Cognitive
Psychology. Routledge, pp. 4–31. https://doi.org/10.4324/9780429318405-2
Swerdlow, N.R., Light, G.A., Thomas, M.L., Sprock, J., Calkins, M.E., Green, M.F.,
Greenwood, T.A., Gur, R.E., Gur, R.C., Lazzeroni, L.C., Nuechterlein, K.H., Radant, A.D.,
Seidman, L.J., Siever, L.J., Silverman, J.M., Stone, W.S., Sugar, C.A., Tsuang, D.W.,
Tsuang, M.T., Turetsky, B.I., Braff, D.L., 2018. Deficient prepulse inhibition in
schizophrenia in a multi-site cohort: Internal replication and extension. Schizophrenia
Research, Impaired sensorimotor Gating in Schizophrenia 198, 6–15.
https://doi.org/10.1016/j.schres.2017.05.013
Takahashi, H., Nakahachi, T., Komatsu, S., Ogino, K., Iida, Y., Kamio, Y., 2014.
Hyperreactivity to weak acoustic stimuli and prolonged acoustic startle latency in children
with autism spectrum disorders. Molecular Autism 5, 1–8. https://doi.org/10.1186/20402392-5-23
Weber-Stadlbauer, U., Richetto, J., Labouesse, M.A., Bohacek, J., Mansuy, I.M., Meyer,
U., 2017. 24. Transgenerational transmission and modification of pathological traits
induced by prenatal immune activation. Molecular Psychiatry 22, 102–112.
https://doi.org/10.1038/mp.2016.41
Weiser, M.J., Mucha, B., Denheyer, H., Atkinson, D., Schanz, N., Vassiliou, E., Benno,
R.H., 2016. 59. Dietary docosahexaenoic acid alleviates autistic-like behaviors resulting

225

from maternal immune activation in mice. Prostaglandins, Leukotrienes and Essential Fatty
Acids (PLEFA) 106, 27–37. https://doi.org/10.1016/j.plefa.2015.10.005
Wu, W.-L., Adams, C.E., Stevens, K.E., Chow, K.-H., Freedman, R., Patterson, P.H., 2015.
57. Wu nAChRa7 The interaction between maternal immune activation and alpha 7
nicotinic acetylcholine receptor in regulating behaviors in the offspring. Brain, Behavior,
and Immunity 46, 192–202. https://doi.org/10.1016/j.bbi.2015.02.005
Yeomans, J.S., Bosch, D., Alves, N., Daros, A., Ure, R.J., Schmid, S., 2010. GABA
receptors and prepulse inhibition of acoustic startle in mice and rats. European Journal of
Neuroscience 31, 2053–2061. https://doi.org/10.1111/j.1460-9568.2010.07236.x
Zhang, Z., van Praag, H., 2015. 105. Maternal immune activation differentially impacts
mature and adult-born hippocampal neurons in male mice. Brain, Behavior, and Immunity
45, 60–70. https://doi.org/10.1016/j.bbi.2014.10.010

226

6

Appendix
Appendix A. Epidemiological evidence connecting viral and viral-related
exposures during pregnancy with offspring risk of ASD or SCZ. ★ Exposure
timing effect, ♦ Exposure type-specific, ♣ Extent effect, ∎ Sex effect, ✖Diagnosisspecific effect, ◮Gene-environment or environment-environment interaction.

Reference

Country +

Exposure type

birth sample

Disor

Significant

der

association

ASD

Yes, measles and mumps

(Deykin and

United States, born

Viral illness (multiple, including

Macmahon,

3-27 years prior to

ssRNA and dsDNA viruses) in

but not rubella or

1979)

study for ASD

household

chickenpox

★♦

cases
(Mednick et al.,

★

Finland, 1957

Influenza epidemic exposure

SCZ

Yes, second trimester

Finland, 1957

Influenza epidemic exposure

SCZ

No

(Barr et al.,

Denmark, 1911-

Occurrence of influenza infection

SCZ

Yes, second trimester

1990)

1950

★

(Sham et al.,

England and Wales,

Influenza epidemic exposure

SCZ

Yes, second trimester

1992)

1970-1979

★

(Takei et al.,

England and Wales,

Exposure to periods of time with

SCZ

Yes, second trimester (5

1993)

1938-1965

recorded deaths from influenza

★

(Takei et al.,
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Influenza outbreak exposure

SCZ

Yes, second trimester

1994)
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★
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★

Netherlands, 1957
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Yes, for
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deaths from infectious disease
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months before birth)
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(Selten and
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SCZ
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infections

(Mino et al.,

Japan, 1957-1965

Influenza epidemic exposure

SCZ

No

(Brown et al.,

United States,
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behavioural outcomes
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infection markers (IgG) (HSV-

other

pathogens

1/2, CMV, rubella, parvovirus

♦
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psychotic

human papillomavirus type 16.)
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Australia, 1930-
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autism, but no for other

♦
♣

types of infection
investigated
ASD and

Yes for fever, no for

~1998-2008

developm

infection

(estimated from

ental

sample age range)

delays

(Zerbo et al.,

United States,

2013)

Occurrence of influenza or fever

(Nielsen et al.,

Denmark, 1978-

Occurrence of infection (stratified

2013)

1998

by organ system) or general

SCZ

exposure to infection

predisposition to infection

(not just prenatal

♦

Yes, but also for general

infection)
(Langridge et al.,

Australia, 1984-

Occurrence of urinary tract

ASD and

Yes for UTI and ID, but

2013)

1999

infection (UTI)

ID

not for UTI and ASD

(Visser et al.,

Netherlands,

Occurrence of viral/bacterial

ASD

Yes. However, for

2013)

~2000-2006

infections

factors other than

(estimated from

infection, subtype of

sample age range)

ASD altered the
association

✖
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(Abdallah et al.,

Denmark (could not

Presence of immune markers

2013)

access for birth

(Cytokines)

ASD

Yes, but associations
change based on specific
cytokine and disease

range)

subtypes
(Mamidala et al.,

India, 2010-2012

2013)

♦

Occurrence of infections

ASD

(stratified by organ system)

Yes for respiratory but
not GI or urinary tract

✖

♦

infections
(Brown et al.,

Finland, 1987-2007

2014)

Presenence of immune marker, C-

autism,

Yes, 43% difference in

reactive protein (CRP)

SCZ

risk between highest and

★

lowest CRP quartiles,

♣

first and early second
trimesters
(Børglum et al.,

Denmark, born

Presence of viral (CMV)

2014)

since 1981

infection marker (IgG, maternal

SCZ

Yes, association between
genotype and CMV, but

origin)

only for certain SNPs

◮

(neonatal blood)
(Canetta et al.,

Finland, 1983-1988

2014)

Presence of immune marker

SCZ

(CRP)

Yes, first and early
second trimesters

(Zerbo et al.,

United States,

Immune marker (cytokines and

ASD,

Yes, but depends

2014)

2000-2001

chemokines)

developm

cytokines and disorder in

ental

question (ASD or

delay

developmental

★
♦
✖

disability). Note: most
samples did NOT have
detectable cytokines
(neonatal blood)
Psychosis

Yes for prenatal vaginal

(Betts et al.,

Australia, 1981-

Occurrence of vaginal/infection

2014)

1984

discharge, infant illness

infection, association

susceptibility

involves infant illness
susceptibility

(Goldstein et al.,

United States,

2014)

Immune marker (cytokines)

SCZ,

Yes for IL-6 and TNFα,

1959-1966 (NCPP,

affective

but associations are

New England

psychosis

gender-specific and not

Family Study)

(AP)

similar for affective
psychosis. Third
trimester

♦
∎

✖
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(Engman et al.,

Swede, 2005-2008

2015)

Presence of CMV infection

ASD

Yes, higher rate of

marker (DNA in dried blood

congenital CMV in ASD

spots)

compared to general rate
in newborn infants in
Sweden (neonatal blood)

(Fang et al.,

Taiwan, 2000-2007

2015)

by organ system) and associated

bacterial infections or >2

★♦

hospital visits

visits due to genital

♣

Occurrence of infection (stratified

ASD

Yes, third trimester,

infections
(Blomström et

Sweden 1975-1985

al., 2015)

Presence of toxoplasma and viral

Non

Yes for Toxoplasma and

(CMV,HSV-1/2) infection

affective

CMV, but associations

markers (antibodies), as well as

psychosis

depends on levels of

♦

acute phase proteins

acute phase proteins

(neonatal blood)
(Zerbo et al.,

United States 1995-

Occurrence of viral or bacterial

2015)

1999

infection (stratified by organ

infections or those that

system)

required hospitalization

(Sakamoto et al.,

Japan 1994-2003

2015)

Presence of CMV infection

ASD

ASD

Yes but only for multiple

♣

Yes, higher rate of

marker (DNA in dried blood

congenital CMV in ASD

spots)

compared to general rate
in newborn infants in
Nagasaki, Japan
(neonatal blood)

(Lee et al., 2015)

Sweden 1984-2007

Occurrence of inpatient infection

ASD/ID

diagnosis

Yes, does not depend on

✖

timing, potentially
higher risk for ASD + ID
rather than ASD alone

(Mazina et al.,

Simons Foundation

ASD-

Yes, associations with

2015)

Autism Research

related

some behavioural

Initiative

phenotype

outcomes in ASD but not

s

others, no effect of

Occurrence of infection or fever

trimester
(Cheslack-

Finland, 1983-1998

Presence of sexually transmitted

SCZ

No, association does not

Postava et al.,

infection (HSV-2, C. trachomatis)

hold after adjusting for

2015)

markers (IgG)

covariates, unadjusted
values modest, early-mid
pregnancy

★
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(Canuti et al.,

United States,

Presence of viral infection marker

SCZ,

Lower viral prevalence

2015)

1959-1966 (NCPP,

(genetic sequence)

bipolar

in cases vs controls

ASD

Yes, only higher levels

New England
Family Study)
(Koks et al.,

Netherlands, 2002-

Presence of immune marker

2016)

2006

(CRP)

of CRP, association with

★

behavioural outcome

♣

measures in patients,
first-second trimester
(Blomström et

Sweden, 1978-1997

al., 2016)

Occurrence of viral or bacterial

Psychiatri

Yes but only with

infection

c

maternal risk of

disorders

psychiatric disorders

(Zerbo et al.,

United States,

Presence of immune marker

ASD and

Yes, lower CRP in ASD

2016)

2000-2003

(CRP)

developm

mothers, but no

ental

associations with

delays

developmental disability,

◮
★✖

mid-pregnancy
Psychosis

Yes, but association

(Allswede et al.,

United States,

Presence of immune markers

2016)

1959-1966 (NCPP)

(cytokines, stratified by subtype -

depends on cytokines

Th1, Th2)

and their levels (anti-

♦
♣

inflammatory Th2, >75th
percentile)
(Nielsen et al.,

Denmark 1977-

Occurrence of hospital

2016)

2002

admissions due to infection

SCZ

Yes, additive but not
synergistic effect of
infection and anemia

(Konrath et al.,

Austria or Germany

Season of Birth

2016)

Schizotyp

Yes, late winter and

al

early spring births

personalit
y
(Hadjkacem et
al., 2016)

Tunisia, 2014

Occurrence of infection (urinary
or respiratory)

ASD

Yes for prenatal urinary
tract infection and
respiratory infection,
although postnatal
infection more
detrimental than
prenatal,

◮
★
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(Brucato et al.,

United States,

Occurrence of genitourinary

2017)

1998-2013

infection, flu or fever

ASD

Yes for fever but not flu
or genitourinary tract

♦

infections
(Garofoli et al.,

Italy, 2007-2012

2017)

Presence of CMV infection

ASD

Yes (neonatal blood)

SCZ

Yes, only affecting

marker (DNA in urine/blood)

(Debost et al.,

Denmark 1980-

Occurrence of hospital

2017)

1998

admissions due to infection

females, but synergistic
effect with peripubertal

∎◮

trauma in males
(Zerbo et al.,

United States 2000-

Occurrence of viral (influenza)

2017)

2010

infection and vaccination

ASD

No

(Jones et al.,

United States,

2017)

2000-2003

Presence of immune markers

ASD/ID,

Yes, although

(Cytokines)

or devel.

associations exist for

★♦

delay

specific cytokines and

✖

dependent on disease
subtypte (ASD +/intellectual disability),
mid-pregnancy
(Mahic et al.,

Norway, 1999-2008

2017)

Presence of toxoplasma or viral

ASD

Yes for HSV2 but not

(rubella, CMV, HSV-1/2)

toxoplasma, HSV1,

infection marker (IgG)

rubella, CMV, mid-

★♦

pregnancy
(Spann et al.,

Finland, 1987-2005

2017)

Presence of toxoplasma infection

ASD

marker (IgG)

Yes for low but not high
levels of maternal

♣

toxoplasma antibody
(Gentile et al.,

Italy, ~2002-2013

Presence of CMV infection

2017)

(estimated)

marker (DNA in blood spots)

(Straughen et al.,

United States,

Occurrence of placental

2017)

2007-2014

inflammation

ASD

Yes (neonatal blood)

ASD

Yes, analysis includes
specific placental

♦

inflammation subtypes
(neonatal blood)
(Slawinski et al.,

United States,

Presence of viral (CMV, HSV2)

2018)

2008-2016

infection markers (IgG)

ASD

Yes, CMV but not
HSV2, association with

♦

behavioural outcome
measures
(Dreier et al.,

Denmark, 1996-

Occurrence of infection (stratified

Psychosis

Yes for fever,

2018)

2002

by organ system)

-like

genitourinary and

♦
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experienc

influenza, but not for

e age11yr

respiratory, no clear
effect of timing of
exposure or
symptomatology

(Hornig et al.,

Norway, 1999-2009

Occurrence of fever

ASD

2018)

(Guisso et al.,

Lebanon, subjects

Occurrence of Viral (influenza,

2018)

age 2-18 (age range

rubella, measles, mumps, CMV,

unclear, no

genital herpese) and bacterial

recruitment

(pyelonephritis, lyme disease)

more fever episodes,

★

second trimester

♣

Yes, bigger effect with

ASD

Yes

ASD

Yes for maternal fever or

timeline)
(Christian et al.,

Jamaica, start 2009

Occurrence of fever and infection

2018)

for children age 2-8

requiring antibiotics

(Mac Giollabhui

United States,

Immune markers (Cytokines)

et al., 2019)

1959-1966 (CHDS)

infection
Psychiatri

Yes, different cytokines

c

associated with different

symptoms

behavioural outcomes

★♦

childhood
(al-Haddad et al.,
2019)

Sweden, 1974-2014

Occurrence of general, severe

ASD, BP,

Yes for ASD and

infection and hospitalization

Depressio

depression but not

n

bipolar disorder, not
dependent on severity

✖
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Appendix B. Summary of interventions previously used in Poly I:C studies
Reference

Gestation

Poly I:C

Day

Dose and

Species

Intervention

9.5

2.5, 5, 10,

Symptoms
treated/prevented

Intervention category

route
(Shi et al., 2003)

Intervention name

Timing

Typical and atypical

Clozapine and

20 mg/kg

Mouse

Acute

antipsychotics

Chlorpromazine: PPI

i.p.

(Clozapine,
Chlorpromazine)

(MacDowell et

9.5

5mg/kg i.p.

Mouse

al., 2017)

Chronic,

Atypical antipsychotic

T-maze performance,

Adult

(Paliperidone)

frontal cortex
inflammatory signaling

(Shin Yim et al.,

12.5, 15.5,

20mg/kg

2017)

18.5

i.p.

Mouse

Acute,

Acute activation and

Optogenetic

inhibition of distinct

Sociability

cell types
(Hsiao et al.,

12.5

2012)
(Zuckerman et

20mg/kg

Mouse

Acute, Adult

i.p.
14.5

4mg/kg i.v.

Rat

Acute, Adult

al., 2003)

Bone Marrow

Open field, Marble

transplant

burying

Typical and atypical

Haloperidol and

antipsychotics

Clozapine: LI

(Haloperidol,
Clozapine)
(Zuckerman and

14.5

Weiner, 2005)

(abortions

4mg/kg i.v.

Rat

Acute, Adult

Atypical antipsychotic

Clozapine: LI

(Clozapine)

with 16.5)
(Klein et al.,

14.5

4mg/kg i.v.

Rat

Acute, Adult

Deep brain stimulation

PFC, dMThalamus and

(PFC, dMThalamus

Global Pallidus Deep

and Global Pallidus)

Brain Stimulation: PPI

Chronic,

Antibiotic

Hippocampal

Adult

(Minocycline)

inflammatory

2013)

(Mattei et al.,

15

4mg/kg i.v.

Rat

2014)

signaling/neurogenesis,
PPI
(Bikovsky et al.,

14.5

4mg/kg i.v.

Rat

Acute, Adult

2016)

Deep brain stimulation

NAc and PFC Deep

(NAc and PFC)

Brain Stimulation: PPI,
LI

(Osborne et al.,
2017)

14.5

4mg/kg i.v.

Rat

Chronic,
Adult

Cannabidiol

Social interaction,
NORT, Y-maze
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(Mattei et al.,

14.5

5mg/kg i.p.

Mouse

2017)

Chronic,

Antibiotic

Hippocampal microglial

Adult

(Minocycline)

profile and activation,
PPI, NORT

(Meyer et al.,

17.5

5mg/kg i.v.

Mouse

2010)
(Malkova et al.,

10.5+12.5+

2014)

14.5

(Ozawa et al.,

11.5-16.5

5mg/kg i.p.

Mouse

Chronic,

Atypical antipsychotic

Adult

(Clozapine)

MWM

Chronic,

5HT2R Antagonist

DOI response

Chronic,

Typical and atypical

Clozapine and

Adult

antipsychotic

Haloperidol: NORT

Adult
5mg/kg i.p.

Mouse

2006)

(Haloperidol,
Clozapine)
(Naviaux et al.,
2014)

12.5 + 17.5

3mg/kg on
12.5 and
1.5mg/kg
on 17.5 i.p.

Mouse

Acute, Adult

Anti-purinergic

Social Behaviour, T

(Suramin)

Maze
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Appendix C. Influence of Skewness and Kurtosis on sample bias
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Appendix D. Correlation between the probability of obtaining a biased sample
from a litter and the whole litter’s absolute skewness or kurtosis.
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Appendix E. Animal Use Protocol approval
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